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1. Abstract 
Recent years have seen the increasing development and application of protease-based sensors 
and switches in the construction of artificial signaling functions in synthetic biology. Even 
though they were extensively characterized in vitro, robust and quantitative assays to 
characterize them in vivo remains elusive. This particularly concerns assays that can provide 
real-time kinetic data on the apparent activity of proteases and protease-based sensors and 
switches in the genetically-tractable E. coli and are compatible with high-throughput screening 
formats. 
 
Scheme 1 Graphical abstract. A protease (blue circular section) is functionally expressed in E. coli and the question 
arises how to transform its catalytic activity into a quantitative, measurable read-out with the mid-term goal to 
engineer and characterize protease switches, sensors and circuits in high-throughput. 
Addressing these limitations, several different protease sensor designs featuring different types 
of fluorescent protein reporters were developed and tested over the course of the project. 
Protease-cleavable degradation tags (degrons) were identified as the best way to directly 
modulate the fluorescent output signal through proteolytic activity in E. coli. To this end, two 
different assay modes were successfully established: The first assay mode is based on a 
conventional positive read-out where the fluorescent signal scales proportionately with the 
protease activity while the second mode provides enhanced quantitative data based on a 
ratiometric two color assay. The assay was validated with the nuclear inclusion protein a (NIa) 
of tobacco vein mottling virus (TVMV) while the general utility of the assay was additionally 
validated with the NIa protease of tobacco etch virus (TEV) and the NS3 protein of hepatitis C 
virus (HCV). Finally, the assay was utilized for the preliminary screening of a library of 
opto-switchable auto-inhibited TVMV candidates.  
 
 8 
2. Motivation and aim of this project 
“We, the Stein Lab, aim to transform protein switches into generally applicable tools for 
synthetic biology. In particular we are interested in the characterization of these switches within 
their cellular context in various in vivo scenarios.” V. Stein 2019 
 
The quote above summarizes the overall goal of our group. To achieve the goal of characterizing 
novel protein switches within living cells a set of easy to adapt assays is required to evaluate 
the performance and consistence of behavior in in vivo scenarios. Therefore, the project was 
conceived to create necessary assays to characterize and engineer protease-based switches, 
signal transducers and actuators in living cells [1-3]. Furthermore theses assays could be 
employed by the SynBio community for the characterization of various other protease-based 
modules for post-translational circuits which we previously summarized [4]. With these assays 
we thought to provide a solid foundation for the development of post-translational circuits and 
the future the creation of tailor-made auto-regulated cell lines for synthetic biology or green 
chemistry approaches. 
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3. Introduction 
3.1. Synthetic biology - from basic parts to auto-regulating cells 
The main goal of synthetic biology is to devise systematic approaches to engineer biological 
functions to specification. The construction of tailored biological functions occurs through 
iterative design-build-and-test cycles. This comprises both the development of enabling 
technologies to facilitate the construction of biological systems with tailored properties and 
functions and their development into distinct biotechnological applications. 
One area of interest concerns the construction of sensors, switches and complex signaling 
functions to detect, compute and translate input signals into tailored output signals. This 
comprises the construction of individual sensors and switches that are composed of a receptor 
and an actuator that are capable of receiving a range of inputs such as light [5], small molecules 
[6, 7] or ions [8] and translate them either into a physical or physiological signal such as 
fluorescence or proteolytic activity. Based on individual protein sensors and switches, more 
complex sensory functions can subsequently be engineered in the form of logic gates, complex 
response functions or cell-cell-communication devices [9-20]. Of particular interest are circuits 
that mediate biomolecular signals entirely by post-translational means independent of 
time-consuming transcription or translation. In this regard, the previously established switches 
and signal transducers based on auto-inhibited proteases are to mention[1, 3]. As well other 
protease-based devices such as Boolean Gates [21-23] or metabolic flux control by regulating 
the abundance of enzymes [24, 25]. 
Normally, these outputs either trigger a reporter signal or a phenotypic response. In this regard, 
reporter signals are extensively used in the development and characterization of individual 
sensors, switches and circuits. Phenotypic responses are frequently developed as tools to 
regulate cell fate, morphology or the metabolic profile of the host cell. Therefore, they are often 
used in medical applications [26] or for bioecological production [27]. In case of reporters, 
there are different types of output signals available such as fluorescent proteins[28]. 
Alternatively, reporters can also be based on light-emitting luciferases. Luciferases carry the 
advantage that they can generate an optical signal directly from within the host cell 
independent of a fluorescent irradiation step [29]. The last class of reporters comprises of 
enzymes like β-galactosidase that turn over a colorless substrate into an optically active product 
and thus generate a colorimetric signal that is cost-effective and easy to detect [30]. Phenotypic 
actuators on the other hand change the viability, morphology or behavior of the host cell. Cell 
fate actuators include amongst others apoptosis inducers [31], morphology comprises amongst 
other of motility [32] or biofilm formation [33] regulators and lastly a metabolic actuator in 
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most cases is an enzyme that is activated through the synthetic device [34]. The often times 
overlooked yet crucially important class of parts are adaptors which interconnect the multiple 
parts of a synthetic device either on genetic or on protein level or direct it to its desired location. 
The first form of adapters are linkers which exist in two variants static linkers or spacers that 
keep two parts at the necessary distance from one another. Close enough for direct interaction 
or co-activity but far enough apart to avoid steric clashes or hindrances. Spacers for DNA, RNA 
or proteins are available in all sorts of lengths or mechanical stiffness [11-13]. The other form 
of linkers are anchors that tether proteins or nucleic acids to membranes or other cellular 
structures. 
Intrinsically, proteases offer a promising building platform for all parts required for all forms of 
synthetic devices. By expressing them in a non-active state (e.g. auto-inhibited) that is activated 
through an input signal a sensor module is realized. Input could be ligand binding [1] or a 
physical parameter like light (see Chapter 4.6). By introducing a different cleavage site in the 
peptide linker interconnecting the protease and the disactivating domain protease can act as 
signal transducers and or signal amplifiers. Lastly proteases can act as actuators by modulating 
protein stability. This modulation can be positive by cleaving off degradation tags (see 
Chapter 4.2) or negative by unmasking cryptic N-degrons (see Chapter 4.3). The following 
chapter describes the requirements and design principles of turning protease into synthetic 
sensors, signal transducers and actuators in further details. 
 
3.2. Proteases as promising building blocks for sensors, signal transducers and 
actuators 
Proteases are a subclass of hydrolases that have evolved to cleave peptide bonds within fully 
maturated proteins or even polyproteins. A large natural repertoire of proteases exist that 
comprise a range of functional and structural properties. This includes proteases with low 
substrate specificities, like trypsin or pepsin. On the other hand, there are sequence specific 
proteases like the viral proteases used in this work (see Chapter 4). These sequence specific 
proteases recognize short sequence motives and subsequently cleave at one specific position 
within their recognition sequence. Therefore, this recognition sequences are often called 
cleavage sites. 
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3.2.1. Potyvirus proteases 
In recent years, proteases originating of various potyviruses (EC: 3.4.22.44) have emerged as 
promising tools in synthetic biology. The most prominent one being the Nuclear Inclusion 
Protein Ia of tobacco etch virus (TEV). Two other commonly used potyvirus protease originate 
from tobacco vein mottling virus (TVMV) and sunflower mild mosaic virus (SuMMV) [21]. For 
both TEV protease (TEV) and TVMV protease (TVMV), the crystal structures were solved 
through efforts made by the Waugh Lab [35, 36]. Both adopt a chymotrypsin-like fold with a 
catalytic triad comprised of a histidine, an aspartic acid and the actual nucleophile a cysteine 
[37, 38]. A structural alignment of both structures is shown in Figure 1. SuMMV has not been 
characterized as well as its two close relatives. But the Voigt Lab has proven that SuMMV shares 
the typical high substrate specificity of potyvirus proteases with TEV and TVMV respectively. 
Hence all three may be used orthogonal to one another even though their recognition sequences 
appear quite similar (see Table 1, [21]). 
Table 1 Commonly used virus proteases and their respective cleavage sites [1, 21, 39] 
Protease 
Cleavage 
site 
TEV 
TVMV 
SuMMV 
consensus 
ENLYFQ|notP 
ETVRFQ|notP 
EEIHLQ|notP 
EX4Q|notP 
HCV DDVTPCSM|S 
SARS-CoV-2 MPro SAVLQ|SGFRK 
 
Figure 1 Structural alignment of TEV and TVMV. Structures are depicted as ribbons, catalytic triad (H46, D81, C151) 
as sticks (catalytic cysteine mutated to alanine in both structures), TEV (PDB: 1Q31) in cyan, TVMV (PDB: 3MMG) in 
tan, catalytic triad colored by heteroatom; structural alignment was performed with UCSF Chimera 1.11.2 
(MatchMaker tool). 
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All three potyvirus proteases can be functionally expressed in E. coli and readily purified from 
lysates [21]. To increase yield, these proteases are frequently fused to maltose binding protein 
(MBP) especially for the purpose of purification. MBP greatly increases the solubility of the 
fused viral protease and thereby acts as a pseudo-chaperone. The increased solubility increases 
the chances of the protease domain to adopt its proper fold. The poor solubility of viral protease 
as well as their slow folding rates originate from the fact there are neither expressed in their 
natural environment, cytosol of their original host cells, nor part of the viral polyprotein, in 
which they were evolved to properly fold. By incorporating the respective cleavage sites into 
the linker between MBP and the protease, MBP is cleaved of in situ if desired [40, 41]. 
Alternatively, chaperones may be co-expressed to increase the yield of fully functional protease 
[42]. 
Over the last six years, V. Stein demonstrated that proteases with specific recognition sequences 
can be turned into tailored molecular switches by covalently linking them with an 
autoinhibitory (AI) domain. These AI domains are derived from the actual cleavage site and act 
as competitive inhibitors. They bind to the active site of the proteases with reasonable high 
affinities but are not cleaved by it. By introduction of sensory domains into the peptide linker 
connecting the AI domain with the protease, a switch can be created. Upon input detection (e.g. 
ligand binding) the sensory domain undergoes a conformational change. Following this change 
the AI domain is removed from the active site due mechanical tension within the peptide 
backbone of the fusion protein. Hence the protease is activated, meaning it is enabled to act on 
its cleavage site. By removing the molecular input signal, the sensory domain adopts its default 
conformation once again. Subsequently the AI domain binds to active site of the protease 
rendering it inactive [1, 3, 4]. 
 
3.2.2. Flavivirus proteases 
Alternatively, proteases from flaviviruses (EC 3.4.21.98) like hepatitis C virus can be used in 
synthetic biology. These proteases offer similar sequence specificities and processivities 
compared to potyviral proteases. In contrast to potyviral proteases, flavivirus proteases are 
serine proteases[43, 44]. Like for TVMV as representative of potyvirus proteases, V. Stein 
demonstrated the general utility of this design principle for protein switches based on 
auto-inhibited protease switches with HCV NS3 protease (HCV) as a representative of flavivirus 
proteases[1, 3]. 
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3.2.3. From site-specific proteases to synthetic devices 
Naturally, those intricate designs require extensive linker optimization to ensure proper folding 
and stability of such large multi-domain fusion proteins and to enable the proper behavior in 
the presence and absence of the input signal. Addressing these limitations, we developed a new 
cloning strategy to facilitate the laborious and time-consuming endeavor of linker optimization. 
The method is particularly amenable to the co-optimization of multiple linkers in a 
multi-domain fusion protein. 
This new strategy was termed iterative Functional Linker Cloning (iFLinkC) and was published 
this year in Nucleic Acid Research[45]. iFLinkC is based on the usage of TypeIIS restriction 
endonucleases which recognize and cleave short non-palindromic sequence motifs that can be 
used to assemble DNA fragments in a direction manner. In addition, the four chosen enzymes 
(BbsI, BtsI, BsrDI and BsaI) cleave directly adjacent to their recognition sequence which renders 
them particularly amenable to the in-frame assembly of fusion proteins. The two key enzymes 
BtsI and BsrDI create essential two nucleotide long overhangs. These two nucleotide overhangs 
that are directly adjacent to the recognition sequence allow the cloning of linkers as short as a 
single glycine residue (single triple guanosine codon) between any two functional domains. For 
further details on iFLinkC refer to Chapter 6.2.9 of this thesis or the corresponding publication 
[45]. 
 
3.2.4. Excurse: Coronavirus proteases 
During the last months another family of RNA virus rose to utmost relevance. Corona viruses 
share a similar replication mechanism to the above mentioned flavivirus and potyvirus. 
Likewise, a site-specific protease exists in their viral polyprotein. Coronavirus share the usage 
of serine proteases with the flaviviruses. But unlike the flavivirus proteases coronavirus 
proteases are always monomeric[46]. In terms of inherent handling properties, this puts them 
somewhere in-between potyvirus and flaviviruses. The lack of a catalytic cysteine renders them 
less vulnerable to oxidation but offers a weaker nucleophile compared to potyviruses. The 
monomeric state increases changes of proper folding when heterologous expressed in e.g. 
E. coli. With the crystal structure from the main protease form corona virus strain SARS-CoV-2 
recently solved, the basis was set to develop potential inhibitors as precursors for drug 
development [47]. 
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3.3. Challenges in the construction of in vivo proteases assays - E. coli a preferable 
host 
The aim of this work was to develop a platform assay to assay the activity of protease switches 
in the cytosol of live E. coli cells and apply it to engineer the function of protease switches in 
high-throughput. 
E. coli has been one of the most pre-dominant host organisms in molecular biology for the last 
three decades. This stands true for modern synthetic biology as well. The advantages of E. coli 
range from fast and easy cultivation to a large repertoire of regulatory elements that can be 
readily used to express proteins in recombinant form. In terms of expressing and functionally 
assaying proteases, direct quantification of peptide bond hydrolysis in vivo is challenging and 
prone to high background noise through the general protein turn-over during cell growth. 
Therefore, most in vivo assays rely on sensors that alter their signaling behavior upon proteolytic 
processing. In addition to diffusion-based effects, cryptic signal sequences that are unmasked 
trough proteolytic cleavage can be utilized as well. In this regard, fluorescent read-outs are the 
most straight forward approach. In particular, fluorescence-based assay methods carry the 
advantage that the output signal can be measured non-invasively without disrupting the cell. 
The latter is only true when extensive and frequent irradiation with short wavelength light is 
omitted. 
Even though E. coli is a widely used host for recombinant protein expression and prototyping 
of synthetic genetic circuits, this can lead to a variety of negative effects [48]. This particularly 
applies to a reduction in growth rates and the capacity of a cell to express proteins. In addition, 
cell viability can be reduced as key components of the transcriptional and translational 
machinery, in particular RNA polymerases and ribosomes, becoming limiting upon recombinant 
overexpression of proteins and circuits [49]. In addition, the intrinsic degradation machinery 
might be overloaded by overexpression of certain circuit proteins. This overload may further 
compromise cell viability or interfere the performance of the circuit (see Chapter 4.2.1). In 
addition, the number of expression vectors is strictly limited to three at a time. This limitation 
is based on the three distinct classes of replication origins (oris) in E. coli (A – ColE1/pMB1, 
B - p15A, C - pSC101). If two plasmids with oris from the same class are present, stable 
propagation is not guaranteed even though two different selection markers are used [50]. 
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3.4. In vivo read-outs for protease activity in E. coli 
3.4.1. Fluorescent Read-outs 
In terms of suitable protease assay, extensive efforts were made to visualize proteolytic activity 
in live (mammalian) cells especially in the context of cell biology. This particularly applies to 
caspases and other proteases that have been linked with cell proliferation or oncogenesis. In 
general terms, a positive read-out in a protease assay is preferred over negative one. This means, 
upon detection of proteolytic activity a fluorescent signal should be generated instead of one 
being reduced or lost. 
Direct sensors 
One way of achieving this was elaborated by the Hardy group. They created a quenching peptide 
that promoted the controlled aggregation and formation of non-fluorescent conglomerates of 
the green fluorescent protein (GFP) when it was fused to its C-terminus. Through introduction 
of a protease cleavage site into the linker interconnecting the quenching peptide and the GFP 
proteolytic dequenching of GFP fluorescence was achieved (Scheme 2) [51-53]. 
 
Scheme 2 An in vivo gain-of-function protease assay based on the principle of fluorescence dequenching. GFP is fused 
to an aggregation inducing peptide which leads to over-aggregation and self-quenching to abolish detectable 
fluorescence. The self-quenching is terminated by proteolytic removal of the aggregation inducing peptide and 
fluorescence is restored. 
In 2013 Do and Boxer reported a protease sensor based on split-GFP. GFP11-1 was expressed 
fused to two different GFP10 β-strands. At the N-terminus, the native GFP10 β-strand was located 
while at the C-terminus the YFP10 β-strand introduced. Both β-strands are identical except for 
position 203. The native GFP possesses a threonine at this position in contrast to YFP which 
features a tyrosine here. Depending on which of the two β-strands folds into the β-barrel a 
 
 16 
different interaction partner for the central fluorophore is provided. Threonine 203 induces 
green fluorescence while tyrosine 203 induces yellow fluorescence (Scheme 3) [54, 55]. 
 
Scheme 3 A color changing split-GFP variant as a ratiometric in vivo protease sensor. GFP11-1 is fused with alternative 
GFP10 β-strands that facilitate a switching from yellow to green fluorescence. In the default state the Y203 containing 
YFP10 β-strand closes the β-barrel fold, hence a yellow fluorescence is emitted, through proteolytic activity YFP10 is 
cleaved off, allowing GFP10 to fold into the β-barrel, through this rearrangement T203 now interacts with the internal 
fluorophore changing the fluorescence from yellow to green. 
 
After linker optimization, a sensor was created carrying a protease cleavage site between GFP1 
and YFP10. In the default state, no green fluorescent signal could be observed. Following 
proteolytic cleavage, a switch from yellow to green fluorescence occurred. The dissociation of 
the YFP10 could be accelerated through irradiation with excitation light for green fluorescence 
(blue light, ~485 nm). This led to a ratiometric yellow-to-green sensor [55]. However, the 
general utility of this design is hampered through linker optimization. This is because one has 
to ensure that after altering the cleavage site the non-cleaved population remains in the yellow 
fluorescing state exclusively. Otherwise, the dynamic range of the sensor is significantly 
reduced. 
 
Other protease sensor designs exploited Förster resonance energy transfer (FRET, [56]) or 
bioluminescence resonance energy transfer (BRET, [57-59]). FRET occurs when two 
fluorophores with overlapping spectra are in close proximity and correct angular orientation to 
one another. In this case, overlapping refers to the emission peak of the donor and the excitation 
peak of the acceptor. If all three criteria (overlapping spectra, close proximity and correct 
angular orientation) are met, excitation energy from the donor fluorophore is transmitted 
emission less to the acceptor fluorophore. In other words, when the donor fluorophore absorbs 
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a photon, the resulting excitation energy is directly transferred to the acceptor fluorophore. The 
now excited acceptor fluorophore then emits a photon to reach its ground state again. Under 
ideal circumstances this leads to a scenario where upon donor excitation acceptor emission is 
exclusively detected. Through this effect, unnaturally high stokes shifts are observed (Scheme 
4) [56]. 
 
Scheme 4 Förster Resonance Energy Transfer (FRET) based protease sensors. As long as both fluorescent proteins 
remain in close proximity emission less energy transfer from the donor fluorophore (CYP in this example) to the 
acceptor fluorophore (YFP in this example) can occur, hence upon exiting the donor fluorophore mostly acceptor 
emission is observed, once a protease cleaves the interconnection linker both fluorescent proteins are separated 
through diffusion and upon donor excitation only donor emission is observed. 
 
BRET is a variation of FRET where a luciferase acts as the energy donor (Scheme 5) [57-59]. 
 
Scheme 5 Bioluminescence Resonance Energy Transfer (BRET) based protease sensors. As long as both the luciferase 
and the fluorescent proteins remain in close proximity, a transfer of energy from the donor (a blue light emitting 
luciferase in this example) to the acceptor fluorophore (CFP in this example) can occur. In the uncleaved state, mostly 
acceptor emission is observed, but once a protease cleaves the linker the luciferase and the fluorescent protein are 
physically separated so that mostly direct luciferase emission is observed 
 
 
 18 
Therefore, irradiation with potentially harmful high-intensity light is omitted, but instead is 
generated in situ through a light-emitting enzymatic reaction. However, the substrate of the 
luciferase has to be administered externally or has to be produced in situ by the cells themselves. 
The first can drastically increase the cost of the experiment or is not applicable at all if the 
substrate is not cell permeable or internalized by the cells through phagocytosis [60]. The latter 
alternative of internal production increases the metabolic burden an assay circuit imposes on 
the host cell. This in turn can reduce robustness or performance of the BRET assay. Therefore, 
BRET assays are mostly used with eukaryotic host which easily take up externally administered 
luciferase substrates through phagocytosis. In conclusion, neither FRET nor BRET is superior 
over the other [61]. 
Fluorescent proteins optimized for FRET are often referred to as “FRET pairs”. For E. coli, one 
such FRET pair is currently available and comprises a cyan fluorescent protein (CyPet) and a 
yellow fluorescent protein (YPet)[62]. When used as protease sensors, FRET/BRET pairs are 
typically connected with a linker that features the cleavage site of a protease. Hence, through 
proteolytic processing the efficiency of the FRET/BRET should decrease. This translates into a 
time-dependent loss of acceptor fluorescence and, in theory, a rise of the donor 
fluorescence/luminescence [63]. Recently, a FRET sensor was used to screen for protease 
inhibitors in vivo [64]. Based on the smallest available luciferase NanoLuc, the Merkx lab 
presented a new set of protease sensors in 2017 [65]. 
Finally, the Campbell lab created a new class of fluorescent protein sensors based on 
dimerization-dependent fluorescent proteins. The principle was termed Fluorescent Protein 
eXchange (FPX; Scheme 6). 
 
Scheme 6 Fluorescence Protein eXchange (FPX) based protease sensors. FPX biosensors rely on 
dimerization-dependent fluorescent proteins. The non-fluorescent enhancer – referred to as the “B domain” (grey) 
– lacks the fluorophore-forming amino acids but provides the essential dimerization partner for the other two 
fluorescent protein – referred to as “A domains” (red and green respectively). In the default state, all three domains 
are part of the same polypeptide chain and the thermodynamically favored dimer of Ared and B is formed; Upon 
proteolytic cleavage, the Ared domain is separate from the polypeptide chain which in turn drastically increases the 
local concentration of Agreen and results in the formation of a green fluorescent dimer 
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The sensor is comprised of three different fluorescent protein domains. Two so called 
“A domains” containing one fluorophore each. The third domain called “B domain” lacks the 
amino acids necessary for fluorophore formation. Upon dimerization with the “B domain”, one 
“A domain” emits green light while the other “A domain” emits red light. Given both domains 
compete for the dimerization interface of the single “B domain”, an equilibrium of three 
different dimerization states is achieved upon expression of the sensor. In the first state Ared 
and B dimerize, in the second state Agreen dimerizes with B and in the third state - the transition 
state - no dimer is formed. In this way, the overall fluorescence of the population depends on 
the distribution of all three states within the thermodynamic equilibrium. In order to create a 
ratiometric sensor, the Campbell lab employed “A domains” with unequal affinities towards the 
B domain. Therefore, in the default state the equilibrium is shifted towards one of the two 
dimers. Hence, the overall fluorescence of the sensor population is shifted accordingly. 
Finally, a protease cleavage site was introduced into the linker between the favored “A domain” 
and the “B domain”. Thus, upon cleavage, the favored “A domain” is separated from the 
“B domain” which drastically increases the local concentration of the disfavored “A domain”. As 
a result, the thermodynamic equilibrium of mutually exclusive binding interaction is shifted 
along with the overall fluorescent signal. In this way, a ratiometric caspase sensor was created 
[66]. Unfortunately, the soluble expression of the full-length sensor in E. coli did not turn out 
feasible (unpublished data, Bachelor thesis T. Maier, see Chapter 4.1). 
Indirect or coupled sensors 
Instead of directly measuring the cleavage through the modulation of a fluorescent sensor 
protein, protease activity can be coupled to key cellular functions such as transcription or 
translocation analogous to naturally protease-regulated processes. 
In 2017 Hahlbrock et al. published a general design principle for proteolytic translocation 
assays. The sensor comprised of a fluorescent protein (e.g. GFP) that was fused to a N-terminal 
nuclear localization sequence (NLS) and a C-terminal nuclear export sequence (NES). The 
recognition sequence for the protease of interest is cloned into the linker between the reporter 
protein and the NES. As long as both localization sequences are present, the fluorescent signal 
associated with the sensor is dispersed over the cytoplasm. Once proteolytic cleavage occurs, 
the nuclear export sequence is removed and the reporter accumulates in the nucleus resulting 
in a concentration of the fluorescent signal within the nucleus (Scheme 7) [67]. 
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Scheme 7 Proteolytic translocation assay. A fluorescent reporter protein is expressed with both a nuclear localization 
sequence (NLS) and a nuclear export sequence (NES). As long as both targeting sequences are present, the 
fluorescence is dispersed over the whole cytoplasm. But once the NES is removed through proteolytic activity, the 
NLS causes accumulation of the fluorescent reporter in the nucleus. 
Translocation assays are however limited to organisms with multiple organelles which does not 
apply to most prokaryotes. In addition, protein localization sequences must be known for any 
given host. Lastly, the throughput of translocation assays is limited as the distribution of the 
fluorescent signal needs to be tracked with subcellular resolution which is technically 
challenging to achieve by means of fluorescence microscopy. Therefore, methods like 
fluorescence activated cell sorting (FACS) or droplet microfluidics-based cell sorting are 
preferable which quantify fluorescence at a similar single cell resolution, provide high through 
put platforms and are commercially available as automated devices. 
Alternatively, proteolytic activity can be coupled to transcription instead of translocation which 
is generally compatible with greater throughput. In this case, the expression of a fluorescent 
reporter protein is modulated by the protease of interest. Different modes of regulating 
transcription through proteolysis have been published. In one example, Pu and colleagues 
engineered a protease-responsive version of T7 RNA polymerases (Scheme 8). In the default 
state, T7 RNA polymerase was fused to inactive T7 lysozyme which rendered T7 RNA 
polymerase unable to bind its promoter. Crucially, the flexible linker connecting T7 RNA 
polymerase and inactive T7 lysozyme featured a cleavage site for the protease of interest. This 
means, upon proteolytic cleavage the inactive T7 lysozyme is separated from the T7 RNA 
polymerase enabling it to bind its promoter and drive the expression of a fluorescent reporter 
protein [68]. 
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Scheme 8 Protease responsive RNA polymerases (RNA pols). In the default state, an T7 RNA polymerase is expressed 
fused to inactive T7 lysozyme that masks the promotor binding site of T7 RNA polymerase. Upon cleavage by a 
protease, the T7 lysozyme is cleaved off the RNA polymerase which in turn renders its capable to recognize its 
respective promoter and thus drives reporter gene expression (gfp in this example). 
Alternatively, transcription can be regulated by protease-responsive repressors (Scheme 9). An 
elegant way of building protease sensitive repressors utilizes transcription activator like 
effectors (TALEs) as programmable repressors. TALEs comprise a class of modular-organized 
DNA binding proteins that naturally occur in bacterial plant pathogens [69]. Notably, the DNA 
binding specificity can be readily programmed as individual modules selectively recognize 
single base independent of sequence context. In addition, the affinity of TALEs to their binding 
sequences correlates with number of repeat units of the TALE contributing to binding. TALEs 
can therefore be rendered protease-responsive by introducing cleavage sites for a protein of 
interest between individual modules. In this way, the repressor loses its affinity for its operator 
as multiple DNA binding sites are physically separated from each. Given the binding specificity 
of TALEs can be readily programmed, no specific operator sequence is required. This is 
especially beneficial for scenarios in which multiple orthogonal proteases are tested within the 
same cell or with the same reporter gene. 
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Scheme 9 Protease sensitive transcriptional repressors. Through proteolytic activity, the multiple DNA binding sites 
of a transcriptional repressor (here, exemplified with a TALE) are separated from one another rendering the 
repressor unable to suppress reporter gene expression. 
In 2016, the Pfleger lab demonstrated that a 19 repeat TALE could completely suppress 
expression driven by a constitutive variant of the lac promoter. Three TEV cleavage sites were 
introduced to the TALE repressor. This resulted in cleavage fragments with four to five repeat 
units each. This reduced the affinity of the TALE sufficiently after proteolytic processing to 
recover around 50% of the fluoresce without TALE expression [70]. 
Finally, transcription factors can be rendered protease-responsive by caging (Scheme 10).  
 
Scheme 10 Caged transcription factors. A transcription factor is expressed flanked by two split-intein fragments 
which immediately induce cyclization once the C-terminus exits the ribosome tunnel. Cyclized transcription factors 
cannot adopt their proper fold and are in turn not capable of binding their cognate repressor. Upon proteolytic 
cleavage, the transcription factor is re-linearized and thus able to adopt its proper fold in order to drive reporter 
gene expression. 
 
Caging is achieved by expressing any given transcription factor as a fusion protein that is 
flanked by two fragments of a split intein. This results in cyclization of the transcription factor 
following ribosomal exit and renders it unable to bind its operator. De-caging is achieved 
through a cleavage site for the protease of interest that is incorporated into one of the linkers 
connecting the transcription factor and one the split intein fragments. Thus, protease activity 
leads to re-linearization of the transcription factor and subsequently refolding into its active 
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conformation. The now active transcription factor can bind to its operator and drive expression 
of the reporter gene. Once again generalization of this system was achieved by employing TALEs 
as programmable transcription factors [71]. 
 
3.4.2. Non-fluorescent read-outs 
Beyond non-fluorescent read-outs, the activity of a protease can be associated with cell growth, 
for instance, by coupling cleavage to the function of an essential gene protein. In one example, 
Köhler and colleagues demonstrated this approach by using a yeast strain with a thermo-labile 
mutant of CDC25. At 30 °C normal growth occurred but by elevating the temperature to 37 °C 
CDC25 was inactivated and in turn it lost the ability to bind and activate endogenous RAS 
(yRAS) and essential membrane anchored protein. In the strain created by the authors yRAS 
was complemented by CDC25 independent human RAS (hRAS). To turn this strain into a 
protease sensor Köhler and coworkers incorporated a TEV cleavage site into the membrane 
anchor of hRAS (Scheme 11). Consequently, cell growth was abolished at the selection 
temperature of 37 °C as long active TEV was present in the cytosol. With this simply assay, the 
authors could screen TEV inhibitors in vivo with a simple colony formation assay on agar plates. 
In addition, optical density measurements of overnight cultures were performed to validate the 
colony formation assay. Even though growth-based proteolytic assays can be established 
relatively easy – provided a suitable target protein can be identified within the given host – the 
lack of real-time data and the diverse molecular factors influences on growth rates, such assays 
primarily yield qualitative data. For instance, in this particular case, it was possible to 
differentiate active from inactive protease variants and potent from mild inhibitors. In contrast, 
apparent protease kinetics or subtle differences between individual candidates typically remain 
beyond the resolution of growth assays [72]. 
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Scheme 11 Proteolytic assay based on growth. A: A thermo-labile CDC25 mutants binds to the yeast RAS (yRAS) 
protein and thereby enables cell growth, when the growth temperature is elevated from 30 °C to 37 °C CDC25 is 
inactivated and yRAS uses its activator, constitutively active human RAS (hRAS) complements the lost yRAS function 
and growth is still possible; B: the protease of interest cleaves the membrane anchor of hRAS at the selection 
temperature; non-membrane-associated hRAS is now unable to complement the lost yRAS activity and growth is 
prohibited. 
 
3.5. Degradation tags as easy-to-adapt tools to generate protease responsive parts 
for synthetic biology 
Beyond transcription, translocation or growth, protease-based activities can also be coupled to 
protein degradation. One mechanism of cellular protein degradation is mediated by the N-End 
rule which was postulated by Alexander Varshavsky as a universal mechanism to modulate the 
half-live of proteins [73-75]. The N-End rule states that the first one to three amino acids at the 
N-terminus of a protein determine its degradation rates – hence, the name N-end rule. The 
exact half-lives underlying the N-end rule vary across individual organisms, but in general terms 
small, hydrophilic and non-charged amino acids increase half-lives. In contrast, bulky, 
hydrophobic or positively charged amino acids decrease half-lives [73-75]. 
In eukaryotes the N-end rule is expanded trough several ubiquitinoylation pathways that 
contribute to increased degradation or fragmentation rates [76]. In prokaryotes however, 
ubiquitinylation does not occur. Here, the caseinolytic protease P (ClpP) complex as well as the 
soluble lon protease recognize and degrade proteins according to the N End rule. Analogous to 
the N-End rule, the C-End rule was discovered by A. Varshavsky stating that cysteine residues 
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found within unstructured C-termini of proteins drastically reduce their half-lives [77]. From 
this naturally occurring sequences, certain degradation signal sequences (degrons) were 
derived. These degrons can be fused to proteins to reduce their half-life even below the 
detection limits of expression assays or Western blots [78, 79]. 
In recent years, optimized degrons for the use in E. coli were published among others by the 
Keith and Voigt groups. The Keith group published the Ntag N-degron while the Voigt group 
published the XLFVQ N-degron and several C-degrons based on the naturally occurring ssrA 
C-degron [21, 80]. In both studies, the utility of the degrons was demonstrated in the form of 
cryptic degrons. A cryptic degron is a degron that is not directly located at the appropriate 
terminus of the protein, but unmasked through a proteolytic cleavage event and in this way 
renders the degron active. 
In 2019 the Liu group from Jiagnan University (China) beautifully demonstrated the 
combination of potyvirus proteases with strong degrons to create fast switching synthetic 
circuits for flux optimization [24]. In another recent example, the potyvirus proteases were 
used to create Boolean Gates - the simplest logic gates - required for computing multi input 
information [23]. 
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4. Results 
4.1. Initial sensor designs – FRET and FPX 
The utility of FRET or FPX sensors to probe potyvirus protease activities in E. coli was elaborated 
in the Bachelor dissertations of Tim Oliver Maier and Isabelle Marquardt. Both dissertations 
were conceptually designed and supervised by myself. 
4.1.1. Bachelor thesis Tim Oliver Maier 
Tim Oliver Maier’s Bachelor thesis was entitled “Development and Characterization of 
Genomically Integrated, Synthetic Protease Switches in E. coli”. A key goal was to validate the 
FPX sensor in E. coli. To facilitate the propagation of expression constructs in E.coli, Tim Maier 
integrated three different variants of TVMV protease (TVMV, TVMV-FKBP and MBP-TEVAI-FKBP-
FRB-TVMV) into the chromosome of E. coli BL21(DE3) cells using the modified clonetegration 
protocol [47] described in the Supplementary Methods (see Chapter 13.3.1). Constructs were 
integrated under control of different mutants of the T7 promoter with varying transcription 
activities [81]. For the majority of the integrated constructs, expression could be detected via 
Western Blotting as confirmed in Figure 2 and Figure 3. 
 
Figure 2 Western Blot and SDS-PAGE of TVMV protease variants expressed in E. coli BL21(DE3) after clonetegration. 
Samples were taken 3 hours after induction of protease expression with 500 µM IPTG. All protease constructs carried 
a C-terminal His6-tag for detection. Western Blot (left) was performed with a murine anti-His6-mAB and rat anti-
mouse mAB HRP-conjugate 0.44 µM PVDF membranes. Bands were visualized with chemiluminescence. Lane index 
of western blot and SDS-PAGE (right) refers to table below the images. Index “E” represents an empty lane. As 
positive control in the Western blot purified His-tagged MBP-TVMVsfGFP-His6 (69.9 kDa) and TVMV-His6 (27.5 kDa) 
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were used. A 12 % polyacrylamide gel with Tris/Glycin buffer system was used. As protein size standard PageRuler™ 
Prestained Protein Ladder (#26616) (ThermoFisher) was used. Western blot is positive for T7n_RBS29_MBP-TVMVTVMV-
FKBP (lane 1), T73_RBS29_MBPTVMVTVMV-FKBP (lane 2), T711_RBS29_MBPTVMVTVMV-FKBP (lane 3) (red arrow) and 
T711_RBS29_MBP-TEVAI-FKBP-FRB-TVMV (lane 4) (green arrow). Electrophoretic mobility of MBP-TVMVTVMV-FKBP 
samples (lane 1-3) correspond to the size of cleaved TVMV-FKBP (without MBP), indicating proteolytic activity of 
these TVMV variants in vivo. Predicted sizes of proteins are given in table below. For MBP-TVMVTVMV-FKBP variants 
predicted sizes for non-cleaved and cleaved proteins (referring to C-terminal cleavage fragment) are given. Figure 
and caption were adapted from the bachelor thesis of Tim Maier. 
 
Figure 3 Western Blot and SDS-PAGE of TVMV protease variants expressed in E. coli BL21(DE3) following integration 
into the chromosomal DNA of E.coli by means of the clonetegration. Samples were taken 3 hours after induction of 
protease expression with 500 µM IPTG. All protease constructs bore a C-terminal His6-tag for detection. Western Blot 
(left) was performed with a murine anti-His6-mAB and rat anti-mouse mAB HRP-conjugate on 0.44 µM PVDF 
membranes. Bands were visualized with chemiluminescence. Lane index of western blot and SDS-PAGE (right) refers 
to table below the images. Index “E” represents an empty lane. As positive control in western blot purified His-tagged 
MBP-TVMVsfGFP-His6 (69.9 kDa) and TVMV-His6 (27.5 kDa) were used. 12 % polyacrylamide gel was with Tris/Glycin 
buffer system used. As protein marker PageRuler™ Prestained Protein Ladder (#26616) (ThermoFisher) was used. 
Western blot is positive for T7n_RBS29_MBP-TVMVTVMV-FKBP (lane 1), T73_RBS29_MBPTVMVTVMV-FKBP (lane 2), 
T711_RBS29_MBPTVMVTVMV-FKBP (lane 3) (red arrow) and T711_RBS29_MBP-TEVAI-FKBP-FRB-TVMV (lane 4) (green 
arrow). Electrophoretic mobility of MBP-TVMVTVMV-FKBP samples (lane 1-3) correspond to the size of cleaved 
TVMV-FKBP (without MBP), indicating proteolytic activity of these TVMV variants in vivo. Predicted sizes of proteins 
are given in table below. For MBP-TVMVTVMV-FKBP variants predicted sizes for non-cleaved and cleaved proteins 
(referring to C-terminal cleavage fragment) are given. Figure and caption were adapted from the bachelor thesis of 
Tim Maier 
To further verify the functional expression of the integrated protease constructs, gel-shift assays 
were performed with a TVMV-cleavable MBP-GFP fusion protein serving as a substrate. To this 
end, the BL21(DE3) strains were transformed with pACYCT2_MBP-TVMVsfGFP-His6. Proteolytic 
activity was confirmed by a shift of the reporter band from 70 kDa (MBP-TVMVsfGFP) to 28 kDa 
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(sfGFP) on a semi-denaturing SDS-PAGE via in gel epi-fluorescence. Figure 4 shows the results 
of the gel-shift assays. Purified MBP-TVMVsfGFP-His6 was included as a control as well as non-
transformed BL21(DE3) cells and wild-type BL21(DE3) transformed exclusively with the 
reporter carrying plasmid. The fluorescent bands in Figure 4 do not match the actual molecular 
masses of the corresponding cleavage fragments due to incomplete denaturation. Therefore, 
the hydrodynamic radii of the proteins may vary greatly based on the degree of denaturing. 
 
Figure 4 Gel shift assay with MBP-TVMVsfGFP-His6 for detection of proteolytic TVMV activity. Fluorescence of SDS-PAGE 
gels was imaged with Amersham imager 600 RGB. Images above are overlays of three fluorescence channels (blue: 
Ex.: 460 nm/Em.:525 nm, green: Ex.:520 nm/Em.:605 nm and red: Ex.:630 nm/Em.:705 nm). GFP fluorescence was 
detected in the blue channel and is visualized by blue bands in overlay images. The able below the images states the 
samples on each lane. Empty lanes are marked with a “E”. 12% polyacrylamide gels with Tris/Glycine buffer system 
were used. As a protein size standard marker PageRuler™ Prestained Protein Ladder (#26616) (ThermoFisher) was 
used. Images were processed with ImageJ. Figure and caption were adapted from the bachelor thesis of Tim Maier. 
 
After Tim Maier verified the proteolytic activity of the non-auto-inhibited variants of the 
chromosomal integrated TVMV variants, he transformed the strains with pBS1A2 carrying the 
full-length FPX sensor under regulation of the RBS from the T7 phage gene 10 [82] and the 
constitutive Anderson-promoter J23101 (BBa_J23101, iGem registry). A schematic depiction of 
his sensor design is shown in Scheme 12. From several tested combination of promoters and 
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ribosome binding sites, this was the only combination were the GFP emission spectrum that 
showed any difference from wild-type BL21(DE3). The results of this experiments are 
summarized in Figure 5. 
 
 
Scheme 12 Schematic depiction of the FPX based sensor design used by T. Maier in his bachelor thesis. The sensor 
comprised of two dimerization dependent fluorescent protein Ared and Agreen which competed for the dimerization 
interface of the fluorophore deficient B to reconstitute their fluorescence. In the default state dimerization of Agreen 
and B should have been preferred and thereby the overall fluorescence of the population should have been green. 
Upon TVMV (blue circular section) cleavage within the linker region (blue segment representing the TVMV cleavage 
site) between B and Agreen, Agreen is separated from the fusion protein and thus intramolecular association of Ared and 
B is now preferred over intermolecular dimerization of B and Agreen. Accordingly, proteolytic activity of TVMV should 
have shifted the overall fluorescence of the population from green to red.  
 
 
 
 30 
 
Figure 5 In cell GFP and RFP emission spectra of FPX1. GFP and RFP emission spectra of cells co-expressing the TVMV-
FPX-sensor and chromosomal integrated TVMV constructs. E. coli BL21 DE3 wildtype cells as negative control. 
Measurements were performed with TECAN Spark®. Excitation wavelength for GFP emission spectrum (505 nm to 
600 nm) was 460 nm with 20 nm bandwidth. Excitation wavelength for RFP emission spectrum (605 nm – 700 nm) 
was 560 nm with 20 nm bandwidth. Fluorescence values were normalized to the OD600 of the samples. Constructs in 
this figure are the chromosomal integrated TVMV variants from Figure 2 and Figure 3 and pBS1A2_J3101_RBS_Ared-
B-TVMVAgreen-Strep. 
 
As evident in Figure 5, distinct emission spectra for GFP or RFP could now be measured after 
inducing the expression of the full-length FPX either without or with co-expression of one his 
TVMV protease constructs. Tim Maier also demonstrated that soluble expression of the three 
domain FPX sensor in E. coli was not feasible. Therefore, the focus shifted to FRET-based 
protease sensors. The rationale behind this was that in contrast to the dimerizing fluorescent 
proteins of FPX, FRET can be performed with monomeric fluorescent proteins. Therefore, it was 
though that aggregation of the sensor proteins could be reduced in E. coli. 
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4.1.2. Bachelor thesis and research internship Isabelle Annina Catherine 
Marquardt 
The widely used FKBP-FRB recruitment system where rapamycin induces the 
heterodimerization of FKBP and FRB was also integrated into the sensor construct with the aim 
of facilitating and accelerating cleavage by means of induced molecular proximity [1, 83]. This 
system was incorporated by I. Marquardt into her FRET sensor design.  
Building on the work in the dissertation of Tim Maier, Isabelle Marquardt expanded the 
repertoire of chromosomally integrated TVMV protease constructs under control various T7 
promoter variants. In her case, this included a native T7 promoter (T7n) and T7C9A (T79). The 
latter was reporter to poses a drastically reduced transcriptional activity [81, 84] . As T. Maier 
before her, she was following the modified clonetegration protocol established in our group by 
M. Röder (see Chapter 13.3.1). All integrated protease constructs showed proteolytic activity 
in vivo. For the native T7 promoter expression could be proven by Western blot analysis but for 
all constructs in vivo activity was proven via gel-shift assays. For this purpose, I. Marquardt 
cloned a new FRET based TVMV sensor using the widely used FRET pair CyPet/Ypet [62]. She 
also included the rapamycin-inducible co-localization system of FKBP12/FRB into her design. 
The sensor design and the basic assay are shown in Scheme 13. To verify the in vivo activity I. 
Marquardt performed the same gel-shift assay that T. Maier used in Chapter 4.1.1. Figure 6 
shows the result of this gel-shift assay. 
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Scheme 13 TVMV FRET sensor design used by I. Marquardt in her bachelor thesis. The sensor comprises of the FRET 
pair CyPet/Ypet and a TVMV cleavage site (blue bar) within the linker region. Adjacent to TVMV cleavage site FRB 
was inserted into the sensor to facilitate Rapamycin dependent recruitment of the FKBP12-fused TVMV to the 
cleavage site. In the default state CyPet and YPet are located in close proximity and FRET occurs, upon rapamycin 
addition (R labeled brown circle) FRB and FKBP12 form a heterodimer and thereby direct the FKBP-fused TVMV to 
its cleavage site. Upon cleavage, CyPet and YPet are separated from one another and FRET is no longer possible. A: 
FRB is located N-terminally of the cleavage site and a larger N-terminal cleavage fragment is generated. B: FRB is 
located C-terminally of the cleavage site and a smaller N-terminal cleavage fragment is generated. 
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Figure 6 Gel-Shift Assay performed by I. Marquardt to verify the in vivo activity of a TVMV-FKBP fusion construct that 
was chromosomal integrated under the control of either the native T7 promoter (T7n) or the T7C9A mutant (T79). The 
two sensor constructs tested (CyPet-FRB-TVMVYPet-His6 = CFTY and CyPet-TVMVFRB-YPet-His6 = CTFY) were expressed 
und the control of the tet promoter of pASK-IBA3. TVMV expression was induced with 500 µM IPTG while sensor 
expression was induced with 200 ng/L AHT, co-localization of protease and sensor was induced by the addition of 
25 nM rapamycin. The first inducer (see table above the gels) was added once cultures reached an optical density of 
approx. 0.3, the second inducer two hours later and rapamycin one hour after the second inducer, finally two hours 
after rapamycin addition (total expression of expression time of first component 6 hours and 4 hours for the second 
one) samples equal to 5 ODU in 40 µL were taken. 10 µL of this sample diluted 1:1 with 2x SDS loading were loaded 
per lane on to 12 % polyacrylamide gels with Tris/Glycine buffer system. Proteins were plotted on 0.44 µM PVDF 
membranes and bands were detected with a murine anti-His6-mAB and rat anti-mouse mAB HRP-conjugate. 
Visualization of bands in semi-denatured SDS-PAGE wit epi-fluorescence in three channels (blue: Ex.: 460 nm/Em.:525 
nm, green: Ex.:520 nm/Em.:605 nm and red: Ex.:630 nm/Em.:705 nm) and on Western blot with chemiluminescence. 
Constructs in this figure E. coli BL21(DE3) with T79_MBP-TVMVTVMV-FKBP-His6 and T7MBP-TVMVTVMV-FKBP-His6 
integrated into HK022 locus and pASK-IBA3_ CyPet-FRB-TVMVYPet-His6 or CyPet-TVMVFRB-YPet-His6. 
The low molecular weight of the TVMV-FKBP bands in Figure 6 B indicated functional 
expression of the TVMV fusion construct because the fused N-terminal solubility tag MBP was 
cleaved off in situ (TVMV cleavage included in the linker region between MBP and TVMV-
FKBP). Expression of TVMV-FKBP under control of the T7C9A (T79) could not be detected but 
the presence of sensor cleavage fragments in left half of Figure 6 A indicated TVMV activity. 
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The appearance of the uncleaved sensor in triple bands in in-gel epi-fluorescence (Figure 6 A) 
or double bands on the Western blot (Figure 6 B) is explained through semi-denaturing 
conditions during sample preparation to enable epi-fluorescence detection of the sensor in the 
gels. Unfortunately, the fixed channels of the used Amersham imager 600 RGB (blue: Ex 460 
nm / Em.:525 nm, green: Ex.:520 nm / Em.:605 nm and red: Ex.:630 nm / Em.:705 nm) did 
not enable differentiation of CyPet and YPet because both were excited in the blue channel. 
Therefore the in vivo emission spectrum of the sensor was measured by I. Marquardt. If FRET 
would have occurred a distinct maxim for YPet fluorescence around 530 nm would be expected 
upon excitation of CyPet fluorescence at 435 nm. The corresponding spectra for all four strains 
generated by I. Marquardt in her thesis can be found in Figure 7. 
 
Figure 7 Emission of TVMV strains created by I. Marquardt transform with pASK-IBA3_CyPet-TVMVFRB-YPet-His6 
following 3 hours of induction of the sensor with 200 ng/L AHT. The fluorescence was measured with the TECAN 
Spark plate reader and normalized to the OD600 of the wells. CyPet fluorescence was exited with 415 ± 20 nm, 
emission was quantified from 460 nm to 550 nm with a bandwidth of 20 nm. Two distinct maxima were observed at 
approx. 480 nm (λmax, em CyPet 477 nm, [62]) and approx. 528 nm (λmax, em YPet 530 nm, [62]). Spectra for chromosomal 
integrated: T7n_MBP-TVMVTVMV in light grey, T7n_MBP-TVMVTVMV-FKBP in yellow, T79_MBP-TVMVTVMV in blue, T79_MBP-
TVMVTVMV-FKBP in dark grey. Strains used in this figure: T7n_MBP-TVMVTVMV-His6, T7n_MBP-TVMVTVMV-FKBP-His6, T79_MBP-
TVMVTVMV-His6, T79_MBP-TVMVTVMV-FKBP-His6 integrated in HK022 locues of BL21(DE3). 
The spectra showed two distinct emission maxima at ~480 nm and ~528 nm which aligned 
with the emission maxima of CyPet and YPet at 477 nm and 530 nm, respectively [62]. This 
results clearly indicated that FRET was observable upon expression of the sensor construct. In 
the subsequent experiments, I. Marquardt tried to co-express both her protease constructs and 
the sensor and monitor the changes of the fluorescence intensities at the two maxima. In theory 
upon excitation with 415 ± 20 nm the emission at the CyPet emission maximum at 477 ± 20 
nm should have increased through proteolytic processing of the sensor while the emission at 
the YPet emission maximum at 530 ± 20 nm should have decreased. The modulation in 
emission intensities should have been the result of FRET abolishment through separation of 
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CyPet and YPet due to TVMV cleavage in the linker region. The result of this experiment is 
shown in Figure 8. For all strains a rise in YPet fluorescence over time was observed meaning 
despite the gel-shift assays revealed partial cleavage of the sensor no TVMV mediated loss in 
YPet fluorescence as a consequence of TVMV-mediated reduction in FRET could be observed by 
I. Marquardt. A similar increase in fluorescence intensity for CyPet was observed. This led to 
the assumption that the production rate of new uncleaved sensor overshadowed any TVMV 
mediated effects. Consequently, the FRET sensor design of I. was discarded. 
 
Figure 8 Monitoring of in vivo TVMV-mediated modulation of the fluorescent signals generated by CyPet-TVMVFRB-
YPet-His6. Data points represent the mean fluorescence intensities of dependent biological triplicates of BL21(DE3) 
strains with TVMV constructs integrated into the HK022 locus transformed with pASK-IBA3_CyPet-TVMVFRB-YPet-His6 
normalized to OD600 of the wells. Sensor expression was induced once cultures reach exponential growth phase and 
protease construct expression was induced one hour later. Measurements were started directly after protease 
expression induction (t0). Fluorescence was excited at 415 ± 20 nm and emission was measured at 477 ± 20 nm (CyPet, 
B) and 530 ± 20 nm (YPet, A). Color code is stated in the legends on the right, a no induction of protease expression 
with T7n_MBP-TVMVTVMV (-IPTG) was included as a negative control. 
 
 
 
 36 
As elucidated above, consistent changes in FRET spectra as a function of protease activity could 
not be observed by I. Marquardt even though the expression and in vivo cleavage of the FRET-
based protease sensor could be verified via in gel epi-fluorescence measurements and by means 
of Western blot analysis. 
Therefore, in order to increase the chances of success, the system was further simplified to two 
completely independent fluorescent proteins. In the linker connecting both fluorescent proteins 
(FPs), a TVMV dependent cryptic N-degron was inserted. This simplification led to the first 
design of degron-based protease sensors. In addition, a sensor design was conceived based on 
a single FP fused to a C-terminal degradation tag (C-degron). This most basic design was used 
to screen for the optimal expression conditions during the assay (see Chapter 4.2). 
4.2.  C-Degron based positive read-out protease assay 
4.2.1. Design of a two-plasmid-based in vivo assay 
For the basic sensor design, a single fluorescent protein – mNeonGreen (mNG) [85] – was fused 
to a recently discovered C-degron. The degron was identified by the Weigand Lab at our 
department in the C-terminus of splice isoform E of the human Myc associated factor X (MAX) 
and termed “E99-134”. This name refers to isoform E of human MAX and amino acid positions 
99 to 134 in that isoform. Fusion of this C-terminal part of MAX isoform E to eGFP or firefly 
luciferase lead to strong downregulation of reporter protein levels without reducing the mRNA 
abundance in human cells Based on a personal communication of on-going research a truncated 
version of the degron E118-134 selected selected as the initial model C-degron for this project. 
The amino acid sequence of E118-134 was FGTWACRVRASHGVCAQ. As expected from C-
degron at least one cysteine residue was present in a putative unstructured sequence. 
Because previous findings indicated that TVMV fusion proteins might have impaired activities, 
all possible combinations and relative orientations of domains both in the sensor and the 
protease constructs were cloned and tested. 
Based on previous findings demonstrating that active TVMV recruitment can accelerate 
cleavage, the FKBP/FRB system was integrated into both the sensor and the protease constructs 
[1, 3]. The general design principle of the assay is depicted in Scheme 14 featuring a minimal 
set of functional domains necessary to conduct the assay. 
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Scheme 14 General design of the single FP C-degron assay for sequence specific proteases. mNeonGreen (mNG) is 
tagged with a C-degron (orange circle). Left: The sensor is expressed and the degron induces rapid degradation (Ø) 
of the sensor to suppress a fluorescent signal in the cell. Center: The protease of interest (blue circular sector) is co-
expressed with the sensor. The two-component recruitment module (teal rectangular section and teal triangle) 
directs the protease to the sensor and the protease binds to its cleavage site (blue part of the linker). Right: The 
protease cleaves off the C-degron and the fluorescent sensor can accumulate and generate a fluorescent signal in 
the cell. 
In the first design iteration, the rapamycin-dependent FKBP-FRB recruitment module was 
tested. Recruitment was included to accelerate the rate of proteolytic cleavage through the 
rapamycin induced colocalization of the TVMV and its substrate. In addition, a recently 
established protein co-expression system (unpublished results by W. Weber) was employed to 
facilitate the stable co-expression of both the protease and the sensor. This co-expression system 
is based on the well-established pPRO24 vector originally created by the Keasling group [87] 
and the pCtrl2 vector that was created in the AG Stein and derived from pACYCT2 [88]. 
pCtrl2 possesses pACYCT2’s class B p15A ori and its chloramphenicol resistance. The key 
difference is the expression cassette: While pACYCT2 features a leaky dual expression cassette, 
pCtrl2 is an extremely tight single expression vector. In addition, protein expression in E. coli 
BL21(DE3) cells was controlled by a lacI/lacO system and driven by the T7 promotor. 
Furthermore, the multiple cloning site (MCS) was flanked by three transcriptional terminators 
on each side to prevent any form of leaky expression. The dual expression system is summarized 
in Scheme 15 while a detailed view of the expression cassette is shown in Figure 9. 
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Scheme 15 Dual expression system for the stable, independent co-expression of a protease and its substrate in 
E. coli BL21(DE3) cells. Origins of replication (oris) in yellow, selection markers in mint green, repressors in purple, 
genetic elements in grey and coding sequences in colors matching their gene product. Left: pPRO24 (Pprp/prpR, class 
A ColE1 ori, AmpR) for propionate inducible expression of protease constructs. Right: pCtrl2 (PT7-lacO/lacI, class B 
p15A ori, CamR) for IPTG/lactose inducible expression of sensor/substrate constructs.  
 
Figure 9 Expression cassette of the newly constructed pCtrl2 (pCtrl2 was generated by W. Weber, unpublished 
results). The expression cassette was cloned between a NcoI and a NdeI restriction site, a XbaI site is located between 
the operator and ribozyme binding site (RBS). T7 promoter in white, lac operator in cyan, RBS in grey and Start-
Codon in blue, restriction sites are annotated above the DNA double strand. pCtrl2 was created on the basis of 
pACYCT2 by W. Weber. Figure was created with SnapGene (GSL Biotech LLC). 
4.2.2. Effect of Rapamycin-Dependent Recruitment based on the FKBP-FRB 
module 
In order to differentiate fluorescence generated from prematurely terminated translation of the 
sensor or cleavage of the degron through unspecific proteases, a mock control was included for 
every protease construct tested. In case of TVMV, the mock was the catalytically inactive C151A 
variant. This single amino acid substitution stripped the protease of its catalytic nucleophile and 
thereby rendered it inactive without negatively impacting its capacity to fold [36]. In this way, 
an identical metabolic burden could be imposed as the exact same proteins were translated 
except that the catalytic cysteine residue was replaced by a catalytically inactive alanine residue. 
In the first set of experiments, three parameters were subsequently tested: (i) the influence of 
the relative orientations of domains on the performance of TVMV was examine, (ii) the effect 
of adding rapamycin and, in this way, induce co-localization of the protease with its substrate, 
and (iii) whether it made any difference if FKBP was fused the protease and FRB to the sensor 
or vice versa. 
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As a positive control for each individual sensor construct, a version without the E118-134 
C-degron was included. The results for one of the tested relative orientations are exemplarily 
shown in Figure 10. Furthermore, experiments concerning the relative orientation of domains 
and the effect of rapamycin-dependent effects are summarized in Table 2. The data for all 
measured orientations can be found in the supplementary figures (Figure S1 to Figure S6). 
Even though rapamycin was added at a concentration of up to 250 nM – while the KD for 
complex formation is in the low nanomolar range [83] – no significant effect of induced 
colocalization was detected. Accordingly, rapamycin was omitted from this point onward in 
order to keep the cost per assay within reasonable limits. 
 
 
Figure 10 Effect of induced co-localization based on the rapamycin-dependent FKBP-FRB protein-protein interaction 
module. A: Schematic depiction of the assay, elements as in Scheme 14, except constitutive recruitment is replaced 
through rapamycin dependent heterodimerization of FKBP and FRB. B: Exemplary data for the relative orientation 
of TVMV-FRB in conjunction with FKBP-mNG-TVMVE118-134. Active TVMV depicted as filled triangles; inactive 
TVMVC151A (mock controls) as empty triangles; positive controls without E118 134 C-degron in grey; actual sensor 
constructs with E118-134 C-degron cloned to the C-terminus in green; all data points represent the mean values of 
three dependent biological replicates measured; the error areas depict the standard error of the mean (SEM) in colors 
matching the corresponding data points, dark checkered areas belong to data sets of active TVMV constructs, plain 
areas belong to data sets of inactive TVMVC151A constructs, rapamycin concentration used stated above the 
corresponding graph, legend at the bottom refers to all graphs. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
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pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein 
Sequences are stated in the supplement (see 13.4.1). 
 
Table 2 FKBP/FRB orientation screening and effect of rapamycin on the protease performance. Rapamycin: positive 
effect (+), negative effect (-) no effect (o). Promising results marked with grey-shading. 
Protease construct Sensor construct Performance Rapamycin 
FRB-TVMV FKBP-mNG-TVMVE118-134 Fluorescence independent of protease activity o 
 mNG-TVMVFKBP-E118-134 Fluorescence independent of protease activity o 
 mNG-FKBP-TVMVE118-134 No expression with degron o 
TVMV-FRB FKBP-mNG-TVMVE118-134 
Protease slightly increases fluorescence 
compared to mock 
o 
 mNG-TVMVFKBP-E118-134 Fluorescence independent of protease activity o 
 mNG-FKBP-TVMVE118-134 No expression with degron o 
FKBP-TVMV FRB-mNG-TVMVE118-134 Fluorescence independent of protease activity o 
 mNG-TVMVFRB-E118-134 Fluorescence independent of protease activity o 
 mNG-FRB-TVMVE118-134 Fluorescence independent of protease activity o 
TVMV-FKBP FRB-mNG-TVMVE118-134 
Protease slightly increases fluorescence 
Compared to mock when Rapamycin is 
present 
+ 
 mNG-TVMVFRB-E118-134 Fluorescence independent of protease activity o 
 mNG-FRB-TVMVE118-134 Fluorescence independent of protease activity o 
 
In order to assess whether low degradation rates or high background fluorescence of free 
riboflavin in the LB medium were the cause of the high fluorescence intensities measured for 
the mock control, the culture medium during the assay was switch to riboflavin free M9 minimal 
medium. In order to omit catabolite repression, switching to a minimal medium also required 
the selection of a carbon source that is compatible with the underlying expression system. In 
2014 Aidelberg et al. unveiled the hierarchy of non-glucose sugar uptake and utilization. This 
hierarchy manifests itself in a characteristic repression cascade that forms part of catabolite 
repression. As long as a higher order sugar is present, all genes for uptake and utilization of 
sugars lower in the hierarchy are repressed [89]. Catabolite repression plays a key role in 
heterologous gene expression in E. coli when promoters of sugar operons, like the widely used 
lac promoter, are driving gene expression. The latter always applies to vectors harboring the T7 
promoter – as is the case for pCtrl2 – because the chromosomal integrated T7 RNA polymerase 
is generally under the control of the T7 promoter in E. coli BL21(DE3). The effect of the sugar 
hierarchy is amplified during cultivation of E. coli in minimal media like the M9 medium 
selected for all further experiments. 
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Based on the findings of Aidelberg and colleagues as wells as tests within our group (research 
Internship I. Marquardt) arabinose was chosen as the carbon source for all experiments in M9 
medium in this work [89]. Additionally, the effect of the genetic background was estimated by 
changing the host strain from BL21(DE3), a lonp- B-strain, to a lonp+ K-strain. 
4.2.3. Effect of lonp+ Genetic Background 
KRX was chosen as a BL21(DE3) replacement because it also harbored a chromosomal 
integrated T7 RNA polymerase with the only difference was that in case of KRX, the T7 RNA 
polymerase expression was under control of a rhamnose-inducible promoter. 
The rationale behind this decision was the thought that the strong over-expression driven by 
the T7 promoter could have overloaded the crippled degradation machinery of BL21(DE3). 
Based on the findings summarized in Table 2, the combination of TVMV-FRB and 
FKBP-mNeonGreen-TVMVE118-134 was chosen as the most promising candidate for further 
improvements. Therefore, these relative orientations were tested in minimal media and with 
cells of the lonp+ E. coli strain KRX. 
In addition, an auto-fluorescence control was devised in order to estimate to what extent 
endogenous riboflavin affected the fluorescent signal in the assay. For this control, cells were 
co-transformed with a protease construct in pPRO24 and with pCtrl2 containing mKOκ a 
non-green fluorescent protein. This control should impose a similar metabolic burden on the 
cells and provide an estimate of any background fluorescence that would arise independent of 
the expression of a fluorescent protein. 
Figure 11 shows the increase in mNG fluorescence over time under the conditions tested. In LB 
medium both strains performed similar: This means, BL21(DE3) displayed higher overall 
expression levels compared to KRX even higher than the detection limit of the plate reader 
which is why some data points in the left graph of Figure 11 A are missing. Figure 11 B shows 
the same data but in M9 minimal medium. The lack of data for KRX in M9 minimal medium 
was caused by a lack of thiamine in the medium which is non-essential for BL21(DE3) but 
essential for KRX. But the results in LB medium indicate that the Lon protease present in KRX 
has no significant impact on the dynamics of the assay. 
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Figure 11 Effect of genetic background and media composition on assay dynamics. Constructs, colors and symbol as 
in Figure 10 except orange triangles depict results for E. coli auto fluorescence control mKOκ as non-green fluorescent 
mNG substitute; tested conditions riboflavin containing LB medium (yellow) vs riboflavin free M9 minimal medium 
(transparent), additional lon- B-strain BL21(DE3) (grey rods) vs lonp+ K-strain KRX (red rods). A: Comparison of lonp- 
BL21(DE3) and lonp+ KRX in LB complex medium. B: Comparison of lonp- BL21(DE3) and lonp+ KRX in M9 minimal 
medium. Data points represent the mean values of dependent biological triplicates measured, the error areas depict 
the SEM, strain and cultured medium used stated above the corresponding graph, legend at the bottom refers to all 
four graphs. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-
TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.1). 
 
4.2.4. Effect of Temperature 
Therefore, another parameter was varied in the following set of experiments, temperature. The 
reason behind this was the idea thermal stress could increase the effectiveness of the degron 
and thereby the dynamic range of the sensor. Figure 12 shows the results for three 
temperatures tested in addition to the previously used 30 °C. 25 °C was chosen to simulate cold 
stress while still allowing cell proliferation. 37 °C was chosen because it is the optimal growth 
temperature for E. coli. Lastly, 40 °C was chosen to simulate heat stress while not outright killing 
the bacteria. The temperature experiments were performed in M9 minimal medium to keep 
background fluorescence as low as possible. 
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Figure 12 Effect of temperature on assay performance. Constructs, colors and symbols as in Figure 11. The analogue 
rod thermometers symbolize the induced thermal stress levels, color code: blueish color for cold stress, green color 
for optimal growth temperature and red color for heat stress. Experimental results for the four different 
temperatures (25, 30, 37 and 40 °C) tested. Data points represent the mean values of dependent biological triplicates 
measured, the error areas depict the SEM, incubation temperatures during assay stated inside the thermometers, 
legend at the bottom refers to all four graphs. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
pPRO24_MBP-TVMVTVMVC151A-FRB pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein 
Sequences are stated in the supplement (see 13.4.1) 
At 25 °C, very low growth rates were observed which led to rather high normalized fluorescence 
values. Compared to 30 °C however, the dynamic range was substantially reduced as both green 
curves aligned nearly perfectly. At 37 °C, the assay already reached saturation after two hours. 
The degron seemed to actively reduce expression and the protease was able to recover some of 
the lost fluorescence. Overall however, no significant improvement was achieved compared to 
30 °C. At 40 °C, the E118-134 degron exerted the highest effect on the normalized fluorescence 
– in this case, the greatest difference between the no-degron-controls (grey curves in Figure 
12) and the actual sensor with the degron fused to the C-terminus (green curves in Figure 12) 
was achieved. However, TVMV seemed to be completely inactivated at this point, which is seen 
by both green curves near to completely align. 
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In summary, alteration in incubation temperature proved not to be an expedient strategy to 
increase the dynamic range of the assay. Therefore, the focus was shifted towards the 
production rate of the sensor. It seemed plausible that by reducing the expression rate of the 
sensor the dynamic range of the assay should have increased by reducing the abundance levels 
of degron tagged sensor in presence of the inactive TVMVC151A. 
 
4.2.5. Effect of sensor production rate through IPTG Titrations 
Until now, an isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration of 500 µM was used 
to express proteins in BL21(DE3) under control of the T7-promoter-lacO system. To examine 
how variable expression of the sensor affects the dynamics of the assay, a serial dilution of IPTG 
was performed. This resulted in a final concentration of IPTG in culture medium that ranged 
from 500 µM down to 0.03 µM. Figure 13 shows the results for the four highest IPTG 
concentrations for which a mNG fluorescent signal could be detected. In contrast, in the lowest 
four concentration, the normalized mNG fluorescence values showed no increase in the 
fluorescent signal even decreased overtime as cell density rose without any fluorescence signal 
rising (see Figure S7). 
As expected, the overall fluorescence values decreased with decreasing inducer concentration. 
The negative control (TVMVC151A-FRB + E118-134, empty green triangles) consistently showed 
the lowest normalized fluorescence values. The two positive controls – TVMV and TVMVC151A 
FRB – with no degron attached (grey filled and empty triangles) showed the highest standard 
error of the mean between the triplicates measured. In addition, in all cases the TVMVC151A 
positive control (empty grey triangles) surprisingly deviated from the TVMV positive control 
(filled grey triangles). Overall, this indicated that titration of the IPTG inducer seemed to be 
too error prone to yield quantitative results. But the general idea to reduce expression of the 
sensor in order to increase the dynamic range appeared to be a promising route for 
optimization. 
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Figure 13 Summary of titrating the sensor with IPTG from 500 µM to 7.8 µM in the culture medium during 
measurements in 1:4 dilution steps. Concentrations from 1.95 to 0.03 µM are found in Figure S7. Constructs, colors 
and symbols as in Figure 12. A: Schematic depiction of the experiment, by reducing the IPTG concentration the 
amount of T7 RNA polymerase was reduced that should in turn decrease the expression rate of the sensor. B: 
Experimental results on the effect of lowered IPTG concentration on the dynamics of the assay. Data points represent 
the mean values of independent biological triplicates, the error areas depict the SEM, the final IPTG concentration in 
the medium stated above the corresponding graph, legend at the bottom refers to all four graphs. Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-
E118-134, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.1). 
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4.2.6. Effect of DMSO on the Bio-availability of Rapamycin in E. coli 
Based on an article on FRB/FKBP filament formation in live E. coli cells, the DMSO 
concentration in the assay was elevated from 0.5 %(v/v) to 2 %(v/v) to match the values in 
this publication [90]. The authors demonstrated rapamycin dependent association of FKBP and 
FRB in live E. coli cells. Which was elusive with the assay to that point in time. The only 
difference between their experiments and the assay was that their lower concentrated 
rapamycin stock solution led to 2 %(v/v) DMSO in the medium when 8 µM rapamycin were 
administrated while our stock solution led to only 0.5 %(v/v) DMSO in the culture medium. 
Figure 14 shows the results with and without 8 µM rapamycin administered with 2 %(v/v) 
DMSO present in the medium regardless of rapamycin was added or not. 
As visible in Figure 14, there was no significant difference in the development of the fluorescent 
signal in the presence or absence of rapamycin. But without a suitable Rapamycin biosensor 
available the question whether the recruitment made no difference or rapamycin could not 
accumulate in sufficient amounts within the cytoplasm could not be conclusively answered at 
this stage. 
Following changes in the genetic background, temperature and concentrations of the inducer 
had no substantial effect on the dynamic range, a literature search was performed to identify 
more potent degrons that previously proved effective in E. coli. To this end, the LVA C-degron 
(Sequence: AANDENYALVA [21]) which was derived from the naturally occurring ssrA degron 
(Sequence: AANDENYALAA [91, 92]) by the Voigt Lab was chosen as the lead candidate. In the 
first try, its effect on the dynamics of the assay was compared relative to the newly discovered 
E118-134 C-degron. 
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Figure 14 Effect of increased DMSO concentration on rapamycin-induced colocalization of the protease and the 
sensor. Constructs, colors and symbols as in Figure 11. A: Schematic depiction of the experiment, identical assay 
conditions as in Figure 10 except DMSO concentration was increased from 0.5 %(v/v) to 2 %(v/v) with the aim of 
increasing the bio-availability of rapamycin in E. coli cells (dark grey rounded rod-shaped border). B: Experimental 
results for the effect of DMSO in the culture medium during measurements. Data points represent the mean values 
of dependent biological triplicates measured, the error areas depict the SEM, rapamycin and DMSO concentrations 
stated above the corresponding graphs, legends at the bottom refers to all graphs. Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-
E118-134, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.1). 
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4.2.7. New C-Degron LVA 
After altering the assay conditions did not seem a promising route to success, the E118-134 was 
replaced by a putative stronger one in the form of the LVA C-degron that has been derived from 
the naturally occurring ssrA degradation tag [21]. To allow for an accurate comparison, all 
constructs remained unchanged except that the E118-134 degron was replaced with the LVA 
degron. Figure 15 shows the direct comparison of both degrons in M9 minimal medium and at 
30 °C. As apparent in Figure 15, both degrons performed nearly identical. Therefore, it was 
concluded that the T7 promoter-based expression rate greatly exceeded the degron induced 
degradation rates. Derivates of the original pCtrl2 with mutations in either the T7 promoter or 
in the ribosome binding site (RBS) or both were tested. These mutations should reduce sensor 
production in a more uniform and less error-prone manner compared to the previous IPTG 
titrations (see Chapter 4.2.5). 
 
Figure 15 Direct comparison of the C-degrons E118-134 and LVA. Constructs, colors and symbols as in Figure 14, 
except LVA C-degron was introduced (light green triangles). B: direct comparison of both degrons in M9 medium at 
30 °C, Data points represent the mean values of dependent biological triplicates measured, the error areas depict 
the SEM, degron used stated in the respective pictograms. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_FKBP-mNG-TVMV-
LVA, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.2). 
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4.2.8. Optimizing Expression of the Protease Sensor 
Based on findings shown Figure 16 and the other pCtrl2 derivatives tested (data can be found 
in the supplement in Chapter 13.2.5 in Figure S15 to Figure S17), pCtrl2_T7.03_U9 was 
chosen as the standard expression vector for all sensor constructs throughout this project. It is 
comprised of a T7 promoter mutant with 3% transcription activity compared to the wild type 
T7 promoter [84] and an RNA thermometer which reduces the translation activity to 5% 
compared to the unmasked RBS [93] (see Table 9). In total, this should have led in theory to 
99.8% reduction in total protein production rate. 
As evident in Figure 16, the sensor production rate of pCtrl2_T7.03_U9 was sufficiently low 
that proteolytic activity of TVMV triggered a substantial increase in mNG fluorescence (filled 
green triangles in Figure 16) relative to the corresponding mock controls TVMVC151A constructs 
(empty green triangles in Figure 16). However, the LVA induced degradation rates seemed to 
exceed the proteolysis rates of TVMV. As visible in the right graph of Figure 16 B, TVMV was 
unable to fully restore the mNG fluorescence compared to the corresponding positive control 
(filled grey triangles). The achieved fold changes and actual normalized fluorescence values 
were nevertheless considered sufficiently high to keep pCtrl2_T7.03_U9 as the expression 
vector for all future sensor constructs. The updated version of the standard dual expression 
system is depicted in Scheme 16 and Figure 17 shows a detailed view of the updated 
expression cassette of pCtrl2. 
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Figure 16 Effect of reduced transcription and translation rates for the sensor on the assay dynamics. Constructs, 
colors and symbols as in Figure 15. A: Schematic depiction of the experiment, several different variants of pCtrl2 with 
different mutation in either the T7 promoter of the ribosome binding site (RBS) or an RNA thermometer partial 
masking the RBS at 30 °C were tested (data not shown). B: Experimental results for the original pCtrl2 vector and the 
best performing derivative pCtrl2_T7.03_U9. pCtrl2_T7.03 bore a mutation in the T7 promoter that reduced 
transcription to approx. 3 % compared to the wild type [84], additional the previously used RBS was replaced with 
U9 RNA thermometer that possessed a approx. 5 % probability to adopt the open conformation at 30 °C [93]; Data 
points represent the mean values of dependent biological triplicates measured, the error areas depict the SEM, pCtrl2 
derivate used stated above the corresponding graph, legend at the bottom refers to all graphs. . Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB, MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, 
pCtrl2_FKBP-mNG-LVA, pCtrl2_mKOκ, pCtrl2_T7.03_U9_FKBP-mNG-TVMV, pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134, 
pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein Sequences are stated in supplement (see 
13.4.3). 
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Scheme 16 Dual expression system for the stable, independent co-expression of proteases and their substrates in 
E. coli BL21(DE3) cells version 2. Origins of replication (oris) in yellow, selection markers in mint green, repressors in 
purple, genetic elements in grey and coding sequences in colors matching their respective gene products. Left: 
pPRO24 (Pprp/prpR, class A ColE1 ori, AmpR) for propionate inducible expression of protease constructs. Right: 
pCtrl2_T7.03_U9 (PT7-lacO-U9/lacI, class B p15A ori, CamR) for IPTG/lactose inducible expression of sensor/substrate 
constructs. 
 
 
Figure 17 Expression cassette of the selected pCtrl2 variant pCtrl2_T7.03_U9. The wild type T7 promoter was replaced 
with a mutant with a single T-to-C mutation [84] and the ribozyme binding site (RBS) was replaced with the synthetic 
U9 RNA thermometer [93]. The expression cassette was cloned between a NcoI and a NdeI restriction site, the XbaI 
site was lost during insertion of the RNA thermometer. T7 promoter mutant in white (T-to-C mutation marked with 
a grey rectangle), lac operator in cyan, synthetic U9 RNA thermometer in violet (Shine-Dalgarno (SD) sequence as a 
grey bar and anti-SD sequence as a grey bar) and Start-Codon in blue, restriction sites above the DNA double strand. 
pCtrl2_T7.03_U9 was created on basis of pCtrl2 by W. Weber, Figure was created with SnapGene (GSL Biotech LLC). 
4.2.9. Effect of induction regime on assay dynamics 
The new expression system enabled a clear differentiation between catalytically-inactive and 
catalytically-active protease variants. But as visible in Figure 16, there was an approximately 
three-hour lag phase between the initiation of protein expression at 0 h and the first time point 
where the signals for the positive controls, the active protease and the inactive, mock protease 
(negative control) started to diverge. 
In order to reduce this delay, an additional incubation step at 30 °C was therefore introduced 
after protease induction but before sensor induction. The incubation times were 0 h (i.e. no 
change to previous approach) 2 h, 4 h and 6 h. The results from this four sets of measurement 
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are shown in Figure 18. The inverted induction order had been tested already during a research 
internship in our group and led to complete abolishment of protease production if propionate 
was added after IPTG (see Bachelor dissertation of Isabelle Marquardt). 
 
Figure 18 Effect of delaying the expression of the sensor relative to the protease. Constructs, colors and symbols as 
in Figure 16. A: Sodium propionate was added at t0 to induce expression of the protease constructs. IPTG was added 
after 0, 2, 4 or 6 h (vertical dashed green line in the graphs in B). B: Experimental results for the postponed sensor 
induction; the dotted horizontal line shows the corrected baseline (autofluorescence subtracted from normalized 
fluorescence values), vertical dashed black lines depict the range in which the slope of linear increase in fluorescence 
was calculated by linear regression. Data points represent the mean values of dependent biological triplicates 
measured, the error areas depict the SEM, time interval between protease expression induction at t0 and sensor 
expression induction stated above the corresponding graph, legend at the bottom refers to all graphs. Constructs 
used: pPRO24_MBP-TVMVTVMV-FRB, MBP-TVMVTVMVC151A-FRB, pCtrl2_T7.03_U9_FKBP-mNG-TVMV, 
pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134, pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein 
Sequences are stated in supplement (see 13.4.3) 
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Based on the developing the normalized mNG fluorescence, over time the slope of the linear 
increase in fluorescence was calculated via a linear regression. The dashed black lines indicate 
the time intervals in which a sufficient linear correlation (R2 ≥ 0.9) was observed. 
The slope of the curves in those intervals was used to estimate and compare the apparent 
protease activities depending on the degron used. Figure 19 shows the calculated slopes 
ordered by duration of the sensor induction postponement for three of the tested time intervals. 
The results for the six-hour postponement were omitted because the low overall expression 
levels did not allow any reliable interpretation of the data. Based on the calculated slopes, the 
apparent protease activity in vivo quantified in terms of the fold-change difference between 
active and inactive protease construct. 
 
Figure 19 Slopes of the linear increase in normalized mNG fluorescence depending on the time interval between 
protease and sensor expression induction. Values for the six-hour interval were omitted. Bars represent the mean 
slope the dependent biological triplicates measured, error bars show the standard error of the mean (SEM). Grey: no 
degron present, dark green: E118-134 C-degron present, light green: LVA C-degron present; filled bars TVMV-FRB 
(active protease), empty bars: TVMV(C151A)-FRB (inactive protease, mock control). Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB, MBP-TVMVTVMVC151A-FRB, pCtrl2_T7.03_U9_FKBP-mNG-TVMV, pCtrl2_T7.03_U9_FKBP-
mNG-TVMVE118-134, pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein Sequences are stated in 
supplement (see 13.4.3) 
 
 
 54 
As expected, a 1-fold change in slope was observed for the positive controls – i.e. without any 
degron fused to the sensor (gray bars in Figure 19). As in previous experiments, TVMV was not 
able to fully restore mNG fluorescence when the LVA degron was employed (light green curves 
in Figure 18, light green bars in Figure 19). Consistent with previous experiments, fluorescence 
was fully restored when the weaker E118-134 degron was used (dark green curves in Figure 
18, dark green bars in Figure 19). Furthermore, significant mNG fluorescence was detected for 
the mock control TVMVC151A only when the E118-134 degron was used. This further confirmed 
that the E118-134 degron was weaker compared to LVA. But apparent protease activities 
received for both degrons showed increased fold changes with increasing time intervals 
between the induction of the protease and the expression of the sensor respectively. 
Even though a 4 h delay displayed the highest fold-changes (paired bars in Figure 19) and the 
shortest delay between the initiation of sensor expression and the subsequent rise in the 
fluorescent signal (Figure 18), a 2 h delay was ultimately chosen for the following reasons: 
First of all, the duration of individual experiments was reduced. Secondly, the absolute 
fluorescent signal values were not significantly reduced compared to when the sensor and the 
protease were expressed simultaneously that in terms of autofluorescence provided better 
signal-to-ratios. In addition, all subsequent measurements were started upon induction of the 
sensor rather than the protease to reduce occupation of the plate reader. Finally, the assay times 
were reduced to 6 h (which corresponds to the 8 h time point in Figure 18) as fluorescent 
signals either became stable or started to decline as cells entered the later growth phases. 
Furthermore, the next set of experiments was conducted with the mNG-based C-degron sensors, 
but this time the rapamycin-dependent FKBP12-FRB module was replaced with a constitutive 
Src Homology 3 (SH3) protein-peptide interaction module. This change enabled constitutive 
recruitment independent of an external stimulus. In addition, the SH3 recruitment was 
previously used in combination with TVMV based switches [1, 3]. 
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4.2.10. SH3 Recruitment Effect of Relative Orientation on Assay Dynamics 
Src Homology 3 (SH3) domains bind are commonly found in many proteins and mediated 
protein-protein-interaction by binding to proline rich peptide motive. The binding affinities are 
dependent on the number of proline residues with the peptide motive. Additional positively 
charged residues within the proline-rich motive can further enhance binding affinities [94]. 
Based on previous results two different ligands for the SH3 domain were tested. One with a 
high affinity (KD = 96 nM, sSH3L) and one with a low affinity (KD =2 µM, wSH3L) [3, 94]. To 
reduce steric hindrance the small SH3 peptide ligands were fused to the protease while the 
larger SH3 domain was incorporated into the sensor. 
All constructs were cloned analogues to the FKBP-FRB constructs listed in Table 2. In contrast 
to Chapter 4.2.2 where the orientation was screen with a single degron, this time it was 
performed with the E118-134 and LVA degrons and both SH3 peptide ligands. The results for 
the best performing orientation are shown in Figure 20 in full detail while Table 3 summarizes 
the results for all other orientations tested. For clarity, the results from Figure 20 are 
highlighted with grey-shading in Table 3. From the two sets with the highest fold changes for 
both degrons (sSH3L- TVMV with SH3-mNG-TVMVdegron or mNG-TVMVSH3-degron).  The 
combination of sSH3L-protease and SH3-mNG-TVMVdegron was selected for further analysis 
because the SH3-mNG-TVMVdegron sensor design displayed the highest overall fluorescence 
values. 
Table 3 SH3 based recruitment - relative orientation screening. All tested relative orientation sorted after the 
respective protease construct. The first column lists the protease constructs, the second the sensor constructs, the 
third column states the fold change in mean slope of the normalized mNG fluorescence averaged over the measured 
dependent biological duplicates of two independent experiments. Relative orientation chosen for further 
experiments as well as featured in Figure 20 is highlighted with grey-shading 
Protease 
construct 
Sensor construct 
Fold 
Change 
Protease 
construct 
Sensor construct 
Fold 
Change 
sSH3L-TVMV SH3-mNG-TVMVE118-134 2 TVMV-sSH3L SH3-mNG-TVMVE118-134 1 
 SH3-mNG-TVMVLVA 4  SH3-mNG-TVMVLVA 5 
 mNG-TVMVSH3-E118-134 2  mNG-TVMVSH3-E118-134 1 
 mNG-TVMVSH3-LVA 4  mNG-TVMVSH3-LVA 3 
 mNG-SH3-TVMVE118-134 1  mNG-SH3-TVMVE118-134 1 
 mNG-SH3-TVMVLVA 2  mNG-SH3-TVMVLVA 1 
wSH3L-TVMV SH3-mNG-TVMVE118-134 2 TVMV-wSH3L SH3-mNG-TVMVE118-134 1 
 SH3-mNG-TVMVLVA 1  SH3-mNG-TVMVLVA 1 
 mNG-TVMVSH3-E118-134 1  mNG-TVMVSH3-E118-134 1 
 mNG-TVMVSH3-LVA 1  mNG-TVMVSH3-LVA 1 
 mNG-SH3-TVMVE118-134 0  mNG-SH3-TVMVE118-134 1 
 mNG-SH3-TVMVLVA -2  mNG-SH3-TVMVLVA -2 
 
 
 56 
 
Figure 20 Summary of SH3-dependent recruitment with both C-degrons E118-134 and LVA. A: Schematic depiction 
of the assay design, components as in Figure 10, except the rapamycin-dependent FRKBP-FRB module was replaced 
with the constitutively active SH3 protein-peptide interaction module. B: Experimental comparison of the two 
previously tested degrons based on the best performing combination of sSH3L-TVMV and SH3-mNG-TVMV sensor; 
continuous assay with the parameters established in Chapter 4.2.9, constructs as listed in the legend, colors and 
symbols as in Figure 18. Data points represent the mean values of dependent biological triplicates measured, the 
error areas depict the SEM. C: slopes for protease and corresponding mock constructs TVMVC151A as pairwise columns. 
Bars represent the average of the two dependent biological replicates measured in two independent experiments, 
error bars represent the standard error of the mean; filled bars for protease constructs, empty bars for mock 
constructs, brackets above the paired bars denote the corresponding fold change in slope. Constructs used: 
pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep pCtrl2_T7.03_U9_myc-SH3-mNG-
TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118-134, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_mKOκ. Protein 
Sequences are stated in the supplement (see 13.4.4) 
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With the best performing orientation identified, the effect of constitutive SH3-based recruitment 
was estimated by repeating the experiments with protease variants that were devoid of the SH3 
peptide ligand (a respective mock control was also included). Due to the reduced number of 
individual combinations the number of repeats was increased from duplicates to quadruplicates 
in order to increase the accuracy of the assay. The results of this experiment are shown in Figure 
21. 
 
Figure 21 Effectiveness of SH3-based recruitment on assay dynamics. Constructs, colors and symbols as in Figure 20. 
A: The activity of protease constructs with and without SH3 ligand (green triangles) were compared. B: Realtime 
data of the protease activity dependent alteration in sensor fluorescence over time, sensor constructs are noted 
above the corresponding graph, data points represent the mean values of dependent biological quadruplicates 
measured, error areas depict the SEM in colors matching the corresponding data set, dark checked areas belong to 
data sets of active proteases, plain areas belong to inactive proteases. C: comparison of the slopes the increase in 
normalized mNG fluorescence, bars represent the mean slope of the dependent biological quadruplicates measured 
over the time interval between 2 h and 5 h, error bars depict the SEM, filled bars show slopes for protease constructs 
with the strong SH3 ligand fused to the N-terminus of the protease, empty bars show the slops for the corresponding 
protease constructs without any SH3 ligand fused. Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, 
pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118.134, pCtrl2_T7.03_U9_myc-SH3-
mNG-TVMVLVA, pCtrl2_mKOκ. Protein Sequences are stated in the supplement (see 13.4.4 and 13.4.5) 
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As evident in Figure 21, the presence of the SH3 ligand had little to no impact on the slopes of 
the protease-activity-dependent increase in sensor fluorescence. In case of the weaker E118-134 
degron, the recruitment delayed the time needed to reach the equilibrium between protease 
processing of the sensor and the increased degron efficacy due to stationary growth phase. 
In general, the apparent catalytic activity of the protease turned out to be the rate-limiting factor 
of the assay. This becomes particularly obvious when comparing the scales of the graph for the 
positive controls (left graph in Figure 21 B) with two other graphs in Figure 21 B. Irrespective 
whether a degron was fused or not, TVMV was able to restore about half of the maximum 
fluorescence. This could mean that for future experiments, the amount of IPTG could be 
reduced in accordance to the findings in Chapter 4.2.5 to enable full processing of all sensor 
molecules through the available protease molecules. 
 
4.2.11. Minimal E118-134 Variant 
The Weigand group previously performed truncation studies with the E118-134 C-degron which 
led to minimal version of the degron. In further experiments, they also demonstrated that three 
repeats of degron yielded in the highest degradation rates (personal communication on 
unpublished results). 
Therefore, the performance of this triple minimal C-degron was once again benchmarked 
against the LVA degron. In order to obtain comparable results, two sets of constructs were 
cloned. The first comprised an α-helical (EAAAK)2 linker and the respective C-degron. The 
second incorporated the flexible SG4 linker that was previously used by the Weigand group. 
Because iFLinkC introduces a single glycine scar between a functional domain and a linker, the 
SG4 linker was realized with the cloning of pL2_SG3. Therefore, the final constructs were 
SH3-mNG-TVMVG(SG3)G-(C-degron). This was the closest to SG4-(C-degron) sequence used by 
the Weigand Lab that could be achieved with the iFLinkC assembly process [45]. 
After all combinations of linkers and degrons were cloned, they were added to the best 
performing sensor construct (SH3-mNG-TVMVdegron). Figure 22 shows the results for this triple 
comparison while the corresponding raw data can be found in Figure S18. 
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Figure 22 Comparison of the E118-134 C-degron with its triple minimal version and the LVA C-degron. Constructs, 
colors and symbols as in Figure 20, except triple minimal E118-134 C-degron (E118min)3 (striped dark green bars). A: 
Schematic depiction of the experiment, three different degrons and two different linkers connecting the cleavage 
site and the degron were tested. B: Fold changes in slope of the increase in protease dependent mNG fluorescence 
ordered by linker degron combination tested, bars represent the mean slope of dependent biological quadruplicates 
measured; error bars represent the SEM (original curves from which the slopes were calculated can be found in Figure 
S18). Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118.134, pCtrl2_T7.03_U9_myc-SH3-
mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV(E118min)3, pCtrl2_T7.03_U9_mKOκ.  Protein Sequences are 
stated in the supplement (see 12.4.5) 
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As is in Figure 22, the triple minimal version performed comparable to its precursor. Both 
degrons were clearly outperformed by the LVA C-degron. This further confirms that E118-134 
is not a strong C-degron when used in lonp- E. coli strains. In addition, the flexible SG3 linker 
(iFLinkC annotation, actual sequence GSG4) turned out to enhance C-degron activity relative to 
the rigid, α-helical EAAAK linker that was used previous experiments. 
 
4.3. N-Degron based Ratiometric Protease Assays 
With a suitable co-expression system for the protease and the sensor established (see 
Chapter 4.2), the C-degron assay was adapted to establish a ratiometric in vivo protease assay. 
To this end, a second fluorescent protein was incorporated in order to enable ratiometric 
measurements. The resulting sensor enabled a more accurate normalization of the fluorescent 
signal. This means, rather than normalizing the fluorescent signal to the optical density, it was 
normalized to the fluorescence of the second FP that was part of the same polypeptide chain 
and therefore should be present in equimolar ratios. The basic principle of the assay is depicted 
in Scheme 17. Both fluorescent proteins are fused together into one fusion protein. The linker 
region comprised the cleavage site and a cryptic N-degron in the P1’ position that was activated 
upon cleavage. This way no additional amino acids remained N-terminally of the N-degron after 
cleavage. Two different N-degrons were tested: FLFVQ and YLFVQ[21] which resulted in the 
corresponding cryptic degrons: ETVRFQ|FLFVQ and ETVRFQ|FLFVQ. 
Scheme 17 depicts the final design of the ratiometric in vivo protease sensor based on cryptic 
N-degrons. 
 
Scheme 17 General design of a ratiometric, two FP cryptic N-degron in vivo assay for site-specific proteases. 
mNeonGreen (mNG) and mCherry (mCh) are connected with a polypeptide linker (grey); the linker features the 
cryptic N-degron (light grey circle) which is comprised of the cleavage site (blue part of the linker), the N-degron and 
the recruitment domain (teal rectangular section). Left: The sensor is expressed and the cryptic N-degron is not 
recognized and therefore both fluorescent signals are detected. Center: the protease (blue circular section) is co-
expressed with the sensor and directed to the sensor through interaction of the two-component recruitment module 
(teal rectangular section and teal triangle); once in close proximity the protease recognizes its cleavage site. Right: 
the protease cleaves off mNG and thereby unmasks the N-degron. Thus, the now freed and thereby activated 
N-degron (pink circle) induces rapid degradation (Ø) of mCh while mNG remains in the cell. In conclusion the red 
fluorescent signal is drastically reduced compared to the green signal. 
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Given the rapamycin-dependent recruitment of the protease and the sensor via a FKBP12-FRB 
dimerization module previously proved non-functional in E. coli (see Chapter 4.2.2), the new 
set of ratiometric sensors was exclusively cloned with the SH3 domain in both N- and C-terminal 
orientations relative to the cryptic N-degron. Insertion sites were chosen to direct the protease 
as close as possible to its cleavage site. The two SH3 ligand presented in Chapter 4.2.10 were 
incorporated only into the protease constructs to reduce steric hindrance. Even though SH3 
based recruitment did not improve apparent protease activities on the single FP sensors (see 
Chapter 4.2.10), it could still have benefited cleavage of the two FP sensor based on the in vitro 
data from Chapter 4.3.1. Table 4 lists all orientations tested, as before promising orientations 
are high-lighted by grey-shading. 
Table 4 SH3/xSHL orientation screening for protease assay performance. Best performing combinations of relative 
orientations high-lighted by grey-shading. 
Protease 
construct 
Sensor construct 
sSH3L-TVMV mNG-TVMVFLFVQ-SH3-mCh 
 mNG-TVMVYLFVQ-SH3-mCh 
 mNG-SH3-TVMVFLFVQ--mCh 
 mNG-SH3-TVMVYLFVQ--mCh 
wSH3L-TVMV mNG-TVMVFLFVQ-SH3-mCh 
 mNG-TVMVYLFVQ-SH3-mCh 
 mNG-SH3-TVMVFLFVQ--mCh 
 mNG-SH3-TVMVYLFVQ--mCh 
TVMV-sSH3L mNG-TVMVFLFVQ-SH3-mCh 
 mNG-TVMVYLFVQ-SH3-mCh 
 mNG-SH3-TVMVFLFVQ--mCh 
 mNG-SH3-TVMVYLFVQ--mCh 
TVMV-wSH3L mNG-TVMVFLFVQ-SH3-mCh 
 mNG-TVMVYLFVQ-SH3-mCh 
 mNG-SH3-TVMVFLFVQ--mCh 
 mNG-SH3-TVMVYLFVQ--mCh 
 
The results for the best performing combination of sSH3L-TVMV and 
mNG-SH3-TVMVFLFVQ-mCh are explanatorily discussed here where all remaining combination 
can be found in Figure 24. As visible in Figure 23, the measured arbitrary units for the mNG 
fluorescence were three orders of magnitudes higher compared to the mCh fluorescence – 
despite the fact, that the gain for mNG was set to 70 while the mCh fluorescence was recorded 
with a gain of 100. In turn, the normalized data found in the third graph Figure 23 B are within 
the range of ten to the power of minus two. Nevertheless, it is clearly visible that active TVMV 
prevents a significant rise in mCherry fluorescence which is slightly more pronounced when the 
values are normalized relative to the mNG fluorescence. 
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Figure 23 Ratiometric in vivo protease assay based on a cryptic N-degron. A: Schematic depiction of the experiments. 
B: Results for the best performing combination of sSH3L-TVMV and mNG-SH3-TVMVFLFVQ-mCh. Data points represent 
the mean of dependent biological triplicates, error bars as colored area represents the SEM, dark checkered areas 
belong to active protease constructs, plain areas belong to inactive protease constructs. Constructs used: 
pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep pCtrl2_T7.03_U9_myc-mNG-SH3-
TVMVFLFVQ-mCh-Strep. Protein sequences are stated in the supplement (see 13.4.7) 
For all combinations of relative orientations, the slope of the linear increase in normalized 
fluorescence (between two and four hours) was calculated and compared to identify the best 
performing combinations. The results of this analysis are plotted in Figure 24. 
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Figure 24 Orientation screen for the ratiometric in vivo protease assay based on cryptic N-degrons. A: Schematic 
depiction of the experiment. B: Comparison of the slopes of the linear increase in normalized mCh fluorescence for 
the orientation screen. The protease constructs used are stated above the corresponding graph, while the sensors 
are listed on the X-axis, bars represent the mean slopes for the dependent biological triplicates measured; error bars 
depict the SEM, filled bars for the active TVMV, empty bars for the mock controls TVMVC151A, brackets above the 
paired bars state the fold change in slope between a protease and its corresponding mock construct. Constructs 
used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVwSH3L-
TVMV-Strep, pPRO24_MBP-TVMVwSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-sSH3L-Strep, 
pPRO24_MBP-TVMVTVMVC151A-sSH3L-Strep, pPRO24_MBP-TVMVTVMV-wSH3L-Strep, pPRO24_MBP-TVMVTVMVC151A-
wSH3L-Strep, pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVFLFVQ-mCh-Strep, pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVYLFVQ-
mCh-Strep. Protein Sequences are stated in the supplement (see 12.4.7) 
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As visible in Figure 24, the best fold changes were achieved when the SH3 domain was located 
N-terminal of the cleavage site. A similar observation was made for the protease constructs 
where an N-terminal SH3 ligand seemed to benefit the most. This orientation corresponds to a 
localization of the active site of TVMV close to its C-terminus [36]. In contrast, no significant 
difference between phenylalanine (F) or tyrosine (Y) at the P1’ position was observed. 
Therefore, it was concluded that TVMV tolerates both amino acid residues at the P1’ site in a 
comparable fashion. In case of a C-terminal localization of the strong SH3 peptide ligand 
apparent protease activity led to reduced mCh degradation. This finding seemed 
counter-intuitive and inconsistent with the other orientations tested. A reasonable explanation 
could a mishap at the picking step. Colonies were picked from quartered plates. Because plates 
were labelled on the bottom in clock-wise manner picking order was counter-clockwise (plates 
were flipped for easier picking). So maybe for this plate the picking order was accidently 
inverted. 
 
4.3.1. Effect of SH3 based Recruitment on Ratiometric Assay Dynamics 
After the best relative orientation for incorporation the SH3 domain/SH3 ligands were 
identified for the ratiometric assay, the effect of the recruitment was quantified analogous to 
the C-degron based sensors (see Chapter 4.2.10). Figure 25 shows the result of the recruitment 
test. Consistent to the approach for the C-degron sensor protease constructs devoid of the SH3 
peptide ligand were included. In contrast to the previous experiments where the strong SH3 
ligand seemed to be superior compared to the weak one, no pronounced effect was observed. 
Indicating that yet again proteolytic activity of the proteases was the limiting factor. 
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Figure 25 Effectiveness of SH3-based recruitment on ratiometric assay dynamics. Constructs, colors and symbols as in 
Figure 24, except no SH3 ligands protease constructs were included as well (upside down triangles) and grey 
coloration for normalized mCh fluorescence replaced with red. A: Schematic depiction of the experiment. The effect 
of the sSH3L ligand on the dynamics of the assay was tested B: Real-time kinetic data of the protease-dependent 
development in the fluorescent signal over time, sensor construct is indicated above the graph, data points represent 
the mean values of dependent biological quadruplicates measured, error areas depict the SEM. C: bars represent the 
mean slope in normalized mCh fluorescence of the dependent biological quadruplicates measured over the time 
interval between 2 h and 5 h, error bars depict the SEM, grey bars show slopes for protease constructs (mCh/red 
fluorescence is lost through proteolytic activity), red bars show the slopes for the corresponding mock constructs 
(mCh/red fluorescence is retained without proteolytic activity), brackets over the paired bars state the fold change 
in protease dependent reduction in slope of the increasing normalized mCh fluorescence compared to the respective 
mock construct TVMVC151A. Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-
TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mNG-
SH3-TVMVYLFVQ-mCh-Strep. Protein sequences are stated in the supplement (see 12.4.7). 
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4.4. Effect of lonp+ Genetic Background 
In the subsequent experiment, two commercially available lonp+ E. coli K-strains were tested. 
The first was Shuffle T7 from New England Biolabs and the second was KRX from Promega. 
Both featured a chromosomal integrated T7 RNA polymerase: under control of an IPTG 
inducible lac promoter (Shuffle T7) and a rhamnose inducible derivative of the araBAD 
promoter (KRX). The latter required switching from M9 minimal medium to LB medium 
because only ribose was lower in hierarchy than rhamnose which however turned out to be 
such poor carbon source that experiments were impossible. This meant switching from a 
mNeonGreen based sensor to a mCherry based sensor to avoid background fluorescence of the 
LB medium. In addition, both strains required consecutive single transformation of the protease 
and sensor carrying constructs instead of the usual double transformation of BL21(DE3). 
Otherwise, insufficient transformation efficiencies were observed. The results of this test are 
shown in Figure 26. 
In general, both strains performed poorly compared to BL21(DE3). Possibly because the lon 
protease present in the cytoplasm might have reduced the amount of TVMV below an effective 
detection limit. For this reason, as well as ease of handling, BL21(DE3) remained the preferred 
expression host for the remainder of this work. Because of the suboptimal performance of the 
newly clone mCh sensor in the two K strains, a control measurement in BL21 was performed to 
validate the function of the mCh sensor. The results of this experiment are found in Figure 27. 
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Figure 26 Comparison of the lonp+ K-strains Shuffle T7 and KRX. A: Schematic depiction of the experiment, the assay 
design was based on the C-degron based assay presented in Chapter 4.2 except for the following changes: (i) the 
non-beneficial recruitment domains were omitted, (ii) mNG was replaced with mCh to reduce any background 
fluorescence associated with riboflavin. B: mCh fluorescence normalized to OD600 over time, strain used stated above 
the corresponding graph, data points represent the mean of the dependent biological quadruplicates measured, 
error areas depict the SEM. C: Bars represent the average of dependent biological quadruplicates measured; error 
bars represent the SEM, pairwise bars for TVMV and corresponding mock construct showing the slope of the linear 
increase in normalized mCh fluorescence, brackets denoted the fold change in slope between paired bars. Constructs 
used: pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-TVMV, 
pCtrl2_T7.03_U9_myc-mCh-TVMVLVA. Protein Sequences are stated in the supplement (see 13.4.8). 
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Figure 27 Validation of the mCh sensor in a BL21(DE3) genetic background. Constructs, colors, symbols as in Figure 
26. A: schematic depiction of the experiment. B: Real-time normalized mCh fluorescence over six hours after induction 
of the mCh sensor following a two hour pre-induction of the protease; Data points represent the mean values for 
the dependent biological quadruplicates measured, error areas depict the SEM; C: Slope of the linear increase in mCh 
fluorescence between 3 and 5 hours, bars represent the mean slope of the dependent biological quadruplicates 
measured, filled bars: active protease, empty bars: inactive protease TVMVC151A (mock control), error bars depicted 
the SEM, brackets above the paired bars depict the fold change in slope between a protease construct and its 
corresponding mock control. Constructs used: pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, 
pCtrl2_T7.03_U9_myc-mCh-TVMV, pCtrl2_T7.03_U9_myc-mCh-TVMVLVA. Protein Sequences are stated in the 
supplement (see 13.4.8). 
In BL21, the shape of the curves perfectly matched those obtained with the mNG sensors. This 
indicates the assay functions independently of the identity of the underlying fluorescent protein. 
The extremely high fold change between active and inactive TVMV is particularly striking 
(Figure 27 B). The high fold change is mainly based on the very slow rise in the mCh fluorescent 
signal when catalytically inactive TVMV is used in conjunction with degron-tagged sensor. The 
most plausible explanation for this phenomenon is the slower maturation rate of mCherry – 15 
min [95] – compared to mNG – 10 min [85] – which gives the ClpP degradation machinery 
more time to degrade the fluorescent reporter before the fluorophore matures. 
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4.5. General Assay Utility with TEV and HCV (Master Thesis C. Rühmkorff) 
After the elementary assay was established for TVMV in Chapter 4.2, the general utility of the 
assay was demonstrated for additional site-specific proteases. To this end, TEV and HCV 
proteases were selected as candidates that have been subject to substantial engineering efforts 
before [1, 3, 45]. The assay could be readily adapted by replacing the appropriate protease and 
the protease cleavage site in the sensor construct by means of the iFLinkC assembly process. 
Considering iFLinkC constitutes a scarless assembly process, constructs were generally 
assembled from elementary parts. The assembly and characterization of all TEV and HCV 
constructs was the subject of the master thesis of C. Rühmkorff. Therefore, all data below were 
generated by him. Figure 28 shows a direct comparison of all three proteases in the same 
measurement using the LVA C-degron assay (Chapter 4.2.7). 
As is evident in Figure 28, the closely related TVMV and TEV proteases perform similarly while 
HCV is only able to manifest a two-fold change. This might be based on the weaker serine 
nucleophile in case of HCV compared to cysteine in case of TVMV and TEV. In addition, the 
difference could be explained by lower expression levels. Nevertheless, discrimination of active 
from inactive variant was possible in all three cases. 
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Figure 28 Direct comparison of three different proteases with the LVA C-degron based assay. A: Schematic depiction 
of the experiment: The basic C-degron assay was performed as explained in Chapter 4.2 with three site-specific 
proteases TEV, TVMV and HCV in direct comparison. B: Real-time kinetic data of in vivo protease activity measured 
over the course of 8 hours; Colors and symbols as in Figure 15, proteases and corresponding inactive variants are 
listed above the corresponding graphs, sensors are listed in the central legend, data points represent the mean values 
of dependent biological quadruplicates measured, error areas depict the SEM. C: Fold changes between active and 
inactive protease variant, bars represent the mean slopes of the protease dependent increase in mNeonGreen 
fluorescence, error bars depict the SEM, filled bars for active proteases, empty bars for inactive proteases, brackets 
above the paired bars state the corresponding fold changes in slope. Constructs used: pPRO24_MBP-TVMVsSH3L-
TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVsSH3L-TEV-Strep, 
pPRO24_MBP-TVMVsSH3LTEVC151A-Strep, pPRO24_MBP-TVMVsSH3L-HCV-Strep, pPRO24_MBP-TVMVsSH3L-HCVS152A-
Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-
mNG-TEV, pCtrl2_T7.03_U9_myc-SH3-mNG-TEVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA, pCtrl2_mKOκ. Protein Sequences are stated in the supplement (see 13.4.9). 
TEV and HCV related constructs were cloned by C. Rühmkorff; all data shown in this figure were generated by C. 
Rühmkorff under my supervision. 
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To confirm the functional expression of all three tested proteases, C. Rühmkorff detected the 
C-terminally Strep-tagged protease constructs by means of Western blotting. To this end, Strep-
tagged proteases were resolved by means of a Strep-tactin-HRP conjugate (BioRad) using 
enhanced chemiluminescence substrate (BioRad). The obtained blots are shown in Figure 29 
and further demonstrate the general utility of the assay for different proteases. 
 
Figure 29 Western blot analysis of protease expression under assay conditions. Double transformed E. coli BL21(DE3) 
cultures were grown in M9 at 37 °C for 2 h. Subsequently, protease expression was induced with 25 mM sodium 
propionate and cultures were incubated at 30 °C. Another two hours later, the expression of the sensor was induced 
with 1 mM IPTG. Samples were taken before protease induction (2h timepoint), before sensor induction (4h 
timepoint) and 6 h after sensor induction (10 h timepoint, the usually endpoint of the in vivo assays). Then 20 µL cell 
suspension with an OD600 = 5 were loaded per lane. The pictograms to the right of the individual Western blots show 
the expected protease bands, the upper band around 68 kDa when the MBP solubility tag is not cleaved off and the 
lower band around 28 kDa for the autocatalytically processed protease construct. The weak band at 35 kDa belongs 
to BirA which corresponds to the the biotin ligase of E. coli and is always detected through Strep-Tactin. The +/- refers 
to the presence of the LVA C-Degron in the co-expressed sensor constructs. The expression of the sensor was generally 
included to fully mimic the assay conditions during expression tests. Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-
Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVsSH3L-TEV/-Strep, 
pPRO24_MBP-TVMVsSH3L-TEVC151A-Strep, pPRO24_MBP-TVMVsSH3L-HCV-Strep, pPRO24_MBP-TVMVsSH3L-HCVS152A-
Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-
mNG-TEV, pCtrl2_T7.03_U9_myc-SH3-mNG-TEVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA. Protein Sequences are stated in supplement (see 13.4.9). TEV and HCV 
related constructs were cloned by C. Rühmkorff; all data shown in this figure were generated by C. Rühmkorff under 
my supervision. 
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Figure 29 reveals substantial leakage of the propionate-inducible promoter when cells are 
grown in M9 minimal media with arabinose as the sole carbon source. This could point towards 
an insufficient level of catabolite repression of the prp operon through arabinose. Otherwise, 
the bands of individual proteases became more intense compared to biotinylated BirA (which 
serves as an internal loading control), the longer overexpression was induced with sodium 
propionate. As expected for the catalytically-inactive variants TVMVC151A, TEVC151A and 
HCVS152A, only bands with a high molecular mass could be detected as individual proteases 
remained fused to MBP. In contrast, for catalytically-active proteases, only processed bands 
were detected which further confirms in vivo activity of the protease. The only exception was 
native TEV protease for which no bands were detected at all. One explanation of this 
observation could be that TEV protease recognizes the C-terminal Strep-Tag as a substrate (TEV-
site: ENLYQS vs Step-TagII: WSHPQFEK) even though there is little sequence similarity 
between them except that both sequences feature a glutamine residue.  
 
4.6. Design of Light-switchable TVMV Switches 
Finally, the newly developed protease assay was applied to engineer a light-responsive variant 
of TVMV protease. Recently, fungal VIVID domains which are highly similar to plant derived 
light-, oxygen-, and voltage-sensitive domains 1 (LOV1 domains) were engineered from 
homodimerizing photo-receptors into strictly heterodimerizing photo-receptors. These novel 
semi synthetic photoreceptors were called magnets. This name was chosen because upon 
irradiation with blue light at 450 nm, the positive magnet and the negative magnets dimerize 
in an anti-parallel orientation just like real bipolar magnets would do [96, 97]. 
The magnet heterodimers spontaneously dissociate in the dark. The creators around Akihiro 
Furuya and Moritoshi Sato from the University of Tokyo provided a whole set of different 
magnets. The negative magnets (nMags) were optimized in regards to their binding affinity to 
accelerate the dimer formation upon irradiation down to the scale of seconds. The positive 
magnets (pMags) were selected to provide different dissociation rates in the dark. The rates 
ranged from hours (original pMag) to a couple of seconds (pMagFast2)[96]. 
In 2017, the Khammash group from ETH Zürich demonstrated that the magnet system can be 
used in E. coli without any further adaptation [98]. With a proof of principle in E. coli reported 
and the magnet co-factor flavin adenine dinucleotide (FAD) being a natural metabolite of E. coli, 
an opto-switch based on the general auto-inhibited TVMV module was designed. 
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The autoinhibited TVMV module features an auto-inhibition domain (AI) which acts as a 
competitive peptide inhibitor that is derived from the natural cleavage site of TVMV. The AI 
domain was developed in previous studies by V. Stein the supervisor of this project and 
published in PNAS in 2014 [1]. The basic idea was to identify peptide sequences that bind to 
the cleavage site with reasonable affinities without being actually cleaved by the protease. By 
covalently linking this peptide inhibitors to the protease via a peptide linker a fully genetically 
encodable synthetic zymogen was created. By introducing an allosteric receptor domain into 
the linker between the AI domain and the protease, synthetic protein switches could be 
engineered in previous studies [99]. The basic design principle of these switches and signal 
transducers is shown in Scheme 18. 
 
Scheme 18 Design of the new blue-light responsive TVMV switched based on V. Stein’s design for allosteric switches 
based on auto-inhibited proteases. 
Table 5 Blue light switchable TVMV with focused linker libraries. Construct is shown from N- to C-terminus. 
AI 
Short 
linkers: 
G1 
G(GS)G 
G(SPA)G 
G(GASPAG)G 
G(P)G 
G(P3)G 
nMagHigh1 
Long linkers: 
G(L(G3S)3ET)G 
G(GS)(G2S)7G 
G(NS3N10)G 
G(((TP)4TGSG)2(TP)4T)G 
G(P19)G 
G(A(EA3K)8AG)G 
pMagFast2 
Short 
linkers: 
G1 
G(GS)G 
G(SPA)G 
G(GASPAG)G 
G(P)G 
G(P3)G 
TVMV 
 
To engineer light-responsive protease switches, a combination of nMagHigh1 and pMagFast2 
was chosen in preliminary studies. According to the Khammash publication, these displayed the 
fasted switching behavior in E. coli. To account for the critical role of linkers, a focused linker 
library was devised featuring a mix of short, long, flexible and rigid linker (Table 5). After 
visual inspection of the crystal structures, short linkers were chosen to connect an AI domain 
and the TVMV protease with the photoreceptor. In contrast, long linkers were chosen to connect 
the nMag and pMag modules. In theory, this arrangement (see Scheme 18) should confer 
enough intrinsic flexibility for the AI domain to bind to the active site of the protease. Upon 
irradiation and subsequent dimerization of the two magnets, the short linkers between the 
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photoreceptor domains and the AI domain would disfavor simultaneous dimerization of the 
photoreceptor domain and binding of AI to the active site of TVMV. Table 5 shows the focused 
library in an N- to C-terminal orientation. 
 
4.7. Combinatorial Assembly of Light-Regulated TVMV Switches with iFLinkC 
The library was assembled in four hierarchic steps by means of a new DNA assembly method 
termed ‘iterative Functional Linker Cloning’ or in short iFLinkC. iFLinkC provides a general 
route to the assembly of complex multi-domain fusion proteins [45] and was specifically applied 
to construct a combinatorial library of light-regulated TVMV switches. 
Briefly, iFLinkC is based on the use of Type IIS restriction enzymes with three distinct feature 
(i) they recognize non-palindromic and thereby directional DNA sequences, (ii) they cut 
directly adjacent of their recognition sequences and (iii) they generate two nucleotide long 
single stranded overhangs. Based on these criteria the two restriction enzymes BtsI and BsrDI, 
both commercially available from New England Biolabs, were selected for iFLinkC. 
The recognition sequences for these two enzymes were cloned flanking the cloning site of the 
two iFLinkC deposit/entry vectors termed pFD and pL2. pFD is the deposit/entry vector for 
Functional Domains which is any part of a fusion protein that is not a linker. Accordingly, pL2 
is the deposit/entry vector for Linkers. Aside from one nucleotide spacers between the coding 
sequence of the deposited part and the flanking restriction sites pFD and pL2 are identical. The 
spacers in pL2 are crucial to ensure that the two nucleotide overhangs generated by BtsI and 
BsrDI are reconstituted into a single in-frame glycine codon. Otherwise, the two nucleotide 
overhangs would result in frame shifts during the iterative assembly steps of iFLinkC. The direct 
consequence of this assembly method is that a one glycine scar between a functional domain 
and a linker is always created. Therefore, all linkers introduced with iFLinkC are G[actual linker 
sequence]G. The only exceptions are the specifically modified plasmid pL2_G1 and pL2_G2 
which introduce a single or two glycine codons into the coding sequence. All other pL2 plasmids 
introduce linkers of at least three amino acids in length. 
Both vectors include the same class A origin of replication and a kanamycin resistance cassette 
separated by an EcoRI restriction site, however both vectors lack an expression cassette. pFD 
and pL2 are explicit deposit vector. Therefore, it is crucial that all protein coding sequences 
stored in either vector are deficient of start or stop codons. 
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In the initial assembly step, a linker or linkers mix is cloned up- or downstream a functional 
domain. Therefore, one deposit vector is digested with BsrDI (the upstream CDS) while the 
other is digested with BtsI (the downstream CDS). It is noteworthy that both enzymes prefer 
elevated temperatures during restriction and in the case of BsrDI may require a specific buffer. 
After the restriction steps at elevated temperature, EcoRI is added to the reaction mixes and 
restriction is continued at 37 °C. After restriction the generated fragments are separated through 
electrophoresis and the desired restriction fragments are recovered und subsequently ligated 
with one another. Due the fact that pFD and pL2 are nearly identical all restriction sites are 
regenerated during ligation. The most upstream part defines the identity of the newly 
assembled construct. In case of a functional domain, the construct is treated as a pFD for further 
assembly steps. In the opposite case, it is treated as linker instead. Scheme 19 depicts the initial 
iFlinkC assembly reaction. After ligation, the newly generated plasmid or plasmid library – 
depending if a single linker or a linker mix was used – can be used to transform E. coli cells for 
plasmid propagation or long-term storage as a glycerol cryo-stock. 
 
Scheme 19 Initial iFLinkC assembly step. In the initial assembly a linker cloned up or down stream of a functional 
domain (downstream in this example). Arrows indicate restriction steps while brackets depict the ligation step. All 
necessary purification steps are omitted, origin of replication (ori) as a yellow rectangle, kanamycin resistance 
cassette (KanR) as a mint green rectangle, functional domain coding sequence (FD) as a red rectangle, linker/linker 
mix (L) as a grey rectangle, restriction side indicated with annotated lines. 
 
For more complex constructs time and effort may be saved by following a hierarchical assembly 
order than a sequential. In this case, the desired fusion protein coding sequences is split into 
sets one domain one linker/linker mix pairs which are assembled simultaneously. By repeating 
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these pairwise assembly steps complex constructs or libraries are assembled in an efficient and 
straight-forward manner. This process is exemplarily depicted in Scheme 20 for a 4-domain-3-
linker/linker mix multi-domain fusion protein.  
 
Scheme 20 Iterative assembly of 4-domain-3-linker multi-domain fusion protein with iFLinkC. In the initial step three 
pairs one functional domain (FD, red rectangles) and one linker/linker mix were assembled. In the following two 
steps the pairwise assembly is continued until the full-length CDS for a 4-domain-3-linker fusion protein is assembled. 
Once the multi-domain fusion protein coding sequence is assembled, it can be cloned into an 
expression vector of choice. This can either be one the iFLinkC expression vectors termed 
iFLinkC_XE or in the case of this work pPRO24 and pCtrl2, respectively (see Chapter 4.2.1). 
Because iFLinkC assembled coding sequences lack a start-codon, the expression vector of choice 
has to provide it. Alternatively, cloning into the final expression vector can be performed with 
PCR based methods that introduce the missing start-codon through primer overhangs. This 
alternative should be considered with caution because many linker coding sequences are GC-
rich, highly repetitive or if linker mixes were used internal homology within the library could 
occur. In this case, PCR based cloning could become quite challenging. For these reasons, we 
recommend classical restriction ligation cloning of iFLinkC assembled constructs or libraries 
into expression vectors. 
Cloning into iFLinkC_XE vectors with BtsI and SpeI automatically provides in frame start and 
stop codons. The start codon is provided through the iFLinkC expression vector while a stop 
codon is included in all iFLinkC assembled coding sequences when they are restricted with SpeI 
instead of the more upstream BsrDI. For this work, I chose adapter cloning to clone BtsI…SpeI 
restriction fragments of my iFLinkC assembled constructs into pPRO24 and pCtrl2. Used 
adapter oligos were phosphorylated and hybridized before used as additional ligation 
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fragments. The sequences of hybridized oligos are listed in Table 6 For better visualization, the 
aptamer cloning step is exemplarily shown in Scheme 21. 
Table 6 Adapter oligos for cloning of iFLinkC assembled constructs and libraries into pPRO24 or pCtrl2. Start-codons 
highlighted in bold. 
Name Sequence Usage 
BtsI-to-NdeI 5’-TATGAGCTCAGGATCTAGTGGG-3’ 
  3’-ACTCGAGTCCTAGATCAC-5’ 
Cloning of iFLinkC assembled constructs to pCtrl2 
SpeI-to-KpnI 5’CTAGTGATACGGGACAGATGGGGTAC-3’ 
   3’-ACTATGCCCTGTCTACCC-5’ 
Cloning of iFLinkC assembled constructs to pCtrl2 
BtsI-to-
EcoRI 
5’-AATTCATGGGATCTGGCTCGATCGGG-3’ 
    3’-GTACCCTAGACCGAGCTAGC-5’ 
Cloning of iFLinkC assembled constructs to 
pPRO24 
SpeI-to-SalI 5’-CTAGGGATACGCAGATGGG-3’ 
    3’-CCTATGCGTCTACCCAGCT-5’ 
Cloning of iFLinkC assembled constructs to 
pPRO24 
 
Scheme 21 Final cloning step into a suitable expression vector. Double stranded adapter oligos in blue, restriction 
step symbolized by the arrow, ligation step by the bracket, oris in yellow, antibiotic resistance cassettes in mint green 
and the repressor in purple. 
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In the context of the optically-regulated protease switches, the linker mixes were cloned 
downstream of the prepended domains. Afterwards, the N-terminal and C-terminal halves were 
assembled. Subsequently, the final library was assembled by joining both halves. Finally, a 
solubility tag was added to the N-terminus in the form of maltose binding protein. In summary, 
the final library comprised of MBP-TVMVAI-[shLinkers]-nMagHigh1-[lgLinkers]-pMagFast2-
[shLinkers]-TVMV-Strep. The C-terminal Strep-Tag was included for subsequent purification of 
potential switches – i.e. a Strep-tagged TVMV was already available as an iFLinkC part. The 
additional TVMV cleavage site between MBP and the AI domain was added to allow activated 
TVMV to cleave off the solubility tag as well as to prevent the selection of switches that required 
MBP for proper switching behavior. 
 
4.8. Screening Light-Regulated TVMV Switches – Preliminary Results 
Figure 30 shows the results of the first library screening. To avoid undesired simultaneous 
excitation of the fluorescent sensor and the photoreceptor domain, the mCh C-degron sensor 
was used. As previously established, the expression of the protease was induced during 
exponential growth phase. After two hours of protease pre-production at 30 °C and exposure to 
ambient light, the sensor production was induced and the 12 cycles of the 5 min irradiation and 
30 min incubation in the dark were performed. Irradiation was performed by placing a black 
96 well plate with transparent bottoms onto a custom-made blue light emitting diode (LED) 
panel at 30 °C (see Figure S20 for a photograph of the device). After 5 min of irradiation, the 
plate was incubated in a TECAN Spark spectrophotometer and continuously shaken at 30 °C. 
mCh fluorescence was quantified at 0, 15 and 30 mins of incubation per cycle. 
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Figure 30 Engineering a blue light switchable TVMV. A: A blue light activated photoreceptor (nMag/pMag) is 
inserted between TVMV and the corresponding auto-inhibitor domain (AI); The three linkers interconnecting the 
photoreceptors, the AI domain and TVMV were recombined through a focused library (see Table 5); Upon irradiation 
with blue light at approx. 460 nm, the two opposite magnet domains form a heterodimer and, in this way, dislodge 
the AI domain from the TVMV active site; Active TVMV cleaves off the C-degron from the mCh sensor (see 
Chapter 4.4). B: results of the initial screening of 87 clones in 96 well plate format, dark grey bars show mCh 
fluorescence prior to irritation, light blue bar shown mCh fluorescence after 12 cycles of 5 min irradiation with blue 
light (approx. 460 nm, custom made device) and subsequent 30 min incubation in the dark (inside TECAN Spark 
reader) mCh fluorescence was quantified at 0, 15 and 30 min of incubation in the dark; 3 dependent biological 
triplicates of TVMVC151A and mCh-TVMVLVA served as negative controls (grey arrows), 3 dependent biological 
replicates of TVMV and mCh-TVMV served as positive control (light red bars instead of light blue bars), and 3 dependent 
biological triplicates of TVMV and mCh-TVMVLVA served as reference for full TVMV activity (dark red bars instead of 
light blue bars, 1 replicate did not display any fluorescence and is excluded), orange box shows the clones picked for 
a retest on the following day. C: results of the control measurement with no irradiation during measurements, 
datapoint represent individual clones, legend at the bottom refers to both graphs. Constructs used: pPRO24_MBP-
TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-TVMV, pCtrl2_T7.03_U9_myc-mCh-
TVMVLVA., pDESTara2_MBP-TVMVAI-L1-nMagHigh1-L2-pMagFast2-L3-TVMV-Strep. Protein Sequences are stated in 
supplement (see 13.4.10). 
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As evident in Figure 30 C, the picked clones showed the same activity as during the primary 
screen even though in the re-test the plates were not irradiated with blue light. To reduce the 
number of false positives, the library was transformed a second time. This time, a 
pre-measurement in the dark for 6 hours was performed and variants with slightly higher 
activity than the mock control were selected to be re-tested. Figure 31 shows the results for 
this inverted screening. 
 
Figure 31 Second screening of the blue light switch library wit pre-incubation in the dark to filter out constitutive 
active variants. A: Schematic depiction of the experiment, same as in Figure 30. B: mCh fluorescence after six-hour 
incubation in the dark of 87 randomly picked clones, controls as in Figure 30, except exclusively final fluorescence 
values plotted and light blue bars show picked clones. C: Results of the control measurement with the 9 picked clones, 
blue bars 12 cycles of 5 min irradiation and 30 min incubation in the dark, dark grey bars constantly in the dark. 
Constructs used: pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-
TVMV, pCtrl2_T7.03_U9_myc-mCh-TVMVLVA., pDESTara2_MBP-TVMVAI-L1-nMagHigh1-L2-pMagFast2-L3-TVMV-Strep. 
Protein Sequences are stated in the supplement (see 13.4.10). 
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Yet again, no blue-light responsive clones could be selected due to a lack of a suitable positive 
control to compared the picked clones to. The degron based assay seems not to be the most 
promising route towards an opto-switch. At the very least, the assay was able to differentiate 
between highly active and largely inactive variants.  
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5. Conclusion and Outlook 
5.1. Conclusion 
The primary aim of this project was to develop an in vivo assay for the real-time characterization 
of protein switches based on auto-inhibited proteases in E. coli. To this end, the assay was 
required to (i) exclusively comprise fully genetically encodable components that can be 
produced in standard E. coli lab strains, (ii) the output signal has to be quantifiable with 
standard lab equipment, and (iii) the assay should be scalable up to ultra-high throughput 
formats like FACS or droplet-based microfluidics. For this aim, a constitutive active protease 
from tobacco vein mottling virus was chosen as a model protease. The reason for this were (i) 
site-specific proteolytic activity, (ii) ease of soluble expression in E. coli and (iii) small 
monomeric protease without any cofactors. In addition, a fluorescent output signal should 
directly depend on the proteolytic activity within the cell. 
After unsuccessful attempts to construct distance and dimerization dependent fluorescent 
protein sensors based on FRET and FPX, the system was simplified. The simpler design 
comprised of a single bright fluorescent protein (mNG) and a C-terminal degradation-tag 
(C-degron). In the linker between reporter and C-degron, a cleavage site for TVMV cleavage 
was introduced. In contrast to other working groups which published similar system since the 
beginning of this project, a unique negative control was established. This negative control was 
the most accurate mock control possible. Instead of co-expressing the sensor and some random 
protein or an orthogonal protease, a single point mutation was introduced to TVMV to replace 
the catalytic cysteine nucleophile with an alanine. This control was crucial during the 
adjustment of the co-expression system. Furthermore, it was used as the lower limit of the 
dynamic range of the sensor. Over the course of this work, the co-expression system for the 
protease and sensor was optimized to enhance the dynamic range of the assay. A key effort 
focused on improving the performance of the protease assay through active recruitment based 
on the rapamycin-dependent FKBP-FRB and constitutive SH3 protein-peptide interaction 
module. In initial tests, the relative orientation of said recruitment domains did influence the 
apparent proteolytic activities. Unfortunately, the best performing variants showed no 
significant improvement in apparent activity compared to native TVMV with no additional 
recruiting domains. Conversely, these results proved that the assay can resolve even minor 
relatively minor changes in the apparent proteolytic activities. 
Furthermore, three different C-degrons were tested overall which lead to different dynamic 
ranges of the assay. This led to first downside of the assay. The assay is prone to the intricate 
network of kinetic rates revolving around the assay components. To be precise, the production 
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rate of both sensor and the protease, degradation rates of both protease and cleavage rate of 
the protease itself. Meaning extensive optimization would be necessary to adjust the assay to 
any given switch if exact in vivo kinetics should be determined. However, for the general 
discrimination of active and inactive states/variants, the assay could be quickly adapted by 
exchanging the cleavage site within the sensors. The general applicability of the assay was 
proven with TEV, another potyvirus protease, as well as HCV, a flavivirus protease with clinical 
relevance. In addition to the protease, the fluorescent protein reporter was also exchanged. 
Precisely, mNeonGreen was exchanged with mCherry. This led to reduced fluorescence 
intensities due to mCherry’s inferior optical properties [85, 95] but in turn led to much higher 
fold changes between active and inactive TVMV variants. These findings prove that the assay 
should be functional irrespective of the fluorescent protein utilized. 
The second design iteration of the assay aimed to increase the quality of the normalization 
condition of the generated fluorescent signals from optical density of the culture to another 
fluorescent signal. Therefore, a sensor with two fluorescent proteins within the same 
polypeptide chain was designed. To this end, a cryptic N-degron was inserted into the linker 
separating the two fluorescent proteins. The cryptic degron comprised of a TVMV cleavage site 
and a strong, semi-synthetic N-degron that overlapped with the P1’ position of the TVMV 
cleavage site. Accordingly, proteolytic activity did not just separate the two fluorescent proteins, 
but also the rapid degradation of the C-terminal fluorescent protein while the N-terminal 
fluorescent protein accumulated in the cell. This sensor design was functional without any 
changes to the previously established co-expression system. While the relative orientation of 
the functional domains influenced the apparent activities, constitutive recruitment by means of 
SH3 domains did not significantly improve the assays dynamics. 
Finally, the first protein switch based on auto-inhibited TVMV was to be characterized. 
Unfortunately, the previously established input signals [1, 3, 45] – i.e. rapamycin – did not turn 
out to be bio available in E. coli hence a new input signal had to be found. Light was selected 
as the first input signal candidate. Based on a semi-synthetic blue light receptor system called 
Magnets. A prototype library for a blue light switchable TVMV was cloned and screened in 
E. coli. The assay proved able to resolve different proteolytic activities within the library that 
ranged from mock-like to native TVMV activities. However, no blue light dependent activity 
could be identified within a total of 194 clones screened. In any case, the results demonstrate 
that the assay can be used to screen that library if better equipment would be available in the 
future. This could facilitate continuous incubation and irradiation alongside online 
measurement combined in one device or automated platform. 
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5.2. Outlook 
Currently, three different follow-up projects for this PhD project are either in planning or in 
early lab stage. The first is a Bachelors Thesis conducted currently adapting the assay to the 
main protease form SARS-CoV-2 corona virus, the second is an opto-switch based on 
Phytochrome B and the third is the establishment of a two-protease signal transducer which in 
itself is not a protein switch but would at least proved that the assay can be employed to 
characterized simple logic gates in live E. coli cells. 
5.2.1. Preliminary results with SARS-CoV-2 MPro (Bachelor Thesis L. Chalwatzis) 
The synthetic DNA coding for the SARS-CoV-2 main protease (SARS-CoV2 MPro) and its 
corresponding cleavage site were ordered and deposited in the iFLinkC storage vector for 
functional domains (pFD). At the time this thesis was written, the assembly process of the 
protease expression constructs as well as its inactive variant SARS-CoV2 MProC145A [47] and the 
corresponding sensor constructs were nearly finished. 
5.2.2. Alternative photo-receptor 
In addition, a second opto-switchable TVMV protease exists in early concept stage. This one is 
based on a second photo-receptor established in E. coli among others by the Weber group at the 
Albert Ludwigs Universität Freiburg. It is based on Phytochrome B (PhyB) which binds to 
phytochrome interacting factor 6 (PIF6) [100, 101]. The advantages of PhyB would be that it 
can be actively switch between heterodimer and monomers by alternating between red light 
and near infrared light, respectively [100, 101]. This is in strict contrast to the magnets-based 
design which relies on spontaneous dissociation in the dark [96-98]. In addition, the PhyB 
dimerization can be suppressed by illumination with green light to avoid undesired reactions 
due to ambient light. The two drawbacks which lead to the current postponement of the design 
are the following. First of all, discussions with the Weber group indicated that PhyB cannot 
simply be cloned into the linker region of the basic auto-inhibited TVMV design because its 
prone to misfolding unless it is in the most N-terminal position. The second more challenging 
aspect concerns its cofactor dependency. While the magnets require FAD which is a natural 
metabolite of E. coli, Phytochrome B requires phycocyanobilin (PCB) for which’s biosynthesis 
pathway E. coli lacks the two final enzymes [96, 97, 100]. Accordingly, a co-expression of two 
additional enzymes would be necessary for the switch’s functionality. Therefore, this opto-
switch should be constructed after a PCB producing operon is integrated into the genome of an 
E. coli strain without negatively impacting its endogenous heme metabolism. 
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5.2.3. Preliminary results for a two-protease signal transducer (Master thesis 
C. Rühmkorff) 
During a practical course conducted throughout this project, several BL21(DE3) strains with 
chromosomal integrated TVMV variants had been generated. All integrations were performed 
as single copy integration using the HK022 phage integrase following the Clonetegration 
protocol [102] modified by M. Röder (see Chapter 13.3.1). Previously, TVMV activity within 
these strains could not be detected with the C-degron based in vivo assay (data not shown). By 
using plasmid-based expression of AI-TVMVHCV, as TVMV signal transducer and amplifier, 
TVMV activity within these strains might have been detectable. Figure 32 shows the results for 
the first test of the signal amplifier using the BL21(DE3)[HK022 attB::T7.03_MBP-
TVMVTVMV-His6] as the first test strain. 
As visible in Figure 32 both AI-TVMVHCV and AI-TVMVHCVS152A behaved like HCVS152A meaning 
no HCV activity and in turn no TVMV activity was detected. One reason could be insufficient 
production of TVMV due a shared promoter with sensor construct. In future experiments, this 
could be circumvented by using three different promoters for all three components. 
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Figure 32 Preliminary results for the two-protease signal transducer. A: Schematic depiction of the design principle 
of the signal transducer: In the default state, the C-degron tagged HCV sensor is co-expressed with auto-inhibited 
HCV; Accordingly, no fluorescent signal is generated; In presence of TVMV, the AI domain is cleaved off and active 
HCV can now remove the C-degron which leads to increase in the mNG-dependent fluorescent signal. B: The three 
graphs show the protease dependent mNG fluorescence over the course of 8 hours. HCV constructs were 
pre-produced from pPRO24 for 2 hours (25 mM sodium propionate) before the sensor and a chromosomal-
integrated variant of TVMV was induced with 500 µM IPTG (both T7.03 promoter, sensor additional U9 RNA 
thermometer); data points represent the mean values for the dependent biological quadruplicates measured, error 
areas depict the SEM, sensor constructs stated above the corresponding graph, bottom left legend refers to all 
graphs. Left: positive controls without any degron attached. Right: actual data with LVA C-degron present, the lower 
right graph shows the same data as the upper right one except the active HCV reference was removed to better 
visualize the differences between HCVS152A and AI-TVMVHCV / AI-TVMVHCVS152A. Constructs used: pPRO24_MBP-HCVHCV-
Strep, pPRO24_MBP-HCVHCVS152A-Strep, pPRO24_MBP-HCVAI(HCV)-TVMVHCV-Strep, pPRO24_MBP-HCVAI(HCV)-
TVMVHCVS152A-Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA. Protein Sequences 
are stated in the supplement (see 13.4.11). 
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5.3. Closing remarks 
A suitable and robust in vivo assay for the characterization of protease-based switches in live 
E. coli was finally established. Due to a lack of bioavailable input signals, a fully operational 
switch could not be identified or characterized.  
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6. Materials and Methods 
6.1. Materials 
6.1.1. Strains 
Table 7 Strains used in this work 
Strain Geneotype Usage Originator 
E. coli 
DH10β  
Δ(ara-leu) 7697 araD139  fhuA ΔlacX74 galK16 galE15 
e14-  ϕ80dlacZΔM15  recA1 relA1 endA1 
nupG  rpsL (StrR) rph spoT1 Δ(mrr-hsdRMS-mcrBC)  
Cloning and plasmid 
propagation 
NEB 
E. coli 
BL21(DE3) 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ΔhsdS 
λ DE3 = λ sBamHIo ΔEcoRI-B int::(lacI::PlacUV5::T7 gene1) 
i21 Δnin5 
expression of 
recombinant proteins; 
in vivo assays 
NEB 
E. coli 
Shuffle T7 
F´ lac, pro, lacIq / Δ(ara-leu)7697 araD139 fhuA2 lacZ::T7 
gene1 Δ(phoA)PvuII phoR ahpC* galE (or U) galK 
λatt::pNEB3-r1-cDsbC (SpecR, lacIq) ΔtrxB rpsL150(StrR) 
Δgor Δ(malF)3 
lon+ E. coli K strain for 
in vivo assays 
NEB 
KRx 
[F´, traD36, ΔompP, proA+B+, lacIq, Δ(lacZ)M15] 
ΔompT, endA1, recA1, gyrA96 (Nalr), thi-1, hsdR17 (rk–, 
mk+), e14– (McrA–), relA1, supE44, Δ(lac-proAB), 
Δ(rhaBAD)::T7 RNA polymerase 
lon+ E. coli K strain for 
in vivo assays 
Promega 
EcJR1 BL21(DE3)::HK022[PT79_MBP-tvmv-TVMV-FKBP-His6] 
Stable, IPTG inducible, 
low level expression of 
a Rapamycin 
recruitable TVMV  
I. Marquardt 
EcJR2 BL21(DE3)::HK022[PT7n_MBP-tvmv-TVMV-His6] 
Stable, IPTG inducible, 
expression of TVMV 
I. Marquardt 
EcJR3 BL21(DE3)::HK022[PT7n_MBP-tvmv-TVMV-FKBP-His6] 
Stable, IPTG inducible, 
expression of a 
recruitable TVMV 
I. Marquardt 
EcJR4 BL21(DE3)::HK022[PT79_MBP-tvmv-TVMV-His6] 
Stable, IPTG inducible, 
low level expression of 
TVMV 
I. Marquardt 
EcJR5 BL21(DE3)::HK022[PT7n_MBP-tev-AI-FKBP-FRB-TVMV-
His6] 
Stable, IPTG inducible, 
expression of a 
rapamycin switchable 
TVMV 
J. Ranglack 
EcJR6 BL21(DE3)::HK022[PT73_MBP-tvmv-TVMV-His6] 
Stable, IPTG inducible, 
medium level 
expression of a 
Rapamycin recruitable 
TVMV 
J. Ranglack 
EcJR7 BL21(DE3)::HK022[PT73_MBP-tev-AI-FKBP-FRB-TVMV-
His6] 
Stable, IPTG inducible, 
medium level 
expression of a 
rapamycin switchable 
TVMV 
J. Ranglack 
EcJR8 BL21(DE3)::HK022[PT711_MBP-TVMV-TVMV-FKBP-His6] 
Stable, IPTG inducible, 
low level expression of 
a Rapamycin 
recruitable TVMV 
J. Ranglack 
EcJR9 BL21(DE3)::HK022[PT7n_MBP-tvmv-TVMV-His6] Same as EcJR2 J. Ranglack 
EcJR10 BL21(DE3)::HK022[PT711_MBP-TEV-AI-FKBP-FRB-TVMV-
His6] 
Stable, IPTG inducible, 
low level expression of 
a rapamycin 
switchable TVMV 
J. Ranglack 
EcJR11 BL21(DE3)::HK022[PT79_MBP-tev-AI-FKBP-FRB-TVMV-
His6] 
Stable, IPTG inducible, 
low level expression of 
J. Ranglack 
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a rapamycin 
switchable TVMV 
EcJR12 BL21(DE3)::HK022[PT79_MBP-tvmv-TVMV-His6] Same as EcJR4 J. Ranglack 
EcJR13 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-sSH3L-(GGS)8-TVMV(C151A)-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
mock  
J. Ranglack 
EcJR14 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-wSH3L-(GGS)8-TVMV(elong.)-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
J. Ranglack 
EcJR15 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-TVMV(C151A)-(GGS)8-sSH3L-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
mock  
J. Ranglack 
EcJR16 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-TVMV(C151A)-(GGS)8-wSH3L-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
mock  
J. Ranglack 
EcJR17 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-TVMV(elong.)-(GGS)8-sSH3L-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
J. Ranglack 
EcJR18 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-TVMV(elong.)-(GGS)8-wSH3L-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
J. Ranglack 
EcJR19 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmvs-
NS3N10-TVMV(elong.)-(GGS)8-wSH3L-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
mock 
J. Ranglack 
EcJR20 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)ET-tvmvs-
NS3N10-sSH3L-(GGS)8-TVMV(elong.)-(GGS)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
J. Ranglack 
EcJR21 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmv-
NS3N10-TVMV(elong.)-(G2S)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
J. Ranglack 
EcJR22 BL21(DE3)::HK022[Pprp_RBS_MBP-L(G3S)3ET-tvmv-
NS3N10-TVMV(C151A)-(G2S)2-Strep] 
Stable, propionate 
inducible expression 
of a recruitable TVMV 
mock 
J. Ranglack 
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6.1.2. Vectors 
Table 8 Vectors used in this work. 
Name 
Promotor - 
repressor 
(inducer) 
Ori (Class) 
Selection 
marker 
Usage Originator 
pPRO24 
prp - PrpR 
(propionate) 
ColE1 + F1 
(A) 
AmpR 
Expression of protease 
constructs 
Addgene 
17805, [87]  
pACYCT2 
pT7 in 
tandem with 
tac – both 
LacI (IPTG) 
p15A (B) CamR 
Basis for creation of 
pCrtl2 
Addgene 
45799, [88]  
p-ET24(+) 
pT7 – LacI 
(IPTG) 
f1 ori (A) KanR 
Intimal expression 
vector for protease 
construcs 
Novagen 
pASK-iba3 
ptet-TetR 
(AHT) 
pBR332 (A) AmpR 
Initial expression vector 
for sensor constructs 
iba 
pCtrl2 
T7 – LacI 
(IPTG) 
p15A (B) CamR 
Overexpression of 
sensor constructs 
W. Weber 
pCtrl2_T7.03_U9 
T7.03 – LacI 
(IPTG); U9 
RNA 
thermometer 
p15A (B) CamR 
Low level expression of 
sensor constructs 
J. Ranglack, 
T7.03: [84]; 
U9: [93] 
pFD none ColE1 (A) KanR 
Deposition of 
functional domains as 
parts for iFLinkC 
Addgene 
137108 
pL2 none ColE1 (A) KanR 
Deposition of linkers as 
parts for iFLinkC 
Addgene 
137090 
pDESTara2 
Araba – AraC 
(arabinose) 
ColE1 (A) AmpR 
Expression of iFLinC 
libraries 
A. Gräwe 
pDESTprp 
prp – PrpR 
(propionate) 
ColE1 (A) AmpR 
Expression of protease 
constructs cloned with 
iFLinkC 
J. Ranglack 
pOSIP-CH 
has to cloned 
alongside the 
insert 
R6KΥ (C) CamR 
Integration of 
expression cassette into 
genome of E. coli using 
HK022 integrase (is 
coded on the vector as 
well) 
Addgene 
#45980 
[102]  
pE-FLP 
pE 
(constitutive) 
pSC101 (C) 
AmpR 
(50 
µg/mL 
Amp !) 
Excission of the 
integration module of 
pOSIP vectors following 
successfully integration 
Addgene 
#45978 
[102] 
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Vector map of pPRO24 
 
Figure 33 Vector map of pPRO24 (Addgene 17805, [87]). The vector comprises of two class A origins of replication, 
an ampicillin resistance cassette and a propionate inducible expression cassette. The expression cassette includes the 
promoter region of the propionate operon (prpBCDE) of E. coli and the repressor gene of the propionate operon 
prpR. Figure generated with SnapGene (GSL Biotech LLC). 
 
 
 
 
 
 
 
 
 92 
Complete nucleotide sequence of pPRO24 
EcoRI and SalI sites used for cloning into pPRO24 highlighted in bold. 
ATCGATTCAGCTTTTCAGCCGCCGCCAGAACGTCGTCCGGCTGATGCCTAAATAATTCGCCGCTGCTGTTTTATCGCCATTAAATTTCTCCAGTGCCTGTTGTGGTG
TCAGTAAGCGTGGAGCGGGAGTTTTCGCCGACTCGCGCGCCAGTTCCGGCAGTAGCAGCTGCAAAAATTGCGGCGTTAAATCCGGCGTCGGTTCCACACTTAAAAAT
AGCGCCAGTCGCTCCATCATATTGCGCAGTTCACGAATATTGCCCGGCCAGTCGTAGTGCACCAGCACGGTTTCGCTTGCCTGTAATCCCTGGCGTAATGCGGCAGA
AAACGGGGTGGAGAGCGCCGCCAGAGACACTTTCAAAAAGCTTTCCGCCAGTGGCAGAATATCCGCCACCCGCTCGCGCAGTGGTGGCAATTGCAGACGCAAAATAC
TCAGCCGATAAAACAGGTCACGGCGAAACTGCCCTTGCCGCATATCTTCTTCCAGATTGCAGTGAGTGGCGCTAATGACCCGCACATCCACCGGAACAGGCTGATGC
CCGCCGACGCGGGTGACCTCTTTTTCTTCCAGCACCCGCAGCAGCCGGGTCTGCAACGGCAGCGGCATTTCGCCAATCTCATCGAGAAACAGCGTACCTCCGTGGGC
GATTTCAAACAGCCCGGCGCGACCGCCGCGTCGCGAGCCGGTAAACGCCCCTTCCTCATAGCCAAACAGTTCTGCTTCCAGCAGCGATTCGGCAATCGCCCCGCAGT
TGACTGCAACAAACGGATGCGACTTTTTGCCCTGTCGCGCATCGTGGCGGGCAAAATATTCCCGATGAATCGCCTGGGCCGCCAGCTCTTTGCCCGTCCCCGTTTCC
CCCTCAATCAACACCGCTGCACTGGAGCGGGCATACAGCAAAATAGTCTGCCGTACTTGTTCCATCTGTGGTGATTGACCGAGCATATCGCCCAGCACGTAACGAGT
TCTCAGGGCGTTGCGGGTGGCATCGTGAGTGTTATGGCGTAACGACATGCGCGTCATATCCAGCGCATCGCTGAACGCCTGGCGCACGGTGGCGGCGGAATAGATAA
AAATTCCGGTCATTCCGGCTTCTTCTGCCAGATCGGTAATCAGCCCCGCGCCGACCACCGCTTCGGTGCCGTTAGCTTTTAGCTCGTTAATCTGCCCGCGTGCGTCT
TCTTCGGTAATGTAGCTACGTTGATCGAGGCGCAAATTAAAGGTTTTTTGAAACGCCACCAGTGCCGGAATAGTTTCCTGATAAGTGACAACGCCGATAGAAGAGGT
GAGTTTTCCGGCTTTTGCCAGTGCCTGTAACACATCGTAGCCGCTCGGTTTAATCAAAATAACTGGCACTGACAGGCGGCTTTTCAGGTACGCGCCGTTAGATCCAG
CGGCGATGATGGCGTCACAGCGTTCGTTTGCCAGTTTCTTGTGGATGTAGGTCACCGCTTTTTCAAAGCCAAGCTGGATAGGGGTAATGTTCGCCAGGTGATCAAAC
TCGAGGCTGATATCGCGAAACAGCTCGAACAGGCGCGTTACAGATACCGTCCAGATAACCGGTTTGTCGTCATTAAGCCGTGGTGGATGTGCCATAGCGCACCGCAA
AGTTAAGAAACCGAATATTGGGTTTAGTCTTGTTTCATAATTGTTGCAATGAAACGCGGTGAAACATTGCCTGAAACGTTAACTGAAACGCATATTTGCGGATTAGT
TCATGACTTTATCTCTAACAAATTGAAATTAAACATTTAATTTTATTAAGGCAATTGTGGCACACCCCTTGCTTTGTCTTTATCAACGCAAATAACAAGTTGATAAC
AAGCTAGCAGGAGGAATTCACCATGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCAGCCTGAT
ACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAAACGCC
GTAGCGCCGATGGTAGTGTGGGGTCTCCCCATGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTG
TTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGGGAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGCCCGCCATAAA
CTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTCTACAAACTCTTTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCT
CATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCC
TTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATC
CTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTGTTGACGCCGGGCAAGAGCAACTCGG
TCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAA
CCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGAT
CGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACT
TACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAAT
CTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATG
GATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTACGCGCCCT
GTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTC
GCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTTGGGTGA
TGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTTGAACAACACTCA
ACCCTATCTCGGGCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAA
ATATTAACGTTTACAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCG
TAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAA
GAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGT
AGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATA
AGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCC
ACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAG
TCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCC
TGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGC
CGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATAGGGTCATG
GCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTG
TCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCG
CTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCC
GGCGTAGAGGATCTGCTCATGTTTGACAGCTTATC 
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Vector map of pCtrl2 
 
Figure 34 Vector map of pCtrl2 (W. Weber unpublished results). The vector comprises of the class B origin of 
replication p15A, a chloramphenicol resistance cassette and a lactose/IPTG inducible expression cassette. The 
expression cassette includes the promoter of the T7 phage and the operator of the E. coli lac operon (lacZYA) and 
the repressor gene of the lac operon lacI (lacI includes W220F mutation for reduced leaky expression). Figure 
generated with SnapGene (GSL Biotech LLC). 
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Vector map pDESTara2 
 
Figure 35 Vector map of pDESTara2 (A. Gräwe, unpublished results). The vector comprises of a class A origin of 
replication, an ampicillin resistance cassette and an arabinose inducible expression cassette. The expression cassette 
includes the promoter of the arabinose operon of E. coli (araBAD) and the repressor gene of the arabinose operon 
araC. The MCS includes a stuffer sequence for better differentiation of NheI…BtsI restriction fragment from 
unrestricted vector during electrophoresis. Figure generated with SnapGene (GSL Biotech LLC). 
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Complete nucleotide sequence of pDESTara2 
BtsI and NheI sites used for cloning of optical regulated TVMV switch candidate library into 
pDESTara2 highlighted in bold. 
GTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGC
TACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCCG
TAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGG
GTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGAT
ACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTT
CCAGGGGGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAA
CGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCA
ATTCCGTAGAGGATCTGCTCATGTTTGACAGCTTATCATCGATGCATAATGTGCCTGTCAAATGGACGAAGCAGGGATTCTGCAAACCCTATGCTACTCCGTCAAGC
CGTAAATTGTCTGATTCGTTACCAATTATGACAACTTGACGGCTACATCATTCACTTTTTCTTCACAACCGGCACGGAACTCGCTCGGGCTGGCCCCGGTGCATTTT
TTAAATACCCGCGAGAAATAGAGTTGATCGTCAAAACCAACGTTGCGACCGACGGTGGCGATAGGCATCCGGGTGGTGCTCAAAAGCAGCTTCGCCTGGCTGATACG
TTGGTCCTCGCGCCAGCTTAAGACGCTAATCCCTAACTGCTGGCGGAAAAGATGTGACAGACGCGACGGCGACAAGCAAACATGCTGTGCGACGCTGGCGATGTCAA
AATTGCTGTCTGCCAGGTGATCGCTGATGTACTGACAAGCCTCGCGTACCCGATTATCCATCGGTGGATGGAGCGACTCGTTAATCGCTTCCATGCGCCGCAGTAAC
AACTGCTCAAGCAGATTTATCGCCAGCAGCTCCGAATAGCGCCCTTCCCCTTGCCCGGCGTTAATGATTTGCCCAAACAGGTCGCTGAAATGCGGCTGGTGCGCTTC
ATCCGGGCGAAAGAACCCCGTATTGGCAAATATTGACGGCCAGTTAAGCCATTCATGCCAGTAGGCGCGCGGGCGAAAGTAAACCCACTGGTGATACCATTCGCGAG
CCTCCGGATGACGACCGTAGTGATGAATCTCTCCTGGCGGGAACAGCAAAATATCACCCGGTCGGCAAACAAATTCTCGTCCCTGATTTTTCACCACCCCCTGACCG
CGAATGGTGAGATTGAGAATATAACCTTTCATTCCCAGCGGTCGGTCGATAAAAAAATCGAGATAACCGTTGGCCTCAATCGGCGTTAAACCCGCCACCAGATGGGC
ATTAAACGAGTATCCCGGCAGCAGGGGATCATTTTGCGCCTCAGCCATACTTTTCATACTCCCGCCATTCAGAGAAGAAACCAATTGTCCATATTGCATCAGACATT
GTCGTCACTGAGTCTTTTACTGGCTCTTCTCGCTAACCAAACCGGTAACCCCGCTTATTAAAAGCATTCTGTAACAAAGCGGGACCAAAGCCATGACAAAAACGCGT
AACAAAAGTGTCTATAATCACGGCAGAAAAGTCCACATTGATTATTTGCACGGCGTCACACTTTGCTATGCCATAGCATTTTTATCCATAAGATTAGCGGATCCTAC
CTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACCCGTTTTTTTGGTCTAGCAAATTCGAGCTTAAATTCTCTAGAAATAATTTTGTTTAACTTTAAGAAG
GAGATATACATATGGGGCACTGCATGGGGGTGTCCAAGGGAGAGGAGGATAATATGGCTTCCCTGCCGGCGACCCATGAACTTCATATCTTTGGTTCGATCAACGGA
GTGGACTTTGATATGGTTGGTCAAGGCACGGGAAACCCGAACGATGGGTATGAAGAGTTGAATCTTAAATCGACAAAAGGGGATCTTCAATTCAGCCCTTGGATTCT
GGTCCCGCATATCGGGTATGGCTTCCACCAGTATTTACCATACCCGGACGGGATGTCTCCATTCCAGGCCGCTATGGTGGATGGCTCTGGTTACCAAGTGCATCGCA
CCATGCAGTTCGAGGACGGAGCATCTCTTACTGTTAACTACCGTTATACCTACGAAGGATCACACATTAAGGGAGAAGCTCAGGTTAAAGGAACGGGATTTCCCGCT
GACGGACCCGTAATGACTAATAGCCTGACAGCTGCCGACTGGTGTCGCAGTAAGAAAACTTATCCTAACGACAAAACGATTATCTCGACGTTCAAATGGTCTTACAC
GACTGGAAATGGGAAGCGCTACCGTAGCACGGCCCGCACGACGTACACCTTTGCCAAACCGATGGCGGCTAACTATCTGAAGAATCAACCCATGTATGTTTTTCGTA
AAACAGAATTGAAACATAGTAAGACTGAACTGAACTTCAAGGAGTGGCAAAAAGCATTTACGGACGTGATGGGGATGGATGAGTTATATAAAGGTGGATCCGGAGGT
AGCTGTCTGAGCTACGACACTGAAATCCTGACGGTAGAATACGGGTTCCTTCCCATCGGTAAGATCGTTGAAGAACGTATCGAGTGTACTGTTTACACTGTGGACAA
AAACGGGTTCGTCTATACGCAGCCGATTGCACAATGGCATAATCGCGGCGAACAAGAGGTTTTTGAGTATTGCCTGGAGGACGGCAGTATCATTCGCGCCACTAAAG
ATCATAAATTTATGACGACCGATGGTCAGATGTTGCCTATTGATGAAATCTTCGAACGTGGGCTTGACTTGAAACAAGTTGATGGCTTACCAGGCATTGCATAAGCT
AGCCGATTCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCT
CACCTTCGGGTGGGCCTTTCTGCGTTTATACTCCGGGAGCTGCATGTGTCAGAGGTTTAACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGAT
AATAATGGTTTCTTAGACGTCAGGTGGCAGGCTTACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCA
TGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTT
CCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCT
TGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTC
GCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGTAGTGCTGCCATAACC
ATGAGTGATAACACAGCGGCCAACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCG
TTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCGATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTA
CTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTTCGCTCAGCACTTCCAGCTGGTTGGTTTATTGCTGATAAATCT
GGAGCCGGTGAGCGTGGATCTCGCGGTATCATAGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGA
TGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTGAATTCAAACTTCATTTTTAA
TTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGA 
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6.1.3. Genetic elements and protein sequences obtained or adopted from third 
parties 
Table 9 Genetic elements and protein sequences obtained or adopted from third parties 
Name Sequence Usage Originator 
PT7.03 5’-TAATACGACTCACTACAGG-3’ Reduced gene expression under 
control of T7 RNA polymerase; 
mutated base in bold, 
introduced to pCtrl2 via NcoI and 
NdeI sites 
[84] 
U9 RNA 
thermometer 
5’-
GATCCCTCCTTACTAGTCTGCAGAAGGAGATA
TA-3’ 
Reduced gene expression at 30 
°C; Shine-Dalgarno sequence in 
italic and anti-Shine-Dalgarno 
sequence in underlined and 
italic, introduced to pCtrl2 via 
NcoI and NdeI sites 
[93] 
TVMV H2N-
SKALLKGVRDFNPISACVCLLENSSDGHSERLFGI
GFGPYIIANQHLFRRNNGELTIKTMHGEFKVKNS
TQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQP
TIKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTS
FWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTT
NGSNYFVEFPEKFVATYLDAADGWCKNWKFN
ADKISWGSFTLVEDAPED-CO2H 
Establishment of in vivo protease 
assay 
[41] 
TVMV site H2N-ETRFQ|S-CO2H Construction of TVMV cleavable 
proteins 
[38] 
FKBP H2N-
GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDG
KKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQ
MSVGQRAKLTISPDYAYGATGHPGIIPPHATLVF
DVELLKLE-CO2H 
Rapamycin inducible recruitment [83] 
FRB H2N-
ILWHEMWHEGLEEASRLYFGERNVKGMFEVLE
PLHAMMERGPQTLKETSFNQAYGRDLMEAQE
WCRKYMKSGNVKDLTQAWDLYYHVFRRI-
CO2H 
Rapamycin inducible recruitment [83] 
mNG H2N-
VSKGEEDNMASLPATHELHIFGSINGVDFDMVG
QGTGNPNDGYEELNLKSTKGDLQFSPWILVPHI
GYGFHQYLPYPDGMSPFQAAMVDGSGYQVHR
TMQFEDGASLTVNYRYTYEGSHIKGEAQVKGT
GFPADGPVMTNSLTAADWCRSKKTYPNDKTIIS
TFKWSYTTGNGKRYRSTARTTYTFAKPMAANY
LKNQPMYVFRKTELKHSKTELNFKEWQKAFTD
VMGMDELYK-CO2H 
Fluorescent reporter for in vivo 
assays 
[85] 
mCherry H2N-
VSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEI
EGEGEGRPYEGTQTAKLKVTKGGPLPFAWDILS
PQFMYGSKAYVKHPADIPDYLKLSFPEGFKWER
VMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTN
FPSDGPVMQKKTMGWEASSERMYPEDGALKG
EIKQRLKLKDGGHYDAEVKTTYKAKKPVQLPG
AYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGG
MDELYK-CO2H 
Fluorescent reporter for in vivo 
assays 
[95] 
mKOκ H2N-
VSVIKPEMKMRYYMDGSVNGHEFTIEGEGTGRP
YEGHQEMTLRVTMAEGGPMPFAFDLVSHVFCY
GHRVFTKYPEEIPDYFKQAFPEGLSWERSLEFED
GGSASVSAHISLRGNTFYHKSKFTGVNFPADGPI
MQNQSVDWEPSTEKITASDGVLKGDVTMYLKL
 [103] 
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EGGGNHKCQFKTTYKAAKEILEMPGDHYIGHRL
VRKTEGNITEQVEDAVAHS-CO2H 
His6-tag H2N-H6-CO2H Protein purification and 
detection on Western blots 
[104] 
MBP H2N-
KIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIK
VTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRF
GGYAQSGLLAEITPDKAFQDKLYPFTWDAVRY
NGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPA
LDKELKAKGKSALMFNLQEPYFTWPLIAADGGY
AFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIK
NKHMNADTDYSIAEAAFNKGETAMTINGPWA
WSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSA
GINAASPNKELAKEFLENYLLTDEGLEAVNKDKP
LGAVALKSYEEELVKDPRIAATMENAQKGEIMP
NIPQMSAFWYAVRTAVINAASGRQTVDEALKD
AQT-CO2H 
Increased solubility of fusion 
partners 
[105] 
Strep-TagII H2N-WSHPQFEK-CO2H Protein purification and 
detection on Western blots 
[106, 107] 
myc-tag H2N-EQKLISEEDL-CO2H detection of proteins on Western 
blots 
[108] 
SH3 domain H2N-
AEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEE
QWWNAEDSEGKRGMIPVPYVEKY-CO2H 
Constitutive protein recruitment [94] 
sSH3L H2N-PPPPLPPKRRR-CO2H Constitutive protein recruitment [94] 
wSH3L H2N-PPPALPPKKR-CO2H Constitutive protein recruitment [94] 
TEV with 
enhanced 
stability 
H2N-
GESLFKGPRDYNPISSTICHLTNESDGHTTSLYGIG
FGPFIITNKHLFRRNNGTLVVQSLHGVFKVKNTT
TLQQHLIDGRDMIIIRMPKDFPPFPQKLKFREPQ
REERICLVTTNFQTKSMSSMVSDTSCTFPSGDGIF
WKHWIQTKDGQCGSPLVSTRDGFIVGIHSASNF
TNTNNYFTSVPKNFMELLTNQEAQQWVSGWR
LNADSVLWGGHKVFMVKPEEPFQPVKEATQL
MNELVYSQ-CO2H 
Alternative to TVMV [109] 
TEV site H2N-ENLYFQ|S-CO2H Construction of TEV cleavable 
constructs 
[109] 
HCV H2N-
AKGSVVIVGRINLSGDTAYSQQTRGAAGIAATS
ATGRDKNQVDGEVQVLSTATQSFLATCVNGVC
WTVYHGAGSKTLAGPKGPITQMYTNVDQDLV
GWPAPPGARSMTPCTCGSSDLYLVTRHADVIPV
RRRGDSRGSLLSPRPVSYLKGSSGGPLLCPSGHVV
GIFRAAVCTRGVAKAVDFIPVESMETTMR-CO2H 
Alternative to TVMV [110] 
HCV site H2N-DDVTPCSM|S-CO2H Construction HCV cleavable 
constructs 
[110] 
E118-134  H2N-FGTWACRVRASHGVCAQ-CO2H Degradation of proteins Weigand 
grouop 
unpublishe
d findings 
E118min H2N-FGTWACR-CO2H Degradation of proteins Weigand 
grouop 
unpublishe
d results 
LVA H2N-AANDENYALVA-CO2H Degradation of proteins [21] 
FLFVQ H2N-FLFVQ-CO2H Degradation of proteins [21] 
YLFVQ H2N-YLFVQ-CO2H Degradation of proteins [21] 
AI(TVMV) H2N-REYVRFAP-CO2H Inhibiting TVMV activity in vivo [1] 
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6.1.4. DNA and Protein size standards 
DNA size standards were purchased from NEB. For the most part Quick-Load® 1 kb Plus DNA 
Ladder was used. Occasionally Quick-Load® 100 bp DNA Ladder was used for DNA fragments 
shorter than 300 bp. Likewise for very long fragments (over 5 kb) Quick-Load® 1 kb DNA 
Ladder was used.  
 
 
Figure 36 DNA size standards. [Figure gladly adopted from New England Biolabs; source: https://www.nebiolabs.com.au/-
/media/nebus/page-images/newsized-brochure-images/markers-and-ladders/dna_markers.png?la-en&rev-
ee28084199b247588a9cfda1292e0b78&hash-02740B22C5139C691D53E1EFF1AD8835AD400D84] 
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6.1.5. Synthetic DNA 
Short single stranded DNA oligo nucleotides (ssDNA oligos) were ordered from Sigma Alrich 
(product number: VC00021). All oligos were ordered with 0.025 µg synthesis scale, purified 
through desalting and shipped in dry format. ssDNA oligos were used directly as primers for 
PCRs or were pairwise hybridized to assemble short functional domains or linkers as parts for 
iFLinkC. Additionally, to before mentioned usages, ssoligos were pairwise hybridized to form 
adaptors in order to ligate ssoverhangs from, by default incompatible, restriction enzymes.  
Long double stranded DNA fragments were ordered from Integrated DNA Technologies (IDT) 
as “gBlock gene fragments™”. gBlocks™ were used to constitute new cloning or expression 
vectors, to code for new functional domains for iFLinkC or in some cases for the cloning of new 
constructs via Gibson Assembly when PCR or restriction enzymes based cloning procedures 
were not suitable or proofed exceptionally difficult. 
 
6.1.6. Antibodies and western blot reagents 
Table 10 Antibodies / reagent used for detection of proteins on western blots. 
Antibody / reagent Host Clonality and Isotype Supplier Product number 
Anti-myc Antibody Sheep polyclonal, IgG Invitrogene PA3-981 
Anti-sheep IgG (H+L) Antibody 
AlexaFluor633 conjugate 
Donkey Polyclonal, IgG Invitrogene A-21100 
6x-His Tag Antibody Mouse Monoconal, IgG2b Invitrogene MA1-21315 
Anti-mouse IgG (H+L) HRP conjugate Rat Monoclonal, IgG1κ Invitrogene 04-6020 
Precision Strep-Tactin HRP conjugate - - BioRad 2-1502-001 
 
If proteins were detected via horse radish peroxidase conjugates, HRP reaction was developed 
using the ClartyTM Western ECL Substrate from Bio Rad (Cat. # 170-5061). 
For in gel epifluorescence images as well as western blots shown (see Chapter 6.2.13) in this 
work the BlueStar Prestained Protein Marker (Nippon Genetics) was used as a protein size 
standard (see Figure 37). 
 
 100 
 
Figure 37 BlueStar Prestained Protein Marker (Nippon Genetics). 4-20% PAA gradient gels with Tris-Glycine buffer 
system, bands sizes in kDa. Figure gladly adopted from Nippon Genetics; [source: 
https://www.nippongenetics.eu/bilder/products/protein-elektrophorese/prestained-protein-marker/blue-star0_500x5200_481x500.jpg] 
  
 
 101 
6.1.7. Restriction endonucleases, polymerase and additional DNA processing 
enzymes 
All DNA processing enzymes were obtained from New England Biolabs (NEB). 
Table 11 DNA processing enzymes 
Enzyme Recognition sequence Usage 
Catalog 
Number 
BamHI-HF® G|GATCC Classical restriction ligation cloning R3136 
BbsI-HF® 
GAAGACN2|N4 
CTTCTGN6| 
iFLinkC R3539 
BsaI-HFv2® 
GGTCTCN|N5 
CCAGAGN5|N 
iFLinkC R3733 
BsrDI 
GCAATGNN| 
CGTTAC|NN 
iFLinkC R0574 
BtsI-v2 
GCAGTGNN| 
CGTCAC|NN 
iFlinkC R0667 
EcoRI-HF® G|AATTC 
Classical restriction ligation cloning, 
iFLinkC 
R3101 
HindIII-HF® A|AGCTT Classical restriction ligation cloning R3104 
KpnI-HF® GGTAC|C Classical restriction ligation cloning R3142 
MfeI-HF® C|AATTG 
Classical restriction ligation cloning, 
iFLinkC 
R3589 
NcoI-HF® C|CATGG Classical restriction ligation cloning R3193 
NdeI CA|TATG Classical restriction ligation cloning R0111 
NheI-HF® G|CTAGC 
Classical restriction ligation cloning, 
iFLinkC 
R3131 
NotI-HF® GC|GGCCGC Classical restriction ligation cloning R3189 
SacI-HF® GAGCT|C Classical restriction ligation cloning R3156 
SalI-HF® G|TCGAC Classical restriction ligation cloning R3138 
SpeI-HF® A|CTAGT 
Classical restriction ligation cloning, 
iFLinkC 
R3133 
XbaI T|CTAGA Classical restriction ligation cloning R0145 
XhoI C|TCGAG Classical restriction ligation cloning R0146 
T4 DNA Ligase Sticky or blunt ends 
Classical restriction ligation cloning, 
iFLinkC 
M0202 
T4 Polynucleotide Kinase 5’ hydroxyl groups Classical restriction ligation cloning, 
iFLinkC 
M0201 
Shrimp Alkaline 
Phosphatase (rSAP) 
5’ and 3’ phosphate 
groups 
Classical restriction ligation cloning, 
iFLinkC 
M0371 
Phusion® High-Fidelity 
DNA Polymerase 
Primer-ssDNA-duplexes 
DNA amplification, DNA sequence 
mutagenesis, colony screenings 
M0530* 
Gibson Assembly® Master 
Mix 
Homologue 35-50 nt 
dsoverhangs 
Gibson Assembly E2611 
*Phusion® High-Fidelity DNA Polymerase was not obtain from NEB but instead produced in-
house (see Chapter 6.2.5). However, 5x Phusion® GC buffer and 5x Phusion® HF buffer, were 
obtained from NEB (catalog numbers: B0519, B0518). 
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6.1.8. Buffers and solutions 
Tris-acetate-EDTA (TAE) buffer 
• 50x TAE 
o 242 g/L Tris, 57.1 mL glacial acetic acid, 100 mL EDTA (500 mM, pH = 8.0), 
fill up to 1 L with ddH2O. 
Phosphate buffers 
Phosphate buffers were prepared using the appropriate volume equivalents of 1 M NaH2PO4 
and 1 M Na2HPO4 stock solutions to yield the desired pH values and buffer capacities (total 
phosphate concentrations) according to Cold Spring Harbor Protocols [111]. 
Phosphate buffered saline 
• 1x PBS 
o 4 mM KH2PO4, 16 mM Na2HPO4, 115 mM NaCl, pH 7.4, prepared as 10x stock, 
steam sterilized and stored at RT 
• PBS blocking buffer 
o 3 %(w/v) BSA, 0.5 %(v/v) Tween20 in 1x PBS, freshly prepared with 10x PBS 
• PBS tween buffer 
o 0.1 %(v/v) Tween20 in 1x PBS, freshly prepared with 10x PBS 
His-tag buffers 
• His binding buffer 
o 20 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 7.4, prepared as 5x stock, 
steam sterilized and stored at RT, 1x working stock degassed and particle free 
• His elution buffer 
o 20 mM NaH2PO4, 500 mM NaCl, 300 mM imidazole, pH 7.4, prepared from 
5x His binding buffer, degassed and particle free 
• Ni solution 
o 100 mM Ni(II)SO4, degassed and particle free 
• Stripping solution 
o 20 mM NaH2PO4, 500 mM NaCl, 50 mM EDTA, pH 7.4, degassed and particle 
free 
 
 103 
6.1.9. Chemicals 
Table 12 Chemicals used in this work 
Chemical  Supplier  
Acetone, synthesis grade Carl Roth 
Acetic acid, glacial Carl Roth 
Adenosine triphosphate (ATP)  Sigma Aldrich 
Agar-Agar, Kobe Carl Roth 
Agarose  Sigma Aldrich 
Ammonium chloride (NH4Cl)  Merck KGaA 
Ammonium heptamolybdate ((NH4)6Mo7O24)  Carl Roth  
Ammonium persulfate Carl Roth 
Ampicillin sodium salt, BioScience Grade Carl Roth  
Anhydrotetracycline hydrochloride (AHT)  Carl Roth  
L(+)-Arabinose Carl Roth 
Boric acid (H3BO3)  AppliChem  
Bovine serum albumin (BSA) Carl Roth 
Calcium chloride (CaCl2)  Carl Roth  
Casein hydrosylate, standard Carl Roth 
Chloramphenicol Carl Roth 
Cobalt(II) chloride (CoCl2)  Merck KGaA 
Copper(II) sulfate (CuSO4)  AppliChem  
Desthiobiotin  IBA GmbH  
Dimethyl sulfoxide (DMSO) for PCR 
                                                 as solvent 
NEB 
Carl Roth 
Dithiothreitol (DTT)  Carl Roth  
dNTP mix Bioline 
Ethanol (EtOH) denatured 
                            pure 
Richter Chemie 
Carl Roth 
Ethylenediaminetetraacetic acid (EDTA)  Carl Roth  
D(+)-Galactose Carl Roth 
D(+)-Glucose, monohydrate  Carl Roth  
Glycerol  Carl Roth  
Glycine, Bioscience grade  Carl Roth  
HABA (2-(4-Hydroxyphenylazo)benzoic acid)  Sigma Aldrich 
Hydrochloric acid 37 % Carl Roth 
Imidazole  Sigma Aldrich 
Iron(II) sulfate (FeSO4)  Carl Roth  
Isopropanol Carl Roth  
Isopropyl β-D-1-thiogalactopyranoside (IPTG)  Carl Roth  
Kanamycin sulfate Carl Roth  
Lactose  Carl Roth  
Magnesium chloride (MgCl2)  Carl Roth  
Magnesium sulfate (MgSO4)  Merck KGaA 
Manganese(II) chloride (MnCl2)  Merck KGaA 
Methanol, blotting grade Carl Roth 
Midori Green Advance  Nippon genetics  
Nickel(II) sulfate (NiSO4) Carl Roth β-Mercaptoethanol Carl Roth  
Peptone from casein  Carl Roth  
Ortho-phosphoric acid, 85 % Carl Roth 
Potassium chloride (KCl)  Carl Roth  
Potassium hydroxide pellets (KOH) Carl Roth 
Potassium phosphate (KH2PO4/K2HPO4)  Carl Roth  
L(+)-Rhamnose, monohydrate Carl Roth 
ROTI®Blue (5x Coomassie staining reagent) Carl Roth 
ROTI® Nanoquant (5x Bradford reagent) Carl Roth 
Rotiphorese® Gel 30 (37.5:1)  Carl Roth  
Salmon sperm DNA sodium salt Carl Roth 
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Sodium chloride (NaCl)  Carl Roth  
Sodium dodecyl sulfate (SDS)  Carl Roth  
Sodium hydroxide pellets (NaOH) Carl Roth 
Sodium phosphate (NaH2PO4/Na2HPO4)  Carl Roth  
Sodium propionate (CH3CH2CO2Na) Sigma Aldrich 
Sulfuric acid, smoking (H2SO4) Carl Roth 
Spectinomycin dihydrochloride pentahydrate Sigma Aldrich 
Streptomycin sulfate, BioScience Grade Carl Roth 
Tetramethylethylenediamine (TEMED)  Carl Roth  
Thiamine hydrochloride Carl Roth 
Tris(hydroxymethyl)-aminomethan (Tris)  Carl Roth  
Triton® X 100 Carl Roth 
Tween®20 Carl Roth 
Yeast extract, micro granulated Carl Roth  
Zinc sulfate (ZnSO4)  AppliChem  
 
6.1.10. Media 
If required sterile filtered antibiotics were added. Ampicillin was added to a final concentration 
of 100 µg/mL, kanamycin at 50 µg/mL, chloramphenicol 25 µg/mL, lastly spectinomycin 
50 µg/mL. 
• Lysogenic broth (LB) medium [112] 
o 0.5 %(w/v) yeast extract, 1 %(w/v) peptone, 1%(w/v) NaCl, pH 7.4, steam 
sterilized and stored at RT, after antibiotics added stored at 4 °C 
• LB agar [112] 
o 0.5 % (w/v) yeast extract, 1 %(w/v) peptone, 1% (w/v) NaCl, pH 7.4, 
1.5 %(w/v) agar, steam sterilized and stored at RT, prior to casting agar was 
melt in a microwave and cooled to lukewarm temperature before adding 
antibiotics and subsequent casting 
Super Optimal broth with Catabolite repression (SOC) medium [113] 
• 2 %(w/v) peptone, 0.5 %(w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
20 mM MgSO4, 20 mM glucose 
o Magnesium and glucose were added from sterile filtered stock solutions under 
laminar flow after stream sterilization to avoid precipitation and Maillard 
product formation respectively. 
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M9 minimal medium 
• 0.6 %(w/v) Na2PO4, 0.3 %(w/v) KH2PO4, 0.5 %(w/v) NaCl, 0.1 %(w/v) NH4Cl, pH 7.4. 
After steam sterilization 0.2 %(w/v) glucose, 3nM (NH4)6Mo7O24, 0.4 µM H3BO3, 
30 nM CoCl2, 10 nM CuSO4, 80 nM MnCl2, 10 nM ZnSO4, 1 mM MgSO4, 100 µM CaCl2 
and 1 µM FeSO4 were added. 
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6.1.11. Technical Equipment and devices 
Table 13 Technical equipment used in this work 
Instrument  Model  Manufacturer  
Agarose gel chambers Perfectblue Mini S/M with various combs peqlab 
Automatic coffee machine Magnifica Delonghi 
Bench top centrifuge  Microstar 17  VWR  
Bench top centrifuge  Minispin plus  Eppendorf  
Bench top incubator  HT Ecotron  Infors  
Bench top rocker Rocker 3D digital IKA 
Bench-top vortex Vortex genie 2 Neo Lab 
Block heater  Touch Screen Block Heater  Thermo Fisher 
Scientific  
Blue light LED table Illuminator Nippon Genetics 
Cell density measurement device ULTROSPEC© 10 cell density meter Biochrom 
Cell homogenizer 
With external air compressor 
EmulsiFlex-C3 
Super Silent compressor 
Avestin 
Aerotech 
Electric pipetting aid Powerpipette pro VWR 
Electroporation device Gene pulser II with capacitance extender plus Bio-Rad 
FPLC Äcta Pure GE Healthcare 
Gel documentation (blue light LEDs) E-BOX  Vilber  
Gel documentation (epi-fluorescence, 
chemo-luminescence) 
Amersham Imager 600 RGB GE Healthcare 
Graduated glass pipettes VWR collection (5 mL, 10 mL, 20 mL) VWR 
Incubator for microtiter plates  Titramax 1000 & Inkubator 1000  Heidolph 
Incubator for petri dishes Icubat Typ 80 Melag Apparate 
Lab Scale SE 1202 VWR 
Large-scale Incubator HT Unitron  Infors 
Low volume UV/Vis 
spectrophotomerter 
Nanodrop OneC  Thermo Fisher 
Scientific  
Magnetic stirrer 
 With heating plate 
LabDisc S040 
LabDisc VMS-A S040 
VWR 
Microtiter plate reader  Spark Tecan 
Microwave oven Inverter Sharp 
PCR cycler  Labcycler Sensoquest 
pH meter pHenomenal pH1102 VWR 
Piston pipettes Research Plus (2.5 µL, 10 µL, 100 µL, 1000 µL, 
5 mL) 
Eppendorf 
Platform shakers with incubator 
hood 
Cetromat R/HK B. Braun Melsungen 
AG 
Power Supply for agarose and SDS 
gels  
PowerPac Basic  Bio-Rad  
Refrigerated centrifuge 
 With various rotors 
Allegra X-30R Centrifuge  Beckman Coulter  
Sonicator CL-18 Qsonica sonicators 
Thermal shaker  Cooling Thermal Shaker Touch  VWR 
Vacuum pump VP100 VWR 
Western blot device Trans-Blot® Turbo™ Bio-Rad 
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6.1.12. Software 
Table 14 Software used in this work 
Software Originator Reference 
UCSF Chimera University of California San Francisco [114-124] 
Microsoft® Office Mircrosoft  
SnapGene® GSL Biotech LLC  
GraphPad Prism GraphPad Software  
Affinity Designer Serif  
Fiji Johannes Schindelin, Albert Cardona, Mark Longair, Benjamin Schmid, 
and others 
[125-127] 
  
 
 108 
6.2. Methods 
6.2.1. E. coli cultivation 
Required solutions: 
• Lysogenic broth (LB) 
o 5 % (w/v) yeast extract, 1 %(w/v) peptone, 1%(w/v) NaCl, pH 7.4 
• LB agar 
o 5 % (w/v) yeast extract, 1 %(w/v) peptone, 1%(w/v) NaCl, pH 7.4, 1.5 %(w/v) 
agar 
• Appropriate antibiotics 
o Usually prepared as sterile filtered 1000x stock in appropriate solvent 
E. coli cells were cultivated in lysogenic broth (LB) medium containing the appropriate 
antibiotics at 37 °C shaking at 200 rpm. For protein production cultures were incubated at 30 °C 
to reduce growth rates as well as thermal denaturing of the proteins of interest. Broth cultures 
were inoculated with single colonies from agar plates, scrapped material from glycerol stocks, 
or from pre-cultures depending on the situation. For plasmid preparation 5 mL broth cultures 
were inoculated in standard glass tubes with metallic lids. For library generation 20 to 50 mL 
broth cultures in 50 to 200 mL Erlenmeyer flasks were performed. Lastly for the purification of 
proteins for in vitro characterizations 500 mL broth cultures in 1 L Erlenmeyer flasks were used. 
All flasks were covered with aluminum foil cut outs. 
 
6.2.2. Chemo-competent E. coli cells and heat shock transformation 
Required solutions: 
• CaCl2 solution 
o 80 mM CaCl2, autoclaved, pre-cooled to 4 °C 
• Cryo solution 
o 80 mM CaCl2, 20 %(v/v) glycerol, autoclaved, pre-cooled to 4 °C 
5 mL LB broth containing appropriate antibiotics, if necessary, were inoculated with a single 
colony or with material scrapped off a cryo-stock. Pre-cultures were incubated overnight at 
37 °C shaking at 180 rpm. On the following morning 200 mL LB broth containing the same 
antibiotics as before were inoculated with 2 mL overnight culture (1:100 dilution). The main 
culture was incubated as stated before until an OD600 of ~0.5 was reached. Cultures were split 
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into 50 mL reaction tubes. Subsequently, tubes were incubated on ice for 30 min. After cooling 
cells were harvested by centrifugation (2500xg, 4 °C, 30 min). All following steps were 
performed on ice. The supernatant was decanted and the precipitated cells were resuspended 
in 5 mL cold CaCl2 solution and transferred to a fresh pre-cooled 50 mL tube. Then, suspensions 
were filled up with CaCl2 solution to a final volume of 50 mL and were incubated for another 
30 min on ice. Cells were harvested once again (parameters as before) and the supernatant was 
discarded. The precipitated cells were gently resuspended in 3.5 mL cold cryo solution. 100 µL 
aliquots in sterile 1.5 mL were prepared, snap-frozen in liquid nitrogen and stored at -80 °C. 
Frozen aliquots were thawed for three to five minutes on ice. For heat-shock transformation 
20 ng plasmid DNA per 100 µL of chemo-competent cells were used. Plasmid DNA solution was 
added by carefully pipetting and subsequently gently stirring the transformation mix with the 
pipette tip. Afterwards transformation mixes were incubated on ice for 30 min. Following the 
incubation, a heat-shock was performed by incubating the tubes at 42 °C in a dry bath for 45 s. 
After heat-shock, cells were cooled down on ice for 5 min. 9 volume equivalents of SOC medium 
were added to the transformation mix and cells were incubated at 37 °C and 200 rpm for ~1h 
to allow expression of the selection marker. Following phenotypic expression transformants 
were selected on LB agar plates containing the appropriate antibiotics. LB agar plates were 
incubated upside down at 37 °C. Usually, colonies were obtained the day after the 
transformation. 
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6.2.3. Room temperature electro-competent E. coli cells and electroporation 
transformation 
Required solutions: 
• Sterile ddH2O 
• DNA preparation in DNase free H2O 
Pre- and main cultures were prepared as describe for chemo-competent E. coli cells (see Chapter 
6.2.2). Once an OD600 of ~0.5 was reached cultures were immediately harvested without an 
incubation on ice. Centrifugation itself was performed the same way as for chemo-competent 
cells except that cells were sedimented at RT (see Chapter 6.2.2). Harvested cells were 
resuspended in 5 mL sterile ddH2O before adjusting the final suspension volume with sterile 
ddH2O to 50 mL. All following steps were performed at room temperature. Subsequently cells 
were precipitated as described earlier. Cells were washed a second time with 50 mL sterile 
ddH2O. Finally, cells were resuspended in 1 mL ddH2O. For electroporation 1 µL of 20 ng/µL 
DNA preparation in DNase free H2O (NEB) was provided in a sterile 1mm electroporation 
cuvette (VWR). The DNA preparation was pipetted onto one of the two short walls of the cavity. 
Afterwards 80 µL electro-competent cell suspension were gently pipetted over the DNA solution 
droplet. This procedure ensured thorough mixture of DNA solution and cell suspension whilst 
omitting extensive sheering forces. Lastly cell suspension was pulsed using the following 
parameters with a Gene pulser II with a capacitance extender plus (Bio-Rad; 300 Ω, 25 µF, 
1.8 kV). Usually time constants of four to eight milliseconds were achieved. If visible or audible 
electrical discharge was observed, or the time constant was below three milliseconds the 
transformation was repeated. In case of multiple discharges occurred using the same DNA 
solution a fresh one was prepared. In event of multiple discharges occurred with different DNA 
solutions the cell suspension was washed once again with 50 mL sterile ddH2O. 
6.2.4. DNA purification from E. coli cells 
Plasmid DNA was prepared from fresh grown overnight cultures of E. coli using the appropriate 
kits from Macherey-Nagel. For 5 to 20 mL cultures the NucleoSpin® NoLid Mini-Prep kit was 
chosen, for larger cultures (up to 200 mL) the NucleoBond® Xtra Midi kit was chosen and lastly 
for the isolation of genomic DNA the NucleSpin® Microbial DNA kit was used. 
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6.2.5. Phusion® High-Fidelity DNA Polymerase -recombinant expression, 
purification and storage 
All credit for this protocol belongs to A. Gräwe 
Required solutions: 
• TB medium 
o Tryptone 12 g/L, Yeast extract 24 g/L, K2HPO4 9.4 g/L, KH2PO4 2.2 g/L, 
autoclaved 
• 1000x IPTG stock solution 
o 500 mM IPTG, sterile filtered 
• Buffer A 
o 50 mM Tris pH 7.4, 10%(v/v) glycerol, autoclaved 
• Buffer B 
o 50 mM Tris pH 7.4, 300 mM NaCl, 30 mM Imidazole, sterile filtered and 
degassed 
• Buffer B2 
o 50 mM Tris pH 7.4, 1 M NaCl, 30 mM Imidazole, sterile filtered and degassed 
• Buffer C 
o 50 mM Tris pH 7.4, 1 M NaCl, 300 mM Imidazole (optimal: use highly pure from 
Sigma → no absorption at 280 nm), sterile filtered and degassed 
• Buffer D 
o 100mM Tris pH 8.2, 0.1mM EDTA, 1mM DTT 
• Buffer E 
o 0.1 mM EDTA, 1mM DTT, 0.2%(v/v) IGEPAL® CA-630, 0.2%(v/v) Tween20 in 
glycerol 
o This is just a virtual specification of buffer E, in reality simply add all components 
aside from glycerol to Phusion® preparations in buffer D to a final concentration 
equal to twice the values shown here and than add one volume equivalent of 
glycerol. 
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Expression 
E. coli BL21(DE3) cells were co-transformed with plasmids pPhusion and pSJS1240 following 
the regular protocol for the transformation of chemo-competent E. coli cells until regeneration. 
Due to cells were transformed with two plasmids at once regeneration time had to be prolonged 
to at least 90 min. Prolonged regeneration was mandatory to allow transformed cells to 
sufficiently express both resistance genes. Otherwise no transformants would have been 
obtained on LB Amp/Spec dual selection plates. A single colony from the selection plate was 
used to inoculate 10 mL TB Amp/Spec medium in a glass tube as a pre-culture. Once the pre-
culture was visibly turbid it was used to inoculated up to 2 L TB Amp/Spec medium in a 
sufficiently large flak or in multiple flasks. The main-culture(s) was (were) grown to an optical 
density at 600 nm of approximately 1. Then expression was induced by adding IPTG to a final 
concentration of 1 mM to the culture medium. Protein expression was performed for 12 h at 
37 °C while vigorously shaking. Cells where harvested by centrifugation and resuspend in 25 mL 
Buffer A per liter culture volume. Subsequently cell suspension was transferred to 50 mL tubes. 
One tube per 25 mL of cell suspension was used. If needed cells were precipitated again and 
the received cell precipitates were stored at -20 °C until cell lysis. 
Purification 
Independent whether cells were stored after harvesting or not, it was ensured that cells were 
suspended in 25 mL Buffer A per liter culture volume before proceeding with the protocol. 
Triton X-100 was added to a final concentration of 0.1 %(v/v), likewise MgSO4 was added to a 
final concentration of 5 mM as well as a few milligrams of DNase (or Barnase) and Lysozyme 
were added. Subsequently cells are lysed by sonication (4x 1 min 75 % amplitude intercepted 
by 1 min rests). Cell debris was precipitated by centrifugation (30 min, 35000xg). The 
supernatant was transferred into fresh 50 mL tubes and endogenous host proteins were 
denatured at 85 °C for 30 min. Denatured proteins were precipitated by centrifugation 
(30 min, 40000xg). The supernatant was transferred into fresh 50 mL tubes. During the last 
centrifugation step Ni-NTA sepharose columns were equilibrated with 10 column volumes (CV) 
buffer B (flow rate: 1 mL/min). Prior to loading the supernatant from the last centrifugation 
step was filtered through a 0.45 µm sterile filters to remove any solid particles large enough to 
damage the column. If multiple tubes had to be used for centrifugation, the filtration step was 
used to pool them into one tube. Lastly the supernatant was loaded onto the column 
(flow rate: 0.1 mL/min). Following the load, the sample tubing was placed into a Buffer B 
reservoir and flushed with 3 CV (flow rate: 1 mL/min). This step was included to compensated 
for the dead volume of the FPLC. Subsequently the column was washed with 2 CV Buffer B2. 
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Followed by a second washing step with 3 CV Buffer B. Now Phusion® High-Fidelity DNA 
polymerase was eluted from the column with Buffer C in fractions equal to 1 CV. Elution was 
continued until no more protein was eluted for at least 5 CV. All protein containing fractions 
were pooled and a Vivaspin 20 (MWCO 10 kDa) column was used to exchange Buffer C with 
Buffer D. At least two concentration steps were executed according to manufacturer’s 
instruction to ensure complete buffer exchange. Finally, protein content was measured using 
the Bradford assay with a BSA standard curve to calibrate the assay. For storage the eluate was 
diluted to 0.4 mgprotein/mL with Buffer D. Lastly the Phusion® High-Fidelity DNA polymerase 
solution was mixed with one volume equivalent Buffer E. Usually the resulting 
Phusion® High-Fidelity DNA polymerase of these preparation was approximately 2 U/µL. 1 mL 
Aliquots were prepared in sterile 1.5 mL screw cap tubes and snap frozen in liquid nitrogen. 
For long term storage aliquots were stored at -80 °C. The working aliquot was stored at -20 °C. 
 
6.2.6. Clonetregration for the genomic integration of protease constructs into 
the genome of E. coli Bl21(DE3) 
The integration of protease constructs into the genome of BL21 (DE3) cells followed the general 
protocol published by St. Pierre et al.[102] slightly modified by M. Röder. The modified protocol 
is found in the supplement of this thesis (see Chapter 13.3.1). 
 
6.2.7. Polymerase chain reaction (PCR) 
All PCRs in this work were performed with Phusion® High-Fidelity DNA polymerase produced 
in house (see Chapter 6.2.5). The tables below show reaction mixes as well as the standard 
cycler program used in this work. By default, 5x HF buffer was used. If this led to failed PCRs 
or undesired product formation 5x GC buffer was used or DMSO was added in concentrations 
varying from 0.5 to 4 %(v/v).  
Table 15 Phusion® High Fidelity DNA polymerase reaction mix 
Component Volume [µL] Final concentration 
5x HF/GC buffer 10 1x 
10 mM dNTP mix 1 0.2 mM 
10 µM forward primer 2.5 25 pmol / 50 µL 
10 µM reverse primer 2.5 25 pmol / 50 µL 
Template 1 µL ≤20 ng / 50 µL 
(DMSO) (0.25 to 2) (0.5 to 4 %(v/v)) 
2 U/µL Phusion® High-Fidelity DNA Polymerase 0.5 1 U/ 50 µL 
ddH2O ad 50 - 
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Table 16 Standard thermocycler program for Phusion® High Fidelity DNA Polymerase 
Step Temperature [°C] Time [s] Cycles 
Initial denaturing 98 300  
Denaturing 
Annealing 
Extension 
98 
52 to 72 depending on primer pair used 
72 
30 
30 
45/kb 
30 
Final extension 72 600  
Hold 4 to 12 ∞  
 
colony PCR 
Colony PCRs were run to screen transformants for correct construct integrity or correct 
integration into the genome. The template for colony PCRs was prepared as follows. Some 
colony material was resuspended in 10 µL ddH2O in a 0.2 mL reaction tube. Cells were 
thermo-lysed at 98 °C for 5 min in a thermocycler. Subsequently 1 µL lysate was used as the 
template for the colony PCR. 
overlap extension PCR (oePCR) 
Overlap extension PCRs were utilized to form one long PCR product from two or more shorter 
ones. Among other things oePCRs were used to insert multiple mutations in a DNA sequence at 
once or to avoid undesired PCR products through self-priming events. In the first step multiple 
standard PCRs were run in parallel. Primers for these initial PCR were designed to yield in 
internal homologous overhangs. These overhangs were used to define the order in which the 
individual fragments were fused together. The length of the overhangs was chosen to be as 
similar as possible within the standard annealing temperature range for primers. Therefore, 
those overhangs were able to mimic primers in the actual oePCR. This PCR was identical to a 
standard PCR with the following changes. First, instead of one template all initial PCR products 
were used as templates. Initial PCR products were added in equimolar concentrations with a 
total amount of template DNA of 20 ng. Second, the forward primer annealed to 5’ end of the 
most upstream template while the reverse primer annealed to the 3’ end of the most 
downstream template. Consequently, through regular priming and internal self-priming of the 
homologues overhangs all fragments were fused into one full-length product. Third and last the 
amplification cycle was split into two cycles if the annealing temperatures of the overhangs 
were incompatible to the annealing temperatures of the used primer pair. The first ten cycles 
used an annealing temperature optimal for annealing of the internal overhangs to drive 
formation of full-length product, through overhang extension, forward. The subsequent twenty 
cycles used an annealing temperature optimal for the flanking primer pair to force amplification 
of the full-length product. The resulting thermocycler program is found in Table 17.  
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Table 17 Thermocycler program for oePCRs with two separated cycles. 
Step Temperature [°C] Time [s] Cycles 
Initial denaturing 98 300  
Denaturing 
Annealing 
Extension 
98 
52 to 72 depending on internal 
overhangs 
72 
30 
30 
45/kb of full-length product 
10 
Denaturing 
Annealing 
Extension 
98 
52 to 72 depending on primer pair used 
72 
30 
30 
45/kb of full-length product 
20 
Final extension 72 600  
Hold 4 ∞  
 
6.2.8. Agarose gel electrophoresis 
Required solutions: 
• 0.5 to 2 %(w/v) agarose in 1x TAE 
o usually 300 mL 1 %(w/v) agarose was prepared in a 500 mL blue cap bottle 
• Midori Green (Nippon genetics) 
Agarose gel electrophoresis was carried out in PerfectBlue Mini chambers (peglab). Agarose 
stocks were melted in a microwave and approx. 30 to 50 mL or 50 to 80 mL were used to cast 
gels in MiniS or MiniM chambers respectively. A standard beaker was used to estimate the 
agarose volume. Prior to casting 2 µL Midori Green (Nippon Genetics) were added to the melted 
agarose. The pipette tip used for transferring Midori Green was used to stir it into the agarose 
to avoid the formation of air bubbles. Prior to loading, samples were prepared with 6x 
QuickLoad® purple loading dye (NEB). For the most part Quick-Load® 1 kb Plus DNA Ladder 
1kb plus functioned as a size standard. Exceptions are noted in chapter 6.1.4. Electrophoresis 
was performed at a constant voltage of 130 V for approximately 35 min. Gels were documented 
using the E-BOX gel documentation (Vilber). DNA bands were excised using standard scalpels 
on a blue light LED table with an in-built eye protection screen (Nippon Genetics). DNA was 
extracted from the gel slices with the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). 
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6.2.9. iFLinkC 
All parts to be used in iFLinkC assemblies must be cloned into the corresponding storage vector 
first. pFD for so called functional domains which are proteins or peptide motives that introduce 
functionalities to the multi-domain fusion protein to be assembled. Linkers are cloned into pL2 
vector. Once all required parts were present within the appropriate storage vectors an iterative 
and hierarchical assembly procedure was abided. First the coding sequence (CDS) of either a 
linker or of a functional domain was selected as the upstream sequence. The upstream sequence 
was always restricted with BsrDI the second enzyme was chosen to yield in well separable 
restriction fragments for easier excision of bands. Either SpeI, EcoRI or MfeI served as the 
second restriction enzyme. The CDS of the other part became the downstream sequence. The 
downstream sequence was always restricted with BtsI. The second enzyme used had to be the 
same as used for the upstream sequence. BsrDI and BtsI required elevated temperatures for full 
activity, 65 °C and 55 °C respectively. Therefore, the second enzymes were added to the reaction 
mixes once they were cooled down to RT from the first digestion step. Both restriction reactions 
were routinely performed for 90 min in a total reaction volume of 50 to 100 µL. Shrimp 
phosphatase (rSAP) was added to the restriction mix generating the fragment carrying the 
origin of replication (ori) to reduce the number of recyclized original backbone propagated after 
the transformation. For the steps at higher temperatures a thermocycler was used to prevent 
evaporation of the reaction mix. Once restriction was completed the resulting fragments were 
separated on an agarose gel (0.5 to 1.5 %(w/v) depending on size of the fragments). The 
desired fragments were extracted from gel slices using the appropriate kit from Macherey & 
Nagel. Following the extraction fragments were ligated using T4 DNA ligase (NEB) in total 
reaction volumes of 10 to 25 µL using 50 to 125 ng of linear DNA fragments. If fragments were 
generated using either SpeI or MfeI the fragment lacking ori and selection marker was added 
in a threefold molecular excess. If EcoRI was used creating one fragment which was baring the 
ori while the other fragment carried the selection marker fragments were used in equimolar 
concentration. Ligation was performed either at 16 °C for one hour or overnight. In rare cases 
ligation was performed at RT for 15 min. Up to 100 µL of competent cells were transformed 
with up to 10 µL of ligation mix. For linker library generation two times 80 µL RT electro-
competent DH10β cells (NEB) were transformed with 10 µL ligation mix each. For individual 
constructs 25 µL of chemo-competent DH10β cells (NEB) were transformed using 5 µL ligation 
mix. Transformants were selected on LB ager plates containing 50 µg/mL kanamycin. In 
addition to the actual cloning reactions controls were performed as well. For this controls 
competent cells were transformed with ligation mixes missing the non-dephosphorylated part. 
If at least 5 times more colony forming units per milliliter ligation and microgram DNA used 
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(CFU*mLligation mix-1*µgDNA-1) were received for the cloning compared to the control two clones 
were picked and used to inoculate overnight broth cultures for plasmid preparation. Lastly the 
integrity of construct was verified using Sanger sequencing (SeqLab, MicroSynth). If libraries 
were cloned only 100 µL of 1:100 and 1:104 dilution of the regenerated transformation cultures 
were plated. The remainder was used to inoculate 50 mL broth cultures containing 50 µg/mL 
kanamycin. From these cultures midi-preps were performed to recover the library. Controls 
were carried out as above and used to calculate the approximately fraction of recyclized clones 
within the library. If this fraction was equal to or greater than 10 % the library was discarded 
and cloning was repeated. In order to estimate diversity within the library five clones received 
from plating of the dilutions were analyzed via Sanger sequencing. 
Because the initial restriction sites, ori and selection markers were regenerated after each round 
of cloning with iFLinkC the constructs from the initial cloning step were suitable parts for a 
second round. Parts with an upstream linker CDS acted as linkers in the subsequent cloning 
steps. Accordingly, parts where the most upstream CDS was a functional domain acted as 
functional domains. Once the desired construct or library was completely assembled the CDS 
was cloned into an expression vector of choice. CDSs were cloned directly in an iFLinkC 
expression vector (pFLinkC-XE, various available) or were cloned into other expression vectors 
such as pPRO24 or pCtrl2. Latter might require adapter cloning to convert the iFLinkC 
restriction enzyme generated overhangs to overhangs of restriction enzymes present in the 
desired non-iFLinkC expression vector. 
6.2.10. DNA sequencing 
The Economy Run service of Sequence Laboratories (SeqLab, MicroSynth) was exclusively 
tasked for DNA sequencing throughout this work. According to service provider’s 
recommendation samples containing 18 ng PCR product per 100 kb fragment length or 
approximately 960 ng plasmid DNA in a total volume of 12 μL 5 mM TrisHCl buffer were 
prepared. Prior to shipping DNA samples were mixed with 3 μL of a 10 μM solution of the 
desired primer in a 1.5 mL reaction tube. Samples were shipped in standard sample bags. 
6.2.11. High pressure cell homogenization 
Required solutions: 
• ≥35 mL cell suspension 
• cell resuspension buffer of choice 
• ddH2O 
• Ethanol 
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o 80 %(v/v) 
o 20 %(v/v) 
• 100 mM NaOH 
High pressure cell homogenization was performed with the EmulsiFlex-C3 (Avestin). First the 
external compressor was set to provide the homogenizer with 8 bar system pressure. Influx of 
air into the homogenizer was carefully omitted during all further steps. This meant adding the 
next solutions when bottom of the sample beaker still was covered with residual liquid from 
previous step. Second the system was washed three times with ½ sample beaker volume (SBV) 
ddH2O. Third the system was primed with two times ½ SBV of the given cell resuspension 
buffer. Forth the homogenization pressure was adjusted while the second ½ SBV cell 
resuspension buffer still was being pumped through the system. Homogenization pressure was 
adjusted to 1.2 to 1.5 kbar for E. coli cells. The system flow was stopped and cell suspension 
was added to a maximum of one ¾ SBV. If sample volume exceeded this value cell suspension 
was added stepwise. During sample homogenization the pressure was constantly readjusted to 
keep it within the before mentioned boundaries. Additionally, the cooler spiral of the outlet 
tubing as well as the collection tube were placed in an ice bath to prevent thermal denaturing 
of the protein of interest. Usually samples were processed three times to ensure near to complete 
cell lysis. Afterwards the system was washed with ~10 mL resuspension buffer to flush the 
remaining cell homogenate out of the system. After this step the pressure was released to the 
system pressure provided by the external compressor. This is crucial to prolong the life span of 
the homogenizer. Subsequently the device was cleaned with ½ SBV of 100 mM NaOH to remove 
and inactivate any intact cells or cell debris left in the system. The remaining caustic soda was 
flushed out with ¾ SBV of ddH2O prior to disinfection of the system. Disinfection was performed 
with ½ SBV of 80 % (v/v) ethanol. Lastly the system was filled with 20 % (v/v) ethanol (~ ½ 
SBV left in the sample beaker). The sample beaker was sealed with the lid and the outlet tubing 
was sealed with a clamp to prevent evaporation of the ethanol in the system. The external 
compressor was switched of and the remaining pressure was carefully released through the 
exhaust valve of the compressor. 
6.2.12. Protein Purification 
Recombinant protein expression was performed with E. coli BL21(DE3) cells transformed with 
an expression vector. All expression vectors bored an, in BL21(DE3) cells, inducible promotor 
in order to separate biomass generation (growth) from heterologous protein overexpression. 
For scouting runs recombinant proteins were produced in 50 mL broth cultures within 200 mL 
Erlenmeyer flasks. Actual expression cultures varied from 200 mL broth cultures in 1 L flasks to 
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1 L broth cultures in 3 L flasks (culture volume equal to or less than ⅓ flask volume). 
Appropriate pre-cultures were used to inoculate an expression culture to a starting OD600 of 
0.05 to 0.1. Expression cultures were incubated shaking at 180 rpm to an OD600 of around 0.6 
prior to induction of protein overexpression. During protein overexpression cultures were 
incubated at 30 °C and 220 rpm. The reduced incubation temperature was chosen to hempen 
cell division and thereby foster protein production. The higher revelation speed increased 
oxygen saturation in the medium and thereby increasing the cellular productivity. 
Cells were harvested by centrifugation (4255xg, 60 min, 4 °C) after at least three hours of 
induced protein overexpression. In most cases proteins were expressed overnight (~12 to 16 h). 
Following harvesting, cells were washed once by resuspending them in ¼ total culture volume 
of pre-cooled resuspension buffer (His-tag: His binding buffer; Strep®-TagII: Buffer W). Cells 
were precipitated once again as stated for harvesting. Subsequently cells were resuspended in 
1/20 total culture volume. For scouting runs this resulted in cell suspension volumes below 
35 mL. Therefore, cells were lysed using a sonicator (see Chapter 6.2.5 - Expression). For 
actual expression cultures if 1/20 total cultures volume was below 35 mL resuspension buffer 
was added to increase the total volume to 35 mL. Cells were homogenized as described in 
Chapter 6.2.11). Solid particles, including cell debris, were separated from the liquid phased 
by centrifugation (25000xg, 60 min, 4 °C). In parallel the Äkta® Pure FPLC system (GE 
Healthcare) was prepared for the purification run as described in the following subchapters. 
The supernatant of the last centrifugation step was loaded onto the appropriate 1 mL column. 
From here the appropriate chromatography protocols were executed. 
Immobilized metal ion affinity chromatography (IMAC) 
Required solution: 
• His binding buffer 
o 20 mM NaH2PO4, 500 mM NaCl, 30 mM imidazole, pH 7.4, prepared as 5x stock, 
steam sterilized stored at RT, 1x working stock degassed and particle free 
• His elution buffer 
o 20 mM NaH2PO4, 500 mM NaCl, 300 mM imidazole, pH 7.4, prepared from 
5x His binding buffer, degassed and particle free 
• Ni solution 
o 100 mM Ni(II)SO4 
• Stripping solution 
o 20 mM NaH2PO4, 500 mM NaCl, 50 mM EDTA, pH 7.4, degassed and particle 
free 
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• 20 % (w/v) Ethanol 
o Degassed and particle free 
• ddH2O 
o degassed and particle free 
IMAC was performed using the Äkta™ Pure FPLC system (GE health care) with 1 mL Protino Ni-
NTA 1 mL FPLC columns (Macherey-Nagel). Prior to all runs all tubing was extensively rinsed 
with ddH2O. Rinsing was essential to remove any remaining ethanol used as a preservative 
during off-times. Residual ethanol mixed with salt containing buffer could have led to 
hazardous precipitation within the system. Following the rinse, the column was installed and 
washed with ten CV of ddH2O (flow-rate 1 mL/min). If the column was not loaded with nickel 
a loading step was performed where the column was filled with Ni solution. Once filled the 
column was incubated for one hour to allow complete formation of the Ni-NTA complexes on 
the sepharose matrix. Following the incubation, the column was washed with 15 CV ddH2O to 
remove any excess nickel. Nickel removal was monitored on the conductivity chromatogram. If 
the conductivity was not on the baseline (ddH2O) level, the washing step was prolonged until 
baseline level was reached again. Subsequently all tubes were filled with the appropriate buffer, 
bypassing the column, until stable UV and conductivity values were detected. Now the system 
was filled with His binding buffer. Once all preparations were done the column was equilibrated 
with binding buffer (flow-rate 1 mL/min) until UV and conductivity values were once again 
stable. Afterwards the sample was loaded onto the column (flow rate 1 mL/min). 
Approximately 95 % of the total sample volume were loaded to prevent accidentally pumping 
of air into the system. Following the load, 10 CV binding buffer were pumped through the 
sample inlet, using the sample pump, to load any leftover sample in the flow path onto the 
column (flow rate 1 mL/min). Protein was eluded from the column using a linear gradient from 
0 t0 100 % (v/v) elution buffer (30 to 300 mM imidazole) over a length of 10 CV whilst 
collection fraction of 0.5 CV (20 fractions in total). After the gradient was completed, elution 
was continued isocratically with 300 mM imidazole over 6 CV to ensure all protein was eluded 
from the column. Following the isocratic step, the column was prepared for storage. For short 
term storage, to be used for the same protein in the near future, the column was washed with 
15 CV ddH2O and subsequently filled with 20 %(v/v) ethanol until stable UV and conductivity 
chromatograms were achieved. Now the column was removed under flow to avoid influx of air. 
Once the column was removed the exterior of all tubing was rinsed with ddH2O and all tubing 
was placed in the water reservoir. Now the whole system was cleaned by manually executing 
pump washes for all used inlets, including the sample pump. Afterwards the outside of all inlet 
tubing was rinsed with 20 %(v/v) ethanol and all tubing was placed in the 20 %(v/v) ethanol 
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reservoir. Like before manual pump washes were executed to disinfect the system. All tubing 
remained in the ethanol reservoir until the next run. Alternative to the simple cleaning of all 
tubing, the column was stripped of its nickel content for either long-term storage or if the 
column was to be re-used for a different protein. Stripping was considered essential to remove 
any traces of the previously purified protein from the column matrix in order to prevent 
cross contamination of protein preparations. For stripping the column was washed with ddH2O 
identically to the short-term storage protocol. Subsequently the column was stripped from 
nickel by administering stripping solution until the blue coloration of the column was entirely 
lost (at least 10 CV). Afterwards the column was washed another time with 15 CV ddH2O and 
from here on the same procedure as for short-term storage was followed.  
Affinity chromatography using the Strep-Tag®II/Strep-Tactin system 
Required solutions: 
• Buffer W 
o 100 mM Tris/HCl pH 8.0, 150 mM NaCl 1 mM EDTA, prepared as 10x stock, 
steam sterilized and stored at RT, 1x working stock degassed and particle free 
• Buffer E 
o 100 mM Tris/HCl pH 8.0, 150 mM NaCl,1 mM EDTA, 2.5 mM desthiobiotin, 
freshly prepared from 10x Buffer W, degassed and particle free 
• Buffer R 
o 100 mM Tris/HCl pH 8.0, 150 mM, NaCl, 1 mM EDTA, 1 mM HABA, freshly 
prepared from 10x Buffer W, degassed and particle free 
• 100 mM Tris 
o Degassed and particle free 
• 20 % (v/v) ethanol 
o Degassed and particle free 
• ddH2O 
o degassed and particle free 
Strep-Tag®II/Strep-Tactin affinitiy chromatography was performed using the Äkta™ Pure FPLC 
system (GE health care) with 1 mL Strep-Tactin columns (iba). Prior to all runs all tubing was 
extensively rinsed with ddH2O to remove any ethanol (see previous subchapter for further 
details). Following the rinse, the column was installed and washed with 10 CV of ddH2O 
(flow-rate 1 mL/min). Subsequently all tubing was filled with the appropriate buffer, bypassing 
the column, until stable UV and conductivity values were detected. Now the system was filled 
with Buffer W. Once all preparations were done the column was equilibrated with Buffer W 
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(flow-rate 1 mL/min) until UV and conductivity values were once again stable. Afterwards, the 
sample was loaded onto the column (flow rate 1 mL/min). Approximately 95 % of the total 
sample volume were loaded to prevent accidently pumping of air into the system. Following 
the load 15 CV Buffer W were pumped through the sample inlet using the sample pump to load 
any leftover sample in the flow path onto the column (flow rate 1 mL/min). Now the column 
was washed with 8 CV Buffer W (flow rate 1 mL/min). Protein was isocratically eluded from 
the column with 3 CV Buffer E (flow rate 0.5 mL/min) whilst collection fractions equal to 0.5 
CV (six fractions in total). Once elution was complete the column was regenerated with Buffer R 
(flow rate 1 mL/min) until the column showed an equally distributed strong red coloration (at 
least 15 CV). Generally, the more often a column had been used already the more Buffer R was 
required. After regeneration the column was rinsed with 100 mM Tris until the red color was 
removed completely. Subsequently the column was washed with 15 CV ddH2O. Now the column 
was prepared for storage by adding 20 %(v/v) Ethanol until a stable UV signal was detected. 
The column was removed under flow to prevent air form entering the column. Strep®-Tactin 
columns were stored at 4 °C and used multiple times as long as the same protein was purified. 
After the column was removed the system was washed with ddH2O to completely flush out any 
residual buffers. Lastly the system as well as all pumps and tubing were filled with 20 %(v/v) 
ethanol to prevent contamination. 
Quality control and storage 
To verify the purity of protein preparations SDS-PAGE was performed with samples taken from 
the supernatant of the last centrifugation step (“load”), from the efflux during sample load 
(“flow-through”), from the efflux during washing (“wash”) and from all protein containing 
elution fractions (“Ei”). Elution fractions were assumed to be protein containing according to 
peak size and morphology in the chromatogram (UV trace). If a fluorescent protein was purified 
protein content was instead estimated through visual inspection of the elution fractions 
(yellowish color for GFP derivatives, orange color for mKOκ derivates and pinkish color for 
mCherry derivates). All sufficiently pure and protein of interest containing fractions, according 
to apparent molecular weight estimated with SDS-PAGE and subsequent Coomassie staining, 
were pooled. After the pooling a buffer exchange was performed using PD10 gravity flow 
columns (GE Healthcare). Proteins were eluted from the PD10 columns with 3.5 mL Buffer W 
and fractions of 500 µL (10 droplets) were collected. The protein concentration of the PD10 
elution fractions was measured via UV/Vis spectroscopy (NanoDrop1000). Yet again if a 
fluorescent protein was purified visual inspection was performed to sort out the desired 
fractions. Protein concentrations were calculated using the proteins specific extinction 
coefficient at either 280 nm (non-fluorescent proteins) or at their respective absorption maxima 
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(fluorescent proteins). If a fusion protein comprised of multiple fluorescent proteins the 
concentration was calculated based on the absorption of the most C-terminal fluorescent protein 
domain. This way the calculated concentration was considered to most truthfully represent the 
actual concentration of full-length protein in the preparation. Finally, all satisfactory fractions 
were pooled sterile filtered. Subsequently glycerol was added to a final concentration of 
25 %(v/v) from a steam sterilized 50 %(v/v) glycerol in 1x Buffer W stock. If necessary the 
protein solution was diluted further with 25 % (v/v) glycerol in 1x Buffer W to a final 
concentration of 100 nM. For storage protein preparations were split into 20 µL aliquots and 
subsequently snap frozen in liquid nitrogen. Frozen aliquots were transferred from the liquid 
nitrogen to 50 mL reactions tubes for easy labeling and handling. Storage tubes were kept at -
80 °C for long-term storage. Individual aliquots were stored at -20 °C during experiments. 
 
6.2.13. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blotting 
SDS-PAGE 
Required solutions: 
• Separation buffer 
o 1.5 M Tris, 0.4 %(w/v) SDS, pH 8.8 
• Stacking buffer 
o 0.5 M Tris, 0.4 %(w/v) SDS, pH 6.6 
• Rotiphorese® Gel 30 (Carl Roth) 
o Stored at 4 °C 
• APS 
o 15 to 20 %(w/v) APS, freshly prepared 
• TEMED 
o Stored at 4 °C 
• ddH2O 
• SDS running buffer 
o 3.02 g/L Tris, 14.4 g/L glycine, 0.1 %(w/v) SDS, prepared as a 10x stock stored 
at RT 
• 2x loading dye 
o 200 mM Na3PO4, 4 %(w/v) SDS, 20 %(v/v) glycerol, 0.002 %(w/v) 
bromophenol blue 
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All SDS-gels were casted with the Mini-PROTEAN® system using short plates together with 
1 mm spacers. Separation gels were casted first to a height of approximately six cm. The casted 
separation gels were covered with isopropanol while hardening to smoothen the top edge and 
absorb excess water released during the process. Separation gel hardening was followed by 
observing the remainder casting solution as well as the appearing of a visible line between 
hardened gel and the isopropanol layer on top. Once the polymerization of the gel was complete 
the isopropanol layer was aspirated and the stacking gel was casted on top of the separation 
gel to a level just below the opening of the chamber. Immediately after casting the comb 
(usually 15 wells) was inserted into the gel casting chamber. Polymerization progress was 
monitored as before. Fully polymerized gels were either used directly or stored covered in moist 
paper towels at 4 °C to prevent dehydration. Excess polymer (displaced upon comb insertion) 
was removed before placing the gels into a Mini-Protein® Tetra cell (Bio-Rad). Table 18 shows 
the composition of the SDS gels used in this work. 
Table 18 Composition of SDS-Gels used in this worked. Volumes listed here suffice for two gels. 
 Volume [mL] 
Component Stacking gel (5 %) Separation gel (12 %) 
ddH2O  2.65 2.9 
Separation buffer -  2.79 
Stacking buffer 1.25 -  
Rotiphorese® Gel 30 
(Carl Roth) 
0.83 5.37 
APS (15 to 20 % (w/v)) 0.2 0.17 
TEMED  0.01 0.007 
 
SDS-PAGE was performed either to analyze the outcome of protein purification experiments or 
evaluate the expression of recombinant proteins. Samples were prepared by taking the volume 
equivalent of cells corresponding to an OD600 of 5 in 40 µL from broth cultures. Subsequently, 
cells were harvested by centrifugation at 13000xg for one minute. The supernatant was 
carefully removed and if necessary cell pellets were transferred in to 1.5 mL reaction tubes or 
directly snap-frozen in liquid nitrogen. Frozen samples were stored at -20 °C until SDS-PAGE 
was performed. Thawed samples were resuspended in 20 µL of sterile water and 20 µL 2x 
loading dye was added. Sample were denatured at 95 °C for 5 min or semi-denatured at 72 °C 
for 3 min. Samples were semi-denatured to retain the fluorescence properties of fluorescent 
proteins. 20 µL of a sample were loaded per well. Electrophoresis was performed at 200 V for 
45 min with Mini Protean system (BioRad) in 1x running buffer. 
Following separation, protein bands were visualized with either epi-fluorescence in an 
Amersham Imager 600 RGB (epi-fluorescence mode, all channels, automatic exposure with 
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maximum dynamic range protocol), or by Coomassie staining using RotiBlue (Carl-Roth), or by 
western blotting. Coomassie stained gels were imaged in an E-BOX Stand-Alone Gel 
Documentation Imaging station equipped with a blue light LED transillumination table (Vilber). 
Western Blots were imaged in an Amersham Imager 600 RGB (chemiluminescence mode, 
colored marker, automatic exposure with maximum dynamic range protocol). 
 
 
Western blotting 
Required solutions: 
• Blotting buffer 
o 48 mM Tris, 39 mM glycine, stored at RT 
• 1x PBS 
o 4 mM KH2PO4, 16 mM Na2HPO4, 115 mM NaCl, pH 7.4, prepared as 10x stock, 
steam sterilized and stored at RT 
• PBS blocking buffer 
o 3 %(w/v) BSA, 0.5 %(v/v) Tween20 in 1x PBS, freshly prepared from 10x PBS 
stock 
• PBS Tween buffer 
o 0.1 %(v/v) Tween20 in 1x PBS, freshly prepared from 10x PBS stock 
After electrophoretic separation of samples on polyacrylamide gels proteins were transferred 
onto 0.2 µm PVDF membranes via semi-dry blotting (Trans-Blot® Turbo, Bio-Rad). Blotting 
was performed at a constant current of 200 mA for 30 min. Subsequently, membranes were 
blocked by gently shaking in 20 mL PBS blocking buffer overnight at 4 °C or for one hour at RT. 
Afterwards membranes were washed two times with 20 mL PBS Tween buffer to remove excess 
BSA. If not stated otherwise, washing steps were performed by gently shaking the membrane 
in PBS Tween buffer for five minutes at room temperature. POIs were detected with primary 
antibodies diluted 1:2000 in 10 mL PBS Tween buffer. Antibody incubation steps were 
performed for one hour at room temperature while gently shaking. Excess antibodies were 
removed by two subsequent washing steps. Secondary antibody-HRP-conjugates targeting the 
primary antibodies were used to visualize the detected protein bands. Alternative, if POIs 
possessed a Strep-Tag II, POI were directly detected and visualized with Strep-Tactin HRP 
conjuagtes (BioRad). Secondary antibody incubation was performed as stated for the primary 
antibodies with the exception of secondary antibodies were diluted 1:5000. As before excess 
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antibodies were removed by two washing steps. Finally, membranes were washed once with 
10 mL 1x PBS to prevent Tween20 interference during the chemiluminescence reaction. 
Chemiluminescence reaction was performed using the Clarity™ Western ECL substrate 
(Bio-Rad). Chemiluminescence was detected using the Amersham Imager 600 RGB 
(Amersham) with automatic exposure (maximum dynamic range protocol). Alternative to HRP 
conjugated secondary antibodies Alexa Fluor 633 conjugated antibodies were used when two 
different proteins were to be detected in the same sample. 
6.2.14. In vivo protease assays for live E. coli cells based on degrons 
Fluorescence rescue in E. coli 
A dual plasmid-based expression system was utilized to co-express protease variants together 
with mNeonGreen (mNG) derivates. The mNeonGreen constructs comprised of the mNG 
domain, a recruitment domain – either SH3, FKBP or FRB. pPro24 was used to produce the 
protease variant under the control of the propionate inducible promoter. pCtrl2 was used to 
produce the sensors under the control of the T7 promoter or mutants thereof. pPro24 bore the 
pB332 ori which is a class A ori which is compatible with pCtrl2’s class B p15A ori. Therefore, 
stable propagation of both plasmids was ensured. To avoid strong background fluorescence the 
M9 minimal medium was used to grow broth cultures. Cultures were cultivated overnight at 
37 °C in 96 deep well plates (200 µL culture volume) or 24 well plates (1 mL culture volume) 
depending on the experiment. For the measurements, cultures were cultivated in black 96 well 
plates with flat and transparent bottoms. The black plates omitted transillumination between 
wells while the clear bottom facilitated transmission measurements through the wells to allow 
online measurements of the optical density of the cultures. Latter was crucial to allow the 
normalization of the measured mNG fluorescence to the optical density of the cultures. 190 or 
195 µL assay cultures were inoculated to an OD600 of 0.1 (190 µL if two inducers were used; 
195 µL if a single inducer was added). Subsequently plates were covered with a lid and 
incubated for two to six hours. The lid was fixated with tape to prevent sliding during 
incubation. This prove to be crucial to prevent abrasion of the lid. Otherwise particles grated 
off from the lid might have fallen into the wells. Protein overexpression was induced by adding 
5 µL inducer stock solution per well (final concentrations: 500 µM IPTG or 25 mM sodium 
propionate). After the first inducer was added the plates were incubated for 2 h at 1050 rpm at 
30 °C. Lastly the second inducers were addend and immediately afterwards plates were placed 
in a TECAN Spark plate reader. mNG fluorescence ((485 ±20) nm / (535 ± 20) nm; 10 flashes; 
gain = 70) and optical density at 600 nm were measured in intervals of 15 min over the course 
of six hours. In between measurements plates were shook with double orbital movements 
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(2 mm amplitude, 185 rpm). To account for possible alterations in E. coli auto-fluorescence due 
to dual overexpression a control was included. This control co-expressed mKOκ instead of a 
mNeonGreen sensor together with the protease/mock construct in question. mKOκ fluorescence 
was omitted through the emission filter setting (see Chapter 13.3.2). Therefore, the change in 
auto-fluorescence in response to the expression of a monomeric fluorescent protein was 
measured exclusively. 
The measured fluorescence intensities were normalized to the respective optical densities at 
600 nm. This was necessary because a higher cell density per well led to higher total 
fluorescence intensities per well. 
 𝑚𝑁𝑒𝑜𝑛𝐺𝑟𝑒𝑒𝑛𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒𝑜𝑝𝑡𝑖𝑐𝑎𝑙𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝑎𝑡600𝑛𝑚 − 𝑎𝑢𝑡𝑜 − 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒𝑢𝑛𝑑𝑒𝑟𝑚𝐾𝑂𝜅𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛𝑜𝑝𝑡𝑖𝑐𝑎𝑙𝑑𝑒𝑛𝑠𝑖𝑡𝑦𝑎𝑡600𝑛𝑚  
 
The normalized data were plotted against the time and the range of linear increase in 
fluorescence was estimated. Usually linear increase fluorescence occurred in between two and 
four to five hours after induction of the sensor. A linear regression analysis was performed 
within this range. The received slopes were deemed a sufficient measure for the apparent in vivo 
activity of the tested construct. Thereafter the fold change in slope of a protease construct 
compared to the corresponding mock construct was calculated. For each biological multiplicate 
the fold changes were averaged to estimate the biological variance of the system. In most cases 
the standard deviation from the mean values were equal to or less than two percent of the mean 
values. 
 
 
Scheme 22 Fluorescence rescue in vivo assay based on conditionally active C-degrons. 
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Ratiometric assay in E. coli 
This assay was based on the fluorescence rescue assay as described in the previous subchapter. 
The aim was to access a more robust normalization condition as well as the discrimination of 
non-expression of the sensor from total abolishment of apparent fluorescence through efficient 
degradation. Thus the C-terminal degrons were replaced by cryptic N-terminal degrons 
published by the Voight lab [21]. The N-terminal degron was masked with mNeonGreen. The 
linker contained the protease cleavage site. The first amino acid of the degron was cloned at 
the P1’ position of the cleavage site. Accordingly, upon protease cleavage the degron containing 
part of the fusion protein was released without any additional amino acids N-terminally of the 
degron which might had interfered with degron activity. The tested degrons were FLFVQ and 
YLFVQ respectively. C-terminally of the N-degron mCherry was cloned (see Scheme 23). 
Therefore, upon successful protease cleavage rapid degradation of mCherry should have 
occurred while mNeonGreen fluorescence should have remained unaffected by protease 
cleavage. In this case the mCherry fluorescence was normalized to mNeonGreen fluorescence. 
In contrast to the fluorescence rescue assay the loss of fluorescence over time was used to 
quantify the apparent in vivo activity of the protease constructs. 𝑚𝐶ℎ𝑒𝑟𝑟𝑦𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒𝑚𝑁𝑒𝑜𝑛𝐺𝑟𝑒𝑒𝑛𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
Due to faster maturation time and higher photon quantum yield the mCherry fluorescence 
values were significantly lower compared to the mNeonGreen fluorescence values. This was 
true even after the gain for mCherry flourescence was increased from 70 to 100. This resulted 
in small quotients between both fluorescence intensities. Nevertheless, the fold change between 
the slopes of the linear regressions were calculated and compared as beforehand. 
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Scheme 23 Ratiometric in vivo protease assay based on Cryptic. N-degron. 
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9. List of Abbreviations 
A alanine 
AHT anhydrotetracycline 
AI auto-inhibiting 
AmpR ampicillin resistance 
APS Ammonium persulfate 
BRET bioluminescence resonance energy transfer 
BSA bovine serum albumin 
C cysteine 
CamR chloramphenicol resistance 
C-degron C-terminal degradation tag 
CDS coding sequence 
CFU colony forming units 
ClpX caseinolytic protease complex 
COVID19 corona virus ID 2019 
SARS-CoV2 MPro Severe acute respiratory syndrome corona virus 2 main protease 
C-terminal located at the C-terminus 
C-terminus Carboxy-Terminus 
CV column volume 
D glutamic acid 
Degron degradation tag 
DMSO Dimethyl sulfoxide 
DNA desoxyribonucleic acid 
DNase desoxyribonuclease 
dNTP Desoxyribonucleotide triphosphate 
DTT dithiothreitol 
E aspartic acid 
E. coli Escherichia coli 
E118min minimal variant of E118-134 
EC enzyme class (IUPAC) 
ECL enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
F phenylalanine 
FACS fluorescence activated cell sorting 
FAD flavin adenine dinucleotide 
FK506 tacrolimus 
FKBP FK506 binding protein 
FP fluorescent protein 
FPLC flow pressure liquid chromatography 
FPX fluorescent protein exchange 
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FRB FKBP rapamycin binding protein 
FRET Förster resonance energy transfer 
G glycine 
GFP green fluorescent protein 
H histidine 
HABA 2-[4 -hydroxy-benzeneazo]benzoic acid 
HCV hepatitis C virus, also as synonym for HCV protease 
His histidine 
HRP horseradish peroxidase 
I isoleucine 
IDT Integrated DNA Technologies 
iFLinkC iterative Functional Linker Cloning 
IGEPAL octylphenoxypolyethoxyethanol 
IMAC Immobilized metal ion affinity chromatography 
IPTG Isopropyl-β-D-thiogalactopyranosid 
K lysine 
kDa kilo Dalton 
L leucine 
Lac lactose 
lacI lac repressor 
lacO lac operator 
LB lysogenic broth 
lonp  lon protease 
LVA derivate of ssrA 
M methionine 
M9 minimal medium 9 
mAB monoclonal antibody 
MBP maltose binding protein 
mCh mCherry 
mCherry monomeric Cherry 
MCS multiple cloning site 
mKOκ monomeric Kusabira-Orange kappa 
mNeonGreen monomeric NeonGreen 
mNG mNeonGreen 
MWCO molecular weight cut off 
N asparagine 
NanoLuc nano luciferase 
NaPro sodium propionate 
N-degron N-terminal degradation tag 
NEB New England Biolabs 
NES nuclear export sequence 
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Ni-NTA nickel nitrilotriacetic acid 
NLS nuclear localization sequence 
nMag negative magnet 
N-terminal located at the N-terminus 
N-terminus amino terminus 
OD600 optical density at 600 nm 
oePCR overlap extension PCR 
ori origin of replication 
P proline 
PAA polyacrylamide 
pAB polyclonal antibody 
PBS phosphate buffered saline 
PCB phycocyanobillin 
PCR polymerase chain reaction 
pFD plasmid for functional domains 
PhyB phytochrome B 
PIF6 phytochrome interacting factor 6 
pL2 plasmid for Linkers 2 
pMag positive magnet 
POI protein of interest 
Pols polymerases 
prp propionate 
PVDF polyvinylidene difluoride 
Q glutamine 
R arginine 
R2 coefficient of determination 
Rap rapamycin 
Ras rat sarcoma 
RBS ribosome binding site 
RFP red fluorescent protein 
RGB red green blue color space 
RNA ribonucleic acid 
rSAP Shrimp Alkaline Phosphatase 
RT room temperature 
S serine 
SBOL Synthetic Biology Open Language 
SBV sample beaker volume 
SDS sodium dodecyl sulfate 
sfGFP super folder GFP 
SH3 Src Homology 3 
SOC Super optimal broth with catabolite supression 
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sSH3L strong SH3 ligand 
ssOligos single stranded oligo nucleotides 
ssoverhang single stranded (DNA) overhang 
ssrA small stable RNA A 
SuMMV sunflower mild mosaic virus, also as synoym for SuMMV protease 
SynBio Synthetic Biology 
T threonine 
TAE Tris-acetate-EDTA 
TALE transcription activator-like effector  
TB terrific broth 
TEMED Tetramethyl ethylenediamine 
TEV tobacco etch virus, also as synonym for TEV protease 
TVMV tobacco vein mottling virus, also as synonym for TVMV protease 
Tween20 Polyoxyethylene (20) sorbitan monolaurate 
UV ultraviolet 
V valine 
W tryptophan 
wSH3L weak SH3 ligand 
xSH3L strong or weak SH3 ligand 
Y tyrosine 
YFP yellow fluorescent protein 
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10. List of Figures 
Figure 1 Structural alignment of TEV and TVMV. Structures are depicted as ribbons, catalytic 
triad (H46, D81, C151) as sticks (catalytic cysteine mutated to alanine in both structures), 
TEV (PDB: 1Q31) in cyan, TVMV (PDB: 3MMG) in tan, catalytic triad colored by 
heteroatom; structural alignment was performed with UCSF Chimera 1.11.2 (MatchMaker 
tool). ............................................................................................................................. 11 
Figure 2 Western Blot and SDS-PAGE of TVMV protease variants expressed in E. coli BL21(DE3) 
after clonetegration. Samples were taken 3 hours after induction of protease expression 
with 500 µM IPTG. All protease constructs carried a C-terminal His6-tag for detection. 
Western Blot (left) was performed with a murine anti-His6-mAB and rat anti-mouse mAB 
HRP-conjugate 0.44 µM PVDF membranes. Bands were visualized with 
chemiluminescence. Lane index of western blot and SDS-PAGE (right) refers to table below 
the images. Index “E” represents an empty lane. As positive control in the Western blot 
purified His-tagged MBP-TVMVsfGFP-His6 (69.9 kDa) and TVMV-His6 (27.5 kDa) were used. 
A 12 % polyacrylamide gel with Tris/Glycin buffer system was used. As protein size 
standard PageRuler™ Prestained Protein Ladder (#26616) (ThermoFisher) was used. 
Western blot is positive for T7n_RBS29_MBP-TVMVTVMV-FKBP (lane 1), 
T73_RBS29_MBPTVMVTVMV-FKBP (lane 2), T711_RBS29_MBPTVMVTVMV-FKBP (lane 3) 
(red arrow) and T711_RBS29_MBP-TEVAI-FKBP-FRB-TVMV (lane 4) (green arrow). 
Electrophoretic mobility of MBP-TVMVTVMV-FKBP samples (lane 1-3) correspond to the size 
of cleaved TVMV-FKBP (without MBP), indicating proteolytic activity of these TVMV 
variants in vivo. Predicted sizes of proteins are given in table below. For MBP-TVMVTVMV-
FKBP variants predicted sizes for non-cleaved and cleaved proteins (referring to C-terminal 
cleavage fragment) are given. Figure and caption were adapted from the bachelor thesis of 
Tim Maier. .................................................................................................................... 26 
Figure 3 Western Blot and SDS-PAGE of TVMV protease variants expressed in E. coli BL21(DE3) 
following integration into the chromosomal DNA of E.coli by means of the clonetegration. 
Samples were taken 3 hours after induction of protease expression with 500 µM IPTG. All 
protease constructs bore a C-terminal His6-tag for detection. Western Blot (left) was 
performed with a murine anti-His6-mAB and rat anti-mouse mAB HRP-conjugate on 0.44 
µM PVDF membranes. Bands were visualized with chemiluminescence. Lane index of 
western blot and SDS-PAGE (right) refers to table below the images. Index “E” represents 
an empty lane. As positive control in western blot purified His-tagged MBP-TVMVsfGFP-His6 
(69.9 kDa) and TVMV-His6 (27.5 kDa) were used. 12 % polyacrylamide gel was with 
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Tris/Glycin buffer system used. As protein marker PageRuler™ Prestained Protein Ladder 
(#26616) (ThermoFisher) was used. Western blot is positive for T7n_RBS29_MBP-
TVMVTVMV-FKBP (lane 1), T73_RBS29_MBPTVMVTVMV-FKBP (lane 2), 
T711_RBS29_MBPTVMVTVMV-FKBP (lane 3) (red arrow) and T711_RBS29_MBP-TEVAI-
FKBP-FRB-TVMV (lane 4) (green arrow). Electrophoretic mobility of MBP-TVMVTVMV-FKBP 
samples (lane 1-3) correspond to the size of cleaved TVMV-FKBP (without MBP), 
indicating proteolytic activity of these TVMV variants in vivo. Predicted sizes of proteins 
are given in table below. For MBP-TVMVTVMV-FKBP variants predicted sizes for non-cleaved 
and cleaved proteins (referring to C-terminal cleavage fragment) are given. Figure and 
caption were adapted from the bachelor thesis of Tim Maier ......................................... 27 
Figure 4 Gel shift assay with MBP-TVMVsfGFP-His6 for detection of proteolytic TVMV activity. 
Fluorescence of SDS-PAGE gels was imaged with Amersham imager 600 RGB. Images 
above are overlays of three fluorescence channels (blue: Ex.: 460 nm/Em.:525 nm, green: 
Ex.:520 nm/Em.:605 nm and red: Ex.:630 nm/Em.:705 nm). GFP fluorescence was 
detected in the blue channel and is visualized by blue bands in overlay images. The able 
below the images states the samples on each lane. Empty lanes are marked with a “E”. 12% 
polyacrylamide gels with Tris/Glycine buffer system were used. As a protein size standard 
marker PageRuler™ Prestained Protein Ladder (#26616) (ThermoFisher) was used. 
Images were processed with ImageJ. Figure and caption were adapted from the bachelor 
thesis of Tim Maier. ....................................................................................................... 28 
Figure 5 In cell GFP and RFP emission spectra of FPX1. GFP and RFP emission spectra of cells 
co-expressing the TVMV-FPX-sensor and chromosomal integrated TVMV constructs. E. coli 
BL21 DE3 wildtype cells as negative control. Measurements were performed with TECAN 
Spark®. Excitation wavelength for GFP emission spectrum (505 nm to 600 nm) was 460 
nm with 20 nm bandwidth. Excitation wavelength for RFP emission spectrum (605 nm – 
700 nm) was 560 nm with 20 nm bandwidth. Fluorescence values were normalized to the 
OD600 of the samples. Constructs in this figure are the chromosomal integrated TVMV 
variants from Figure 2 and Figure 3 and pBS1A2_J3101_RBS_Ared-B-TVMVAgreen-Strep. .. 30 
Figure 6 Gel-Shift Assay performed by I. Marquardt to verify the in vivo activity of a TVMV-
FKBP fusion construct that was chromosomal integrated under the control of either the 
native T7 promoter (T7n) or the T7C9A mutant (T79). The two sensor constructs tested 
(CyPet-FRB-TVMVYPet-His6 = CFTY and CyPet-TVMVFRB-YPet-His6 = CTFY) were expressed 
und the control of the tet promoter of pASK-IBA3. TVMV expression was induced with 500 
µM IPTG while sensor expression was induced with 200 ng/L AHT, co-localization of 
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protease and sensor was induced by the addition of 25 nM rapamycin. The first inducer 
(see table above the gels) was added once cultures reached an optical density of approx. 
0.3, the second inducer two hours later and rapamycin one hour after the second inducer, 
finally two hours after rapamycin addition (total expression of expression time of first 
component 6 hours and 4 hours for the second one) samples equal to 5 ODU in 40 µL were 
taken. 10 µL of this sample diluted 1:1 with 2x SDS loading were loaded per lane on to 12 
% polyacrylamide gels with Tris/Glycine buffer system. Proteins were plotted on 0.44 µM 
PVDF membranes and bands were detected with a murine anti-His6-mAB and rat anti-
mouse mAB HRP-conjugate. Visualization of bands in semi-denatured SDS-PAGE wit epi-
fluorescence in three channels (blue: Ex.: 460 nm/Em.:525 nm, green: Ex.:520 
nm/Em.:605 nm and red: Ex.:630 nm/Em.:705 nm) and on Western blot with 
chemiluminescence. Constructs in this figure E. coli BL21(DE3) with T79_MBP-TVMVTVMV-
FKBP-His6 and T7MBP-TVMVTVMV-FKBP-His6 integrated into HK022 locus and pASK-IBA3_ 
CyPet-FRB-TVMVYPet-His6 or CyPet-TVMVFRB-YPet-His6. .................................................... 33 
Figure 7 Emission of TVMV strains created by I. Marquardt transform with pASK-IBA3_CyPet-
TVMVFRB-YPet-His6 following 3 hours of induction of the sensor with 200 ng/L AHT. The 
fluorescence was measured with the TECAN Spark plate reader and normalized to the 
OD600 of the wells. CyPet fluorescence was exited with 415 ± 20 nm, emission was 
quantified from 460 nm to 550 nm with a bandwidth of 20 nm. Two distinct maxima were 
observed at approx. 480 nm (λmax, em CyPet 477 nm, [62]) and approx. 528 nm (λmax, em YPet 
530 nm, [62]). Spectra for chromosomal integrated: T7n_MBP-TVMVTVMV in light grey, T7n_MBP-
TVMVTVMV-FKBP in yellow, T79_MBP-TVMVTVMV in blue, T79_MBP-TVMVTVMV-FKBP in dark grey. 
Strains used in this figure: T7n_MBP-TVMVTVMV-His6, T7n_MBP-TVMVTVMV-FKBP-His6, T79_MBP-
TVMVTVMV-His6, T79_MBP-TVMVTVMV-FKBP-His6 integrated in HK022 locues of BL21(DE3). ........ 34 
Figure 8 Monitoring of in vivo TVMV-mediated modulation of the fluorescent signals generated 
by CyPet-TVMVFRB-YPet-His6. Data points represent the mean fluorescence intensities of 
dependent biological triplicates of BL21(DE3) strains with TVMV constructs integrated into 
the HK022 locus transformed with pASK-IBA3_CyPet-TVMVFRB-YPet-His6 normalized to 
OD600 of the wells. Sensor expression was induced once cultures reach exponential growth 
phase and protease construct expression was induced one hour later. Measurements were 
started directly after protease expression induction (t0). Fluorescence was excited at 415 
± 20 nm and emission was measured at 477 ± 20 nm (CyPet, B) and 530 ± 20 nm (YPet, 
A). Color code is stated in the legends on the right, a no induction of protease expression 
with T7n_MBP-TVMVTVMV (-IPTG) was included as a negative control. ........................... 35 
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Figure 9 Expression cassette of the newly constructed pCtrl2 (pCtrl2 was generated by W. 
Weber, unpublished results). The expression cassette was cloned between a NcoI and a 
NdeI restriction site, a XbaI site is located between the operator and ribozyme binding site 
(RBS). T7 promoter in white, lac operator in cyan, RBS in grey and Start-Codon in blue, 
restriction sites are annotated above the DNA double strand. pCtrl2 was created on the 
basis of pACYCT2 by W. Weber. Figure was created with SnapGene (GSL Biotech LLC). 38 
Figure 10 Effect of induced co-localization based on the rapamycin-dependent FKBP-FRB 
protein-protein interaction module. A: Schematic depiction of the assay, elements as in 
Scheme 14, except constitutive recruitment is replaced through rapamycin dependent 
heterodimerization of FKBP and FRB. B: Exemplary data for the relative orientation of 
TVMV-FRB in conjunction with FKBP-mNG-TVMVE118-134. Active TVMV depicted as filled 
triangles; inactive TVMVC151A (mock controls) as empty triangles; positive controls without 
E118 134 C-degron in grey; actual sensor constructs with E118-134 C-degron cloned to the 
C-terminus in green; all data points represent the mean values of three dependent 
biological replicates measured; the error areas depict the standard error of the mean (SEM) 
in colors matching the corresponding data points, dark checkered areas belong to data sets 
of active TVMV constructs, plain areas belong to data sets of inactive TVMVC151A constructs, 
rapamycin concentration used stated above the corresponding graph, legend at the bottom 
refers to all graphs. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-
134, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.1). .......... 39 
Figure 11 Effect of genetic background and media composition on assay dynamics. Constructs, 
colors and symbol as in Figure 10 except orange triangles depict results for E. coli auto 
fluorescence control mKOκ as non-green fluorescent mNG substitute; tested conditions 
riboflavin containing LB medium (yellow) vs riboflavin free M9 minimal medium 
(transparent), additional lon- B-strain BL21(DE3) (grey rods) vs lonp+ K-strain KRX (red 
rods). A: Comparison of lonp- BL21(DE3) and lonp+ KRX in LB complex medium. B: 
Comparison of lonp- BL21(DE3) and lonp+ KRX in M9 minimal medium. Data points 
represent the mean values of dependent biological triplicates measured, the error areas 
depict the SEM, strain and cultured medium used stated above the corresponding graph, 
legend at the bottom refers to all four graphs. Constructs used: pPRO24_MBP-TVMVTVMV-
FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-
E118-134, pCtrl2_mKOκ Protein Sequences are stated in the supplement (see 13.4.1). . 42 
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Figure 12 Effect of temperature on assay performance. Constructs, colors and symbols as in 
Figure 11. The analogue rod thermometers symbolize the induced thermal stress levels, 
color code: blueish color for cold stress, green color for optimal growth temperature and 
red color for heat stress. Experimental results for the four different temperatures (25, 30, 
37 and 40 °C) tested. Data points represent the mean values of dependent biological 
triplicates measured, the error areas depict the SEM, incubation temperatures during assay 
stated inside the thermometers, legend at the bottom refers to all four graphs. Constructs 
used: pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB pCtrl2_FKBP-
mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein Sequences are stated 
in the supplement (see 13.4.1) ..................................................................................... 43 
Figure 13 Summary of titrating the sensor with IPTG from 500 µM to 7.8 µM in the culture 
medium during measurements in 1:4 dilution steps. Concentrations from 1.95 to 0.03 µM 
are found in Figure S7. Constructs, colors and symbols as in Figure 12. A: Schematic 
depiction of the experiment, by reducing the IPTG concentration the amount of T7 RNA 
polymerase was reduced that should in turn decrease the expression rate of the sensor. B: 
Experimental results on the effect of lowered IPTG concentration on the dynamics of the 
assay. Data points represent the mean values of independent biological triplicates, the error 
areas depict the SEM, the final IPTG concentration in the medium stated above the 
corresponding graph, legend at the bottom refers to all four graphs. Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, 
pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein Sequences are stated in the 
supplement (see 13.4.1). .............................................................................................. 45 
Figure 14 Effect of increased DMSO concentration on rapamycin-induced colocalization of the 
protease and the sensor. Constructs, colors and symbols as in Figure 11. A: Schematic 
depiction of the experiment, identical assay conditions as in Figure 10 except DMSO 
concentration was increased from 0.5 %(v/v) to 2 %(v/v) with the aim of increasing the 
bio-availability of rapamycin in E. coli cells (dark grey rounded rod-shaped border). B: 
Experimental results for the effect of DMSO in the culture medium during measurements. 
Data points represent the mean values of dependent biological triplicates measured, the 
error areas depict the SEM, rapamycin and DMSO concentrations stated above the 
corresponding graphs, legends at the bottom refers to all graphs. Constructs used: 
pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, 
pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein Sequences are stated in the 
supplement (see 13.4.1). .............................................................................................. 47 
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Figure 15 Direct comparison of the C-degrons E118-134 and LVA. Constructs, colors and 
symbols as in Figure 14, except LVA C-degron was introduced (light green triangles). B: 
direct comparison of both degrons in M9 medium at 30 °C, Data points represent the mean 
values of dependent biological triplicates measured, the error areas depict the SEM, degron 
used stated in the respective pictograms. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-
134, pCtrl2_FKBP-mNG-TVMV-LVA, pCtrl2_mKOκ Protein Sequences are stated in the 
supplement (see 13.4.2). .............................................................................................. 48 
Figure 16 Effect of reduced transcription and translation rates for the sensor on the assay 
dynamics. Constructs, colors and symbols as in Figure 15. A: Schematic depiction of the 
experiment, several different variants of pCtrl2 with different mutation in either the T7 
promoter of the ribosome binding site (RBS) or an RNA thermometer partial masking the 
RBS at 30 °C were tested (data not shown). B: Experimental results for the original pCtrl2 
vector and the best performing derivative pCtrl2_T7.03_U9. pCtrl2_T7.03 bore a mutation 
in the T7 promoter that reduced transcription to approx. 3 % compared to the wild type 
[84], additional the previously used RBS was replaced with U9 RNA thermometer that 
possessed a approx. 5 % probability to adopt the open conformation at 30 °C [93]; Data 
points represent the mean values of dependent biological triplicates measured, the error 
areas depict the SEM, pCtrl2 derivate used stated above the corresponding graph, legend 
at the bottom refers to all graphs. . Constructs used: pPRO24_MBP-TVMVTVMV-FRB, 
MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, 
pCtrl2_FKBP-mNG-LVA, pCtrl2_mKOκ, pCtrl2_T7.03_U9_FKBP-mNG-TVMV, 
pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134, pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, 
pCtrl2_T7.03_U9_mKOκ Protein Sequences are stated in supplement (see 13.4.3). ....... 50 
Figure 17 Expression cassette of the selected pCtrl2 variant pCtrl2_T7.03_U9. The wild type 
T7 promoter was replaced with a mutant with a single T-to-C mutation [84] and the 
ribozyme binding site (RBS) was replaced with the synthetic U9 RNA thermometer [93]. 
The expression cassette was cloned between a NcoI and a NdeI restriction site, the XbaI 
site was lost during insertion of the RNA thermometer. T7 promoter mutant in white (T-
to-C mutation marked with a grey rectangle), lac operator in cyan, synthetic U9 RNA 
thermometer in violet (Shine-Dalgarno (SD) sequence as a grey bar and anti-SD sequence 
as a grey bar) and Start-Codon in blue, restriction sites above the DNA double strand. 
pCtrl2_T7.03_U9 was created on basis of pCtrl2 by W. Weber, Figure was created with 
SnapGene (GSL Biotech LLC). ....................................................................................... 51 
 
 147 
Figure 18 Effect of delaying the expression of the sensor relative to the protease. Constructs, 
colors and symbols as in Figure 16. A: Sodium propionate was added at t0 to induce 
expression of the protease constructs. IPTG was added after 0, 2, 4 or 6 h (vertical dashed 
green line in the graphs in B). B: Experimental results for the postponed sensor induction; 
the dotted horizontal line shows the corrected baseline (autofluorescence subtracted from 
normalized fluorescence values), vertical dashed black lines depict the range in which the 
slope of linear increase in fluorescence was calculated by linear regression. Data points 
represent the mean values of dependent biological triplicates measured, the error areas 
depict the SEM, time interval between protease expression induction at t0 and sensor 
expression induction stated above the corresponding graph, legend at the bottom refers to 
all graphs. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, MBP-TVMVTVMVC151A-FRB, 
pCtrl2_T7.03_U9_FKBP-mNG-TVMV, pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134, 
pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein Sequences are 
stated in supplement (see 13.4.3) ................................................................................. 52 
Figure 19 Slopes of the linear increase in normalized mNG fluorescence depending on the time 
interval between protease and sensor expression induction. Values for the six-hour interval 
were omitted. Bars represent the mean slope the dependent biological triplicates measured, 
error bars show the standard error of the mean (SEM). Grey: no degron present, dark 
green: E118-134 C-degron present, light green: LVA C-degron present; filled bars TVMV-
FRB (active protease), empty bars: TVMV(C151A)-FRB (inactive protease, mock control). 
Constructs used: pPRO24_MBP-TVMVTVMV-FRB, MBP-TVMVTVMVC151A-FRB, 
pCtrl2_T7.03_U9_FKBP-mNG-TVMV, pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134, 
pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein Sequences are 
stated in supplement (see 13.4.3) ................................................................................. 53 
Figure 20 Summary of SH3-dependent recruitment with both C-degrons E118-134 and LVA. 
A: Schematic depiction of the assay design, components as in Figure 10, except the 
rapamycin-dependent FRKBP-FRB module was replaced with the constitutively active SH3 
protein-peptide interaction module. B: Experimental comparison of the two previously 
tested degrons based on the best performing combination of sSH3L-TVMV and SH3-mNG-
TVMV sensor; continuous assay with the parameters established in Chapter 4.2.9, constructs 
as listed in the legend, colors and symbols as in Figure 18. Data points represent the mean 
values of dependent biological triplicates measured, the error areas depict the SEM. C: 
slopes for protease and corresponding mock constructs TVMVC151A as pairwise columns. 
Bars represent the average of the two dependent biological replicates measured in two 
independent experiments, error bars represent the standard error of the mean; filled bars 
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for protease constructs, empty bars for mock constructs, brackets above the paired bars 
denote the corresponding fold change in slope. Constructs used: pPRO24_MBP-TVMVsSH3L-
TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep pCtrl2_T7.03_U9_myc-SH3-
mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118-134, pCtrl2_T7.03_U9_myc-SH3-
mNG-TVMVLVA, pCtrl2_mKOκ. Protein Sequences are stated in the supplement (see 13.4.4)
 ..................................................................................................................................... 56 
Figure 21 Effectiveness of SH3-based recruitment on assay dynamics. Constructs, colors and 
symbols as in Figure 20. A: The activity of protease constructs with and without SH3 ligand 
(green triangles) were compared. B: Realtime data of the protease activity dependent 
alteration in sensor fluorescence over time, sensor constructs are noted above the 
corresponding graph, data points represent the mean values of dependent biological 
quadruplicates measured, error areas depict the SEM in colors matching the corresponding 
data set, dark checked areas belong to data sets of active proteases, plain areas belong to 
inactive proteases. C: comparison of the slopes the increase in normalized mNG 
fluorescence, bars represent the mean slope of the dependent biological quadruplicates 
measured over the time interval between 2 h and 5 h, error bars depict the SEM, filled bars 
show slopes for protease constructs with the strong SH3 ligand fused to the N-terminus of 
the protease, empty bars show the slops for the corresponding protease constructs without 
any SH3 ligand fused. Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, 
pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-Strep, 
pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118.134, pCtrl2_T7.03_U9_myc-SH3-mNG-
TVMVLVA, pCtrl2_mKOκ. Protein Sequences are stated in the supplement (see 13.4.4 and 
13.4.5).......................................................................................................................... 57 
Figure 22 Comparison of the E118-134 C-degron with its triple minimal version and the LVA 
C-degron. Constructs, colors and symbols as in Figure 20, except triple minimal E118-134 
C-degron (E118min)3 (striped dark green bars). A: Schematic depiction of the experiment, 
three different degrons and two different linkers connecting the cleavage site and the 
degron were tested. B: Fold changes in slope of the increase in protease dependent mNG 
fluorescence ordered by linker degron combination tested, bars represent the mean slope 
of dependent biological quadruplicates measured; error bars represent the SEM (original 
curves from which the slopes were calculated can be found in Figure S18). Constructs 
used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118.134, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-
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TVMV(E118min)3, pCtrl2_T7.03_U9_mKOκ.  Protein Sequences are stated in the 
supplement (see 12.4.5) ............................................................................................... 59 
Figure 23 Ratiometric in vivo protease assay based on a cryptic N-degron. A: Schematic 
depiction of the experiments. B: Results for the best performing combination of sSH3L-
TVMV and mNG-SH3-TVMVFLFVQ-mCh. Data points represent the mean of dependent 
biological triplicates, error bars as colored area represents the SEM, dark checkered areas 
belong to active protease constructs, plain areas belong to inactive protease constructs. 
Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-
TVMVC151A-Strep pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVFLFVQ-mCh-Strep. Protein 
sequences are stated in the supplement (see 13.4.7) ..................................................... 62 
Figure 24 Orientation screen for the ratiometric in vivo protease assay based on cryptic N-
degrons. A: Schematic depiction of the experiment. B: Comparison of the slopes of the 
linear increase in normalized mCh fluorescence for the orientation screen. The protease 
constructs used are stated above the corresponding graph, while the sensors are listed on 
the X-axis, bars represent the mean slopes for the dependent biological triplicates 
measured; error bars depict the SEM, filled bars for the active TVMV, empty bars for the 
mock controls TVMVC151A, brackets above the paired bars state the fold change in slope 
between a protease and its corresponding mock construct. Constructs used: 
pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, 
pPRO24_MBP-TVMVwSH3L-TVMV-Strep, pPRO24_MBP-TVMVwSH3L-TVMVC151A-Strep, 
pPRO24_MBP-TVMVTVMV-sSH3L-Strep, pPRO24_MBP-TVMVTVMVC151A-sSH3L-Strep, 
pPRO24_MBP-TVMVTVMV-wSH3L-Strep, pPRO24_MBP-TVMVTVMVC151A-wSH3L-Strep, 
pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVFLFVQ-mCh-Strep, pCtrl2_T7.03_U9_myc-mNG-
SH3-TVMVYLFVQ-mCh-Strep. Protein Sequences are stated in the supplement (see 12.4.7)
 ..................................................................................................................................... 63 
Figure 25 Effectiveness of SH3-based recruitment on ratiometric assay dynamics. Constructs, 
colors and symbols as in Figure 24, except no SH3 ligands protease constructs were 
included as well (upside down triangles) and grey coloration for normalized mCh 
fluorescence replaced with red. A: Schematic depiction of the experiment. The effect of the 
sSH3L ligand on the dynamics of the assay was tested B: Real-time kinetic data of the 
protease-dependent development in the fluorescent signal over time, sensor construct is 
indicated above the graph, data points represent the mean values of dependent biological 
quadruplicates measured, error areas depict the SEM. C: bars represent the mean slope in 
normalized mCh fluorescence of the dependent biological quadruplicates measured over 
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the time interval between 2 h and 5 h, error bars depict the SEM, grey bars show slopes for 
protease constructs (mCh/red fluorescence is lost through proteolytic activity), red bars 
show the slopes for the corresponding mock constructs (mCh/red fluorescence is retained 
without proteolytic activity), brackets over the paired bars state the fold change in protease 
dependent reduction in slope of the increasing normalized mCh fluorescence compared to 
the respective mock construct TVMVC151A. Constructs used: pPRO24_MBP-TVMVsSH3L-
TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-Strep, 
pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVYLFVQ-mCh-
Strep. Protein sequences are stated in the supplement (see 12.4.7). .............................. 65 
Figure 26 Comparison of the lonp+ K-strains Shuffle T7 and KRX. A: Schematic depiction of the 
experiment, the assay design was based on the C-degron based assay presented in Chapter 
4.2 except for the following changes: (i) the non-beneficial recruitment domains were 
omitted, (ii) mNG was replaced with mCh to reduce any background fluorescence 
associated with riboflavin. B: mCh fluorescence normalized to OD600 over time, strain used 
stated above the corresponding graph, data points represent the mean of the dependent 
biological quadruplicates measured, error areas depict the SEM. C: Bars represent the 
average of dependent biological quadruplicates measured; error bars represent the SEM, 
pairwise bars for TVMV and corresponding mock construct showing the slope of the linear 
increase in normalized mCh fluorescence, brackets denoted the fold change in slope 
between paired bars. Constructs used: pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-
TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-TVMV, pCtrl2_T7.03_U9_myc-mCh-
TVMVLVA. Protein Sequences are stated in the supplement (see 13.4.8). ......................... 67 
Figure 27 Validation of the mCh sensor in a BL21(DE3) genetic background. Constructs, colors, 
symbols as in Figure 26. A: schematic depiction of the experiment. B: Real-time 
normalized mCh fluorescence over six hours after induction of the mCh sensor following a 
two hour pre-induction of the protease; Data points represent the mean values for the 
dependent biological quadruplicates measured, error areas depict the SEM; C: Slope of the 
linear increase in mCh fluorescence between 3 and 5 hours, bars represent the mean slope 
of the dependent biological quadruplicates measured, filled bars: active protease, empty 
bars: inactive protease TVMVC151A (mock control), error bars depicted the SEM, brackets 
above the paired bars depict the fold change in slope between a protease construct and its 
corresponding mock control. Constructs used: pPRO24_MBP-TVMVTVMV-Strep, 
pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-TVMV, 
pCtrl2_T7.03_U9_myc-mCh-TVMVLVA. Protein Sequences are stated in the supplement (see 
13.4.8).......................................................................................................................... 68 
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Figure 28 Direct comparison of three different proteases with the LVA C-degron based assay. 
A: Schematic depiction of the experiment: The basic C-degron assay was performed as 
explained in Chapter 4.2 with three site-specific proteases TEV, TVMV and HCV in direct 
comparison. B: Real-time kinetic data of in vivo protease activity measured over the course 
of 8 hours; Colors and symbols as in Figure 15, proteases and corresponding inactive 
variants are listed above the corresponding graphs, sensors are listed in the central legend, 
data points represent the mean values of dependent biological quadruplicates measured, 
error areas depict the SEM. C: Fold changes between active and inactive protease variant, 
bars represent the mean slopes of the protease dependent increase in mNeonGreen 
fluorescence, error bars depict the SEM, filled bars for active proteases, empty bars for 
inactive proteases, brackets above the paired bars state the corresponding fold changes in 
slope. Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-
TVMVC151A-Strep, pPRO24_MBP-TVMVsSH3L-TEV-Strep, 
pPRO24_MBP-TVMVsSH3LTEVC151A-Strep, pPRO24_MBP-TVMVsSH3L-HCV-Strep, 
pPRO24_MBP-TVMVsSH3L-HCVS152A-Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-TEV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TEVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA, pCtrl2_mKOκ. Protein Sequences are stated in 
the supplement (see 13.4.9). TEV and HCV related constructs were cloned by C. 
Rühmkorff; all data shown in this figure were generated by C. Rühmkorff under my 
supervision. ................................................................................................................... 70 
Figure 29 Western blot analysis of protease expression under assay conditions. Double 
transformed E. coli BL21(DE3) cultures were grown in M9 at 37 °C for 2 h. Subsequently, 
protease expression was induced with 25 mM sodium propionate and cultures were 
incubated at 30 °C. Another two hours later, the expression of the sensor was induced with 
1 mM IPTG. Samples were taken before protease induction (2h timepoint), before sensor 
induction (4h timepoint) and 6 h after sensor induction (10 h timepoint, the usually 
endpoint of the in vivo assays). Then 20 µL cell suspension with an OD600 = 5 were loaded 
per lane. The pictograms to the right of the individual Western blots show the expected 
protease bands, the upper band around 68 kDa when the MBP solubility tag is not cleaved 
off and the lower band around 28 kDa for the autocatalytically processed protease 
construct. The weak band at 35 kDa belongs to BirA which corresponds to the the biotin 
ligase of E. coli and is always detected through Strep-Tactin. The +/- refers to the presence 
of the LVA C-Degron in the co-expressed sensor constructs. The expression of the sensor 
was generally included to fully mimic the assay conditions during expression tests. 
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Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-
TVMVC151A-Strep, pPRO24_MBP-TVMVsSH3L-TEV/-Strep, 
pPRO24_MBP-TVMVsSH3L-TEVC151A-Strep, pPRO24_MBP-TVMVsSH3L-HCV-Strep, 
pPRO24_MBP-TVMVsSH3L-HCVS152A-Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-TEV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TEVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, 
pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA. Protein Sequences are stated in supplement (see 
13.4.9). TEV and HCV related constructs were cloned by C. Rühmkorff; all data shown in 
this figure were generated by C. Rühmkorff under my supervision. ............................... 71 
Figure 30 Engineering a blue light switchable TVMV. A: A blue light activated photoreceptor 
(nMag/pMag) is inserted between TVMV and the corresponding auto-inhibitor domain 
(AI); The three linkers interconnecting the photoreceptors, the AI domain and TVMV were 
recombined through a focused library (see Table 5); Upon irradiation with blue light at 
approx. 460 nm, the two opposite magnet domains form a heterodimer and, in this way, 
dislodge the AI domain from the TVMV active site; Active TVMV cleaves off the C-degron 
from the mCh sensor (see Chapter 4.4). B: results of the initial screening of 87 clones in 
96 well plate format, dark grey bars show mCh fluorescence prior to irritation, light blue 
bar shown mCh fluorescence after 12 cycles of 5 min irradiation with blue light (approx. 
460 nm, custom made device) and subsequent 30 min incubation in the dark (inside 
TECAN Spark reader) mCh fluorescence was quantified at 0, 15 and 30 min of incubation 
in the dark; 3 dependent biological triplicates of TVMVC151A and mCh-TVMVLVA served as 
negative controls (grey arrows), 3 dependent biological replicates of TVMV and mCh-TVMV 
served as positive control (light red bars instead of light blue bars), and 3 dependent 
biological triplicates of TVMV and mCh-TVMVLVA served as reference for full TVMV activity 
(dark red bars instead of light blue bars, 1 replicate did not display any fluorescence and 
is excluded), orange box shows the clones picked for a retest on the following day. C: 
results of the control measurement with no irradiation during measurements, datapoint 
represent individual clones, legend at the bottom refers to both graphs. Constructs used: 
pPRO24_MBP-TVMVTVMV-Strep, pPRO24_MBP-TVMVTVMVC151A-Strep, 
pCtrl2_T7.03_U9_myc-mCh-TVMV, pCtrl2_T7.03_U9_myc-mCh-TVMVLVA., pDESTara2_MBP-
TVMVAI-L1-nMagHigh1-L2-pMagFast2-L3-TVMV-Strep. Protein Sequences are stated in 
supplement (see 13.4.10). ............................................................................................ 79 
Figure 31 Second screening of the blue light switch library wit pre-incubation in the dark to 
filter out constitutive active variants. A: Schematic depiction of the experiment, same as in 
Figure 30. B: mCh fluorescence after six-hour incubation in the dark of 87 randomly picked 
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clones, controls as in Figure 30, except exclusively final fluorescence values plotted and 
light blue bars show picked clones. C: Results of the control measurement with the 9 picked 
clones, blue bars 12 cycles of 5 min irradiation and 30 min incubation in the dark, dark 
grey bars constantly in the dark. Constructs used: pPRO24_MBP-TVMVTVMV-Strep, 
pPRO24_MBP-TVMVTVMVC151A-Strep, pCtrl2_T7.03_U9_myc-mCh-TVMV, 
pCtrl2_T7.03_U9_myc-mCh-TVMVLVA., pDESTara2_MBP-TVMVAI-L1-nMagHigh1-L2-
pMagFast2-L3-TVMV-Strep. Protein Sequences are stated in the supplement (see 13.4.10).
 ..................................................................................................................................... 80 
Figure 32 Preliminary results for the two-protease signal transducer. A: Schematic depiction of 
the design principle of the signal transducer: In the default state, the C-degron tagged HCV 
sensor is co-expressed with auto-inhibited HCV; Accordingly, no fluorescent signal is 
generated; In presence of TVMV, the AI domain is cleaved off and active HCV can now 
remove the C-degron which leads to increase in the mNG-dependent fluorescent signal. B: 
The three graphs show the protease dependent mNG fluorescence over the course of 8 
hours. HCV constructs were pre-produced from pPRO24 for 2 hours (25 mM sodium 
propionate) before the sensor and a chromosomal-integrated variant of TVMV was induced 
with 500 µM IPTG (both T7.03 promoter, sensor additional U9 RNA thermometer); data 
points represent the mean values for the dependent biological quadruplicates measured, 
error areas depict the SEM, sensor constructs stated above the corresponding graph, 
bottom left legend refers to all graphs. Left: positive controls without any degron attached. 
Right: actual data with LVA C-degron present, the lower right graph shows the same data 
as the upper right one except the active HCV reference was removed to better visualize the 
differences between HCVS152A and AI-TVMVHCV / AI-TVMVHCVS152A. Constructs used: 
pPRO24_MBP-HCVHCV-Strep, pPRO24_MBP-HCVHCVS152A-Strep, pPRO24_MBP-
HCVAI(HCV)-TVMVHCV-Strep, pPRO24_MBP-HCVAI(HCV)-TVMVHCVS152A-Strep, 
pCtrl2_T7.03_U9_myc-SH3-mNG-HCV, pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA. Protein 
Sequences are stated in the supplement (see 13.4.11). ................................................. 86 
Figure 33 Vector map of pPRO24 (Addgene 17805, [87]). The vector comprises of two class A 
origins of replication, an ampicillin resistance cassette and a propionate inducible 
expression cassette. The expression cassette includes the promoter region of the propionate 
operon (prpBCDE) of E. coli and the repressor gene of the propionate operon prpR. Figure 
generated with SnapGene (GSL Biotech LLC). ............................................................... 91 
Figure 34 Vector map of pCtrl2 (W. Weber unpublished results). The vector comprises of the 
class B origin of replication p15A, a chloramphenicol resistance cassette and a lactose/IPTG 
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inducible expression cassette. The expression cassette includes the promoter of the T7 
phage and the operator of the E. coli lac operon (lacZYA) and the repressor gene of the lac 
operon lacI (lacI includes W220F mutation for reduced leaky expression). Figure generated 
with SnapGene (GSL Biotech LLC). ............................................................................... 93 
Figure 35 Vector map of pDESTara2 (A. Gräwe, unpublished results). The vector comprises of 
a class A origin of replication, an ampicillin resistance cassette and an arabinose inducible 
expression cassette. The expression cassette includes the promoter of the arabinose operon 
of E. coli (araBAD) and the repressor gene of the arabinose operon araC. The MCS includes 
a stuffer sequence for better differentiation of NheI…BtsI restriction fragment from 
unrestricted vector during electrophoresis. Figure generated with SnapGene (GSL Biotech 
LLC). ............................................................................................................................. 94 
Figure 36 DNA size standards. [Figure gladly adopted from New England Biolabs; source: 
https://www.nebiolabs.com.au/-/media/nebus/page-images/newsized-brochure-
images/markers-and-ladders/dna_markers.png?la-en&rev-
ee28084199b247588a9cfda1292e0b78&hash-
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13.2. Supplementary Figures 
13.2.1. Orientation screen FKBP/FRB 
 
Figure S1 TVMV-FRB and FRB-TVMV probed with FKBP-mNeonGreen-TVMVE118-134 sensor. Top: without addition of 
Rapamycin. Bottom: With addition of 250 nM Rapamycin. Left: FRB-TVMV with FRB-mock control with and without 
degron present at the sensor. Right: TVMV-FRB with mock-FRB control with and without degron present at the 
sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, green: 
degron present at the sensor. Constructs used: pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMVE118-134, 
pCtrl2_mKOκ, pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pPRO24_MBP-TVMVFRB-TVMV, 
pPRO24_MBP-TVMVFRB-TVMVC151A. 
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Figure S2 TVMV-FKBP and FKBP-TVMV probed with FRB-mNeonGreen-TVMVE118-134 sensor. Top: without addition 
of Rapamycin. Bottom: With addition of 8 µM Rapamycin. Left: TVMV-FKBP with FRB-mock control with and without 
degron present at the sensor. Right: FKBP-TVMV with mock-FRB control with and without degron present at the 
sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, green: 
degron present at the sensor. Constructs used: pCtrl2_FRB-mNG-TVMV, pCtrl2_FRB-mNG-TVMVE118-134, pCtrl2_mKOκ, 
pPRO24_MBP-TVMVTVMV-FKBP, pPRO24_MBP-TVMVTVMVC151A-FKBP, pPRO24_MBP-TVMVFKBP-TVMV, pPRO24_MBP-TVMVFKBP-
TVMVC151A. 
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Figure S3 FRB-TVMV and TVMV-FRB probed with mNeonGreen-FKBP-TVMVE118-134 sensor. Top: without addition of 
Rapamycin. Bottom: With addition of 250 nM Rapamycin. Left: FRB-TVMV with FRB-mock control with and without 
degron present at the sensor. Right: TVMV-FRB with mock-FRB control with and without degron present at the 
sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, green: 
degron present at the sensor. Constructs used: pCtrl2_mNG-FKBPTVMV, pCtrl2_ mNG-FKBPTVMVE118-134, 
pCtrl2_mKOκ, pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pPRO24_MBP-TVMVFRB-TVMV, 
pPRO24_MBP-TVMVFRBd-TVMVC151A. 
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Figure S4 FKBP-TVMV and TVMV-FKBP probed with mNeonGreen-FRB-TVMVE118-134 sensor. Top: without addition 
of Rapamycin. Bottom: With addition of 8 µM Rapamycin. Left: FKBP-TVMV with FKBP-mock control with and 
without degron present at the sensor. Right: TVMV-FKBP with mock-FKBP control with and without degron present 
at the sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, 
green: degron present at the sensor. Constructs used: pCtrl2_mNG-FRBTVMV, pCtrl2_mNG-FRBTVMVE118-134, 
pCtrl2_mKOκ, pPRO24_MBP-TVMVTVMV-FKBP, pPRO24_MBP-TVMVTVMVC151A-FKBP, pPRO24_MBP-TVMVFKBP-TVMV, 
pPRO24_MBP-TVMVFKBP-TVMVC151A. 
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Figure S5 FRB-TVMV and TVMV-FRB probed with mNeonGreen-TVMVFKBP-E118-134 sensor. Top: without addition of 
Rapamycin. Bottom: With addition of 250 nM Rapamycin. Left: FRB-TVMV with FRB-mock control with and without 
degron present at the sensor. Right: TVMV-FRB with mock-FRB control with and without degron present at the 
sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, green: 
degron present at the sensor. Constructs used: pCtrl2_mNG-TVMVFKBP, pCtrl2_mNG-TVMVFKBP-E118-134, 
pCtrl2_mKOκ, pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pPRO24_MBP-TVMVFRB-TVMV, 
pPRO24_MBP-TVMVFRB-TVMVC151A. 
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Figure S6 FKBP-TVMV and TVMV-FKBP probed with mNeonGreen-TVMVFRB-E118-134 sensor. Top: without addition 
of Rapamycin. Bottom: With addition of 8 µM Rapamycin. Left: FKBP-TVMV with FKBP-mock control with and 
without degron present at the sensor. Right: TVMV-FKBP with mock-FKBP control with and without degron present 
at the sensor. Filled triangles: active protease, empty triangles: mock protease, grey: no degron present at the sensor, 
green: degron present at the sensor. 
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13.2.2. IPTG - Titration 
 
Figure S7 IPTG concentration from 1.95 µM to 0.03 µM in 1:4 dilution steps. Constructs, colors and symbols as in 
Figure 13. A: Schematic depiction of the experiment. B: Experimental results for the lowest IPTG concentrations 
tested. Constructs used: pPRO24_MBP-TVMVTVMV-FRB, pPRO24_MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, 
pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ Protein Sequences are stated in supplement (see 13.4.1). 
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13.2.3. Orientation screen C-degron based assay with SH3 based recruitment 
 
Figure S8 Fluorescence rescue assay with two C-degrons. Results for N-terminal SH3 Ligand combined with 
mNeonGreen-SH3-TVMVdegron orientation. 
 
Figure S9 Fluorescence rescue assay with two C-degrons. Results for N-terminal SH3 Ligand combined with 
mNeonGreen-TVMVSH3-degron orientation. 
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Figure S10 Fluorescence rescue assay with two C-degrons. Results for N-terminal SH3 Ligand combined with 
SH3-mNeonGreen-TVMVdegron orientation. 
 
 
Figure S11 Fluorescence rescue assay with two C-degrons. Results for C-terminal SH3 Ligand combined with 
mNeonGreen-SH3-TVMVdegron orientation. 
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Figure S12 Fluorescence rescue assay with two C-degrons. Results for C-terminal SH3 Ligand combined with 
mNeonGreen-TVMVSH3-degron orientation. 
 
Figure S13 Fluorescence rescue assay with two C-degrons. Results for C-terminal SH3 Ligand combined with 
SH3-mNeonGreen-TVMVdegron orientation. 
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13.2.4.  New C-degron LVA – raw data 
 
Figure S14 Fluorescence rescue assay with two C-degrons. Results for the re-tested orientation of sSH3L-protease and 
SH3-mNeonGreen-TVMVC-degron. 
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13.2.5. Optimizing the expression of the protease sensor 
 
Figure S15 Expression control of the considered pCtrl2. Graphs depicted the fluorescence intensities for the mKOκ 
reporter gene under control of two different T7 promoter variants and two different ribosome biding sites (RBS). T7.wt_sRBS 
is the native pCtrl2 vector architecture. T7.100 is the same wild type promoter but with reduced distance between lac 
operator and RBS, T7.03 poses a T-to-C two nucleotides upstream of the transcription start, U9 is a synthetic RNA 
thermometer that masks the Shine-Dalgarno (SD) sequence with an anti-SD sequence via stem loop formation at 
temperatures below 37 °C. Data points depict the mean values measured for dependent biological quadruplicates measured, 
error bars/areas show the standard error of the mean (SEM). Top: Graphs show mKOκ reporter fluorescence after the first 3 
hours of induction with 500 µM IPTG, on the left including the native pCtrl2 (named T7.wt_sRBS in this data set) and on the 
right without the native pCtrl2 for better differentiation of the considered pCtrl2 variants. Bottom: Bar plots show the 
fluorescence after 3 hours, error bars depict the SEM, on left including native pCtrl2 and on the right without it for better 
differentiation of the considered pCtrl2 variants. All data shown here were generated by W. Weber the creator of pCtrl2 and 
all its variants. 
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Figure S16 Comparison of all three considered pCtrl2 variants using the E118-134 C-Degron. Symbols, colors and 
constructs as in Figure 16. Transcription was reduced either by reducing the distance between T7 promoter and Start-
Codon (T7.wt to T7.100) or by introducing a mutation to the native T7 promoter that reduced transcription to 
approx. 3 % [84]; alternatively the previously used RBS (sRBS) was replaced with the synthetic U9 RNA thermometer 
that possessed a approx. 5 % probability to adopt the open conformation at 30 °C [93]; Data points represent the 
mean values of dependent biological triplicates measured, the error areas depict the SEM, pCtrl2 derivate used stated 
above the corresponding graph, legend at the bottom refers to all graphs. Constructs used: pPRO24_MBP-TVMVTVMV-
FRB, MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-E118-134, pCtrl2_mKOκ, 
pCtrl2_T7.100_FKBP-mNG-TVMV, pCtrl2_T7.100_FKBP-mNG-TVMV-E118-134, pCtrl2_T7.100_mKOκ, 
pCtrl2_T7.03_sRBS_FKBP-mNG-TVMV, pCtrl2_ T7.03_sRBS_FKBP-mNG-TVMV-E118-134, pCtrl2_ T7.03_sRBS_mKOκ, 
pCtrl2_T7.03_U9_FKBP-mNG-TVMV, pCtl2_T7.03_U9_FKBP-mNG-TVMVE118-134, pCtrl2_T7.03_U9_mKOκ Protein 
Sequences are stated in supplement (see 13.4.3). 
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Figure S17 Comparison of all three considered pCtrl2 variants using the LVA C-Degron. Symbols, colors and constructs 
as in Figure 16. Transcription was reduced either by reducing the distance between T7 promoter and Start-Codon 
(T7.wt to T7.100) or by introducing a mutation to the native T7 promoter that reduced transcription to approx. 3 % 
[84]; alternatively the previously used RBS (sRBS) was replaced with the synthetic U9 RNA thermometer that 
possessed a approx. 5 % probability to adopt the open conformation at 30 °C [93]; Data points represent the mean 
values of dependent biological triplicates measured, the error areas depict the SEM, pCtrl2 derivate used stated 
above the corresponding graph, legend at the bottom refers to all graphs. Constructs used: pPRO24_MBP-TVMVTVMV-
FRB, MBP-TVMVTVMVC151A-FRB, pCtrl2_FKBP-mNG-TVMV, pCtrl2_FKBP-mNG-TVMV-LVA, pCtrl2_mKOκ, 
pCtrl2_T7.100_FKBP-mNG-TVMV, pCtrl2_T7.100_FKBP-mNG-TVMV-LVA, pCtrl2_T7.100_mKOκ, pCtrl2_T7.03_sRBS_FKBP-
mNG-TVMV, pCtrl2_ T7.03_sRBS_FKBP-mNG-TVMV- LVA, pCtrl2_ T7.03_sRBS_mKOκ, pCtrl2_T7.03_U9_FKBP-mNG-TVMV, 
pCtl2_T7.03_U9_FKBP-mNG-TVMVLVA, pCtrl2_T7.03_U9_mKOκ Protein Sequences are stated in supplement (see 
13.4.3). 
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13.2.6. Triple minimal E118-134 – raw data 
 
Figure S18 Comparison of the E118-134 C-degron with its triple minimal version and the LVA C-degron raw data. 
Constructs, colors and symbols as in Figure 22. Graphs depict the real-time data of the protease activity dependent 
alteration in mNGs fluorescence, the respective sensors used shown in the respective pictograms, data points 
represent the mean values of dependent biological quadruplicates measured, error areas depict the SEM, the legend 
uses placeholder colors for the constructs with degrons fused, in the respective graph the placeholder colors are 
replaced with the colors according to degron (matching Figure 22, excepts striped bars for (E118min)3 are replaced 
with half-filled triangles). Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-
TVMVC151A-Strep, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVE118.134, 
pCtrl2_T7.03_U9_myc-SH3-mNG-TVMVLVA, pCtrl2_T7.03_U9_myc-SH3-mNG-TVMV(E118min)3, 
pCtrl2_T7.03_U9_mKOκ.  Protein Sequences are stated in the supplement (see 12.4.5) 
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13.2.7. Orientation Screen ratiometric 
 
Figure S19 Raw data Orientation screen ratiometric in vivo protease assay based on cryptic N-degrons. A: Schematic 
depiction of the experiment. B: Normalized mCherry fluorescences order by combination of relative orientations, 
data points represent the mean values of the dependent biological triplicates measured, error areas depict the SEM. 
Constructs used: pPRO24_MBP-TVMVsSH3L-TVMV-Strep, pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep, 
pPRO24_MBP-TVMVwSH3L-TVMV-Strep, pPRO24_MBP-TVMVwSH3L-TVMVC151A-Strep, pPRO24_MBP-TVMVTVMV-sSH3L-
Strep, pPRO24_MBP-TVMVTVMVC151A-sSH3L-Strep, pPRO24_MBP-TVMVTVMV-wSH3L-Strep, 
pPRO24_MBP-TVMVTVMVC151A-wSH3L-Strep, pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVFLFVQ-mCh-Strep, 
pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVYLFVQ-mCh-Strep. Protein Sequences are stated in the supplement (see 12.4.7) 
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13.2.8. Preliminary Results opto-switch – custom-made blue LED panel 
 
Figure S20 Custom-made LED panel for irradiating the blue light switch library. 
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13.3. Supplementary Methods 
13.3.1. Modified clonetegration protocol 
All credit for this modified protocol goes to our former master student Mr. Markus Röder. The 
original protocol is found in One-Step Cloning and Chromosomal Integration of DNA by St. 
Pierre et al., 2013, ACS Synth. Biol. 2013, 2, 537−541. 
http://pubs.acs.org/doi/abs/10.1021/sb400021j 
Introduction 
One-step cloning and chromosomal Integration of DNA is a method for integration DNA into 
prokaryotic chromosomes that approaches the simplicity of cloning DNA within 
extrachromosomal vectors. With a single transformation step, efficient integration is achieved. 
Therefore, the working group developed new vectors combining integrase-expression and 
integration plasmid: One-Step Integration Plasmid, pOSIP (Figure S21). 
 
Figure S21 Plasmid map of pOSIP-CH. Created with SnapGene. 
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The genes for ccdb and ori resemble the multiple cloning site. For chromosomal integration, 
both ccdb and ori have to be deleted. ccdb is a potent toxin preventing usual cloning and 
expression strains from growing. The ori is not needed anymore since you only want colonies 
with successful integration. Note, that a second ori (R6Kγ ori) is present. The pir-dependent 
R6Kγ origin is unnecessary for clonetegration, but allows the user to maintain a plasmid version 
of the pOSIP clone in a pir-containing strain (E. coli BW23474 is able to propagate this ori and 
is currently available in the working group of Stein). The multiple cloning site is flanked by 
forward and reverse transcription terminators to isolate integrated OSIP plasmid from 
transcription in chromosomal regions flanking integration site and vice versa. The arrangement 
of terminators is depicted in Figure S22. 
 
Figure S22 The identity and direction of the transcriptional terminators protecting the cloning module of pOSIP are 
shown. 
For plasmid propagation of original pOSIPS, use a ccdb resistant E. coli strain (e.g. DB3.1). See 
Table S1 for OSIP plasmids which are currently used in the working group of Stein. DB3.1 is 
also available. 
Table S1 Details of OSIP plasmids currently available in the working group of Stein 
Plasmid Origin of 
integrase 
E. coli strain 
for 
propagation 
Antibiotics Growth 
temperature 
Copy 
number 
Addgene links 
pOSIP-
CH 
HK022 DB 3.1 chloramphenicol 30 °C high 
copy 
http://www.addgene.org/45980/ 
 
pOSIP-
KO 
186 DB 3.1 kanamycin 30 °C high 
copy 
http://www.addgene.org/45985/ 
 
pE-FLP - E811 ampicillin 
50 µg/ml 
30 °C low 
copy 
http://www.addgene.org/45978/ 
 
The integration of properly assembled pOSIP-insert molecules occurs during post-
transformation outgrowth. Verification of integration can be performed by colony PCR using 
sets of primers that were optimized from the original CRIM set. In this work, primers for colony 
PCR are modified for E. coli BL21(DE3). When using a different strain check for primer binding 
first. 
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Methods 
One-Step chromosomal integration 
Like standard plasmid cloning, clonetegration requires the initial assembly of one or multiple 
DNA fragments into pOSIP using one’s favourite cloning technique, such as Gibson assembly, 
Clonetech In-Fusion®, or traditional restriction digest and ligation. Resulting cloning mixtures 
are then directly transformed into chemically competent E. coli BL21(DE3) cells. You can also 
use electro-competent cells for higher efficiency. After transformation, let your cells regenerate 
at 37 °C for 1 h under shaking like a “normal” transformation. Integration of properly assembled 
pOSIP-insert molecules occurs during post-transformation outgrowth at 30 °C. Use 15 µg/ml 
chloramphenicol or kanamycin only. Due to low copy number of antibiotic resistance 
transcripts, growth will be slow and can take up to 20 h until colonies show up. 
Verification of integration 
For verification of integration use the cost-efficient colony PCR. The colony PCR is designed to 
run with four primers simultaneously resulting in two PCR products. Primer arrangement is 
shown in Figure S23. 
 
Figure S23 Following successful site-specific recombination between the pOSIP attP sequence and chromosomal attB 
site, single integration produces two fragments, one from P1 and P2, and one from P3 and P4. Blue (genome), grey 
circles (attP and attB sites), green (FRT sites), beige (integration module), red (terminators), light blue (insert). P is 
for primer. 
Following primers are currently available (Table S2). 
Table S2 Primer sequences for colony PCR and insert extraction for BL21(DE3) strain. 
Primer name Primer sequence (5’->3’) Use for plasmid 
P2 seq pOSIPs ACTTAACGGCTGACATGG all 
P3 seq pOSIPs ACGAGTATCGAGATGGCA all 
P1 seq HK022 GGAATCAATGCCTGAGTG pOSIP-CH 
P4 seq HK022 GGCATCAACAGCACATTC pOSIP-CH 
P1 seq 186_IS2 CCCTGGAGCCAAAATATCC pOSIP-KO 
P4 seq 
186_IS2_mod 
TCCGGAATGCCCGCATTG pOSIP-KO 
pOSIP seq for CAAGAATTAATTCCCAATTCCCCAGG all 
pOSIP seq rev ATTACTCAACAGGTAAGGCG all 
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When using pOSIP-CH use primers P2 seq pOSIPs, P3 seq pOSIPs, P1 seq HK022 and P4 seq 
HK022. When using pOSIP-KO use primers P2 seq pOSIPs, P3 seq pOSIPs, P1 seq 186_IS2 and 
P4 seq 186_IS2_mod. All primers can be found in the “clonetegration” box in a -20 °C freezer.  
You can use the following pipette scheme and cycling program (adjusted to Phusion 
polymerase):  
Table S3 Pipette scheme and cycling program for colony PCR 
 
 
 
 
 
Note, that the elongation time is independent of your insert and does not need further 
adjustment. 
The use of different pOSIPs will grant you bands of different sizes. For single integration 
following bands are expected (Figure S24): 
 
Figure S24 Colony-PCR of randomly picked colonies after one-step chromosomal integration. A, chromosomal 
integration with pOSIP-CH. M, SmartLadder by eurogentec; 1-5, randomly picked colonies. B, chromosomal 
integration with pOSIP-KO. M, SmartLadder by eurogentec; 1-2, randomly picked colonies. E. coli BL21(DE3) was 
used. Bp are for E. coli K12-MG1655. 
 
 
P1 (10 µM) 2.5 µl 
P4 (10 µM) 2.5 µl 
P2 (10 µM) 2.5 µl 
P3 (10 µM) 2.5 µl 
H2O 28.7 
µl 
dNTPs (10 mM) 1 µl 
HF-Buffer (10x) 10 µl 
Phusion 0.3 µl 
B A 
5 min 98 °C  
30 sec 98 °C 
30x 20 sec 50 °C 
50 sec 72 °C 
5 min 72 °C  
∞ 4 °C  
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However, as seen in Figure S24, B lane 1, only one band is shown at around 600 bp, while a 
second distinct band is missing. I encountered this numerous times that only one band was 
shown even though that both bands were shown before when testing the same clone. Hence, a 
negative colony PCR does not mean the colony is negative. You might have to consider to repeat 
the colony PCR multiple times. After checking for single integration by colony PCR you might 
want to check for activity of your protein. Furthermore, your insert should be sequenced. 
Sequencing of DNA Constructs 
For sequencing, amplify your insert from colonies by PCR. Use primers pOSIP seq for and pOSIP 
seq rev from Table S4. Choose an elongation time suitable for your insert. You can use the 
following pipette scheme and cycling program (adjusted to Phusion polymerase): 
Table S4 Pipette scheme and cycling program for PCR. 
 
 
 
 
You can simply clean your amplified product by a PCR clean-up kit and prepare it for 
sequencing. Both primers can be used for sequencing, but you will want to tick “GC-rich 
sequence” in your sequencing options. Also consider designing primers which bind within your 
insert! 
Excision of integration module 
Remember that antibiotic resistance is also integrated using pOSIPs. To excise the integration 
module, prepare chemically competent cells of your colonies containing your sequenced insert. 
Now, transform at least 50 µl of your competent cells with pE-FLP (>50 ng) to excise everything 
between the FRT sites (Figure S23 Following successful site-specific recombination between 
the pOSIP attP sequence and chromosomal attB site, single integration produces two fragments, 
one from P1 and P2, and one from P3 and P4. Blue (genome), grey circles (attP and attB sites), 
green (FRT sites), beige (integration module), red (terminators), light blue (insert). P is for 
primer. Figure S23, green arrows). After transformation, incubate your cells in SOC-medium 
for 3 h at 30 °C. This turned out to be a critical step. After regeneration, centrifuge the 
transformation mix and resuspend the pellet in a smaller volume. Now plate half of the volume 
on LB-agar plates (10 µg/ml ampicillin) and incubate your plates at 30 °C overnight. Plate 
pOSIP seq for (10 µM) 2.5 µl 
pOSIP seq rev (10 µM) 2.5 µl 
H2O 33.7 µl 
dNTPs (10 mM) 1 µl 
HF-Buffer (10x) 10 µl 
Phusion 0.3 µl 
5 min 98 °C  
30 sec 98 °C 
30x 20 sec 59 °C 
X sec 72 °C 
5 min 72 °C  
∞ 4 °C  
 
 
 191 
untransformed cells as well as a control onto plates with same antibiotic concentration. Since 
the antibiotic concentration is really low you might want to stamp your cells onto LB-agar plates 
with higher ampicillin concentration to make sure no satellite colonies show up. Also stamp 
your colonies onto LB-agar plates supplemented with either chloramphenicol or kanamycin to 
make sure the cells lost their resistance. The excision efficiency is reported to be 100%. You can 
also run a colony PCR with P1 and P4 suitable for your original plasmid. pE-FLP contains a 
temperature-sensitive replicon of pCP20, meaning that the plasmid is only propagated at 30 °C. 
Simply grow your colonies at 37 °C to prevent any further pE-FLP propagation. Inoculate 5 ml 
LB-media without antibiotics with a colony and incubate it overnight at 37 °C. Next day, plate 
your cells onto LB-agar plates without antibiotics, LB-agar with ampicillin (5 µg/ml, 25 µg/ml) 
and again chloramphenicol/kanamycin. Meanwhile prepare a glycerol stock of your colonies. 
When no colonies show up on plates with antibiotics you can be sure that the resistance was 
excised efficiently and that the pE-FLP plasmid is lost. 
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13.3.2. In vivo protease assays 
Plate reader specifications fluorescence rescue assay for E. coli 
Table S5 Plate reader settings for the mNG C-degron assay 
Parameter Value 
Plate [COR96fb clear bottom] - Corning 96 Flat Black 
Lid lifter No lid 
Humidity Cassette No humidity cassette 
Smooth mode Selected 
Temperature control On 
Target temperature 30 °C 
Mode Kinetic 
Kinetic duration 6 h 
Interval time 15 min 
Mode Absorbance 
Name OD600 
Measurement wavelength 600 nm 
Number of flashes 10 
Settle time 50 ms 
Mode Fluorescence Top Reading 
Name mNeonGreen 
Excitation Monochromator 
Excitation wavelength 485 nm 
Excitation bandwidth 20 nm 
Emission Monochromator 
Emission wavelength 535 nm 
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Emission bandwidth 20 nm 
Gain 70 
Mirror Automatic (Dichroic 510) 
Number of flashes 10 
Integration time 40 µs 
Lag time 0 
Settle time 0 
Z-Position 20000 µm 
Z-Position mode Manual 
Shaking (Double Orbital) Duration Continuous 
Shaking (Double Orbital) Position Current 
Shaking (Double Orbital) 
Amplitude 
1 mm 
Shaking (Double Orbital) Frequency 270 rpm 
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Plate reader setting for the ratiometric assay 
Table S6 Plate reader settings for the ratiometric mNG-mCh N-degron assay 
Parameter Value 
Plate [COR96fb clear bottom] - Corning 96 Flat Black 
Lid lifter No lid 
Humidity Cassette No humidity cassette 
Smooth mode Selected 
Temperature control On 
Target temperature 30 °C 
Mode Kinetic 
Kinetic duration 6 h 
Interval time 15 min 
Mode Absorbance 
Name OD600 
Measurement wavelength 600 nm 
Number of flashes 10 
Settle time 50 ms 
Mode Fluorescence Top Reading 
Name mNeonGreen 
Excitation Monochromator 
Excitation wavelength 485 nm 
Excitation bandwidth 20 nm 
Emission Monochromator 
Emission wavelength 535 nm 
Emission bandwidth 20 nm 
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Gain 70 
Mirror Automatic (Dichroic 510) 
Number of flashes 10 
Integration time 40 µs 
Lag time 0 
Settle time 0 
Z-Position 20000 µm 
Z-Position mode Manual 
Mode Fluorescence Top Reading 
Name mCherry 
Excitation Monochromator 
Excitation wavelength 578 nm 
Excitation bandwidth 20 nm 
Emission Monochromator 
Emission wavelength 619 nm 
Emission bandwidth 20 nm 
Gain 100 
Mirror Automatic (Dichroic 510) 
Number of flashes 10 
Integration time 40 µs 
Lag time 0 
Settle time 0 
Z-Position 20000 µm 
Z-Position mode Manual 
Shaking (Double Orbital) Duration Continuous 
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Shaking (Double Orbital) Position Current 
Shaking (Double Orbital) Amplitude 1 mm 
Shaking (Double Orbital) Frequency 270 rpm 
 
Plate reader settings for the mCherry C-degron assay 
Table S7 Plate reader settings for the mCh C-degron assay 
Parameter Value 
Plate [COR96fb clear bottom] - Corning 96 Flat Black 
Lid lifter No lid 
Humidity Cassette No humidity cassette 
Smooth mode Selected 
Temperature control On 
Target temperature 30 °C 
Mode Kinetic 
Kinetic duration 6 h 
Interval time 15 min 
Mode Absorbance 
Name OD600 
Measurement wavelength 600 nm 
Number of flashes 10 
Settle time 50 ms 
Mode Fluorescence Top Reading 
Name mCherry 
Excitation Monochromator 
Excitation wavelength 578 nm 
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Excitation bandwidth 20 nm 
Emission Monochromator 
Emission wavelength 619 nm 
Emission bandwidth 20 nm 
Gain 100 
Mirror Automatic (Dichroic 510) 
Number of flashes 10 
Integration time 40 µs 
Lag time 0 
Settle time 0 
Z-Position 20000 µm 
Z-Position mode Manual 
Shaking (Double Orbital) Duration Continuous 
Shaking (Double Orbital) Position Current 
Shaking (Double Orbital) 
Amplitude 
1 mm 
Shaking (Double Orbital) Frequency 270 rpm 
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13.4. Constructs used in this work 
The constructs used for the experiments shown in Results Chapter are listed below ordered by 
the respective figures. 
13.4.1. Figure 10 
FKBP-mNeonGreen-TVMV 
MSSGSSGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGW
EEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLEGGSGGSGVSKGEEDNMASL
PATHELHIFGSINGVDFDMVGQGTGNPNDGYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPD
GMSPFQAAMVDGSGYQVHRTMQFEDGASLTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSL
TAADWCRSKKTYPNDKTIISTFKWSYTTGNGKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTEL
KHSKTELNFKEWQKAFTDVMGMDELYKGGSGGSGETVRFQ|SGIA* 
 
Figure S25 Vector map pCtrl2_FKBP-mNG-TVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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FKBP-mNeonGreen-TVMV(E118-134) 
MSSGSSGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGW
EEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLEGGSGGSGVSKGEEDNMASL
PATHELHIFGSINGVDFDMVGQGTGNPNDGYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPD
GMSPFQAAMVDGSGYQVHRTMQFEDGASLTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSL
TAADWCRSKKTYPNDKTIISTFKWSYTTGNGKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTEL
KHSKTELNFKEWQKAFTDVMGMDELYKGGSGGSGETVRFQ|SGGAEAAAKEAAAKAGGFGTWAC
RVRASHGVCAQ* 
 
Figure S26 Vector map pCtrl2_FKBP-mNG-TVMVE118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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TVMV/TVMV(C151A)-FRB 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGETVRFQ|SGG
ASPAGGSKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHG
EFKVKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESS
HIVHKEDTSFWQHWITTKDGQC/AGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAAD
GWCKNWKFNADKISWGSFTLVEDAPEDGGASPAAPAPASPAAPAPSAPAGGILWHEMWHEGLEE
ASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDL
TQAWDLYYHVFRRIGIA* 
 
Figure S27 Vector map pPRO24_MBP-TV>MV-TVMV-FRB. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S28 Vector map pPRO24_MBP-TVMV-TVMVC151A-FRB. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.2. Figure 15 
FKBP-mNG-TVMVLVA 
MSSGSSGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGW
EEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLEGGSGGSGVSKGEEDNMASL
PATHELHIFGSINGVDFDMVGQGTGNPNDGYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPD
GMSPFQAAMVDGSGYQVHRTMQFEDGASLTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSL
TAADWCRSKKTYPNDKTIISTFKWSYTTGNGKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTEL
KHSKTELNFKEWQKAFTDVMGMDELYKGGSGGSGETVRFQ|SGGAEAAAKEAAAKAGGAANDEN
YALVAGIA* 
 
Figure S29 Vector map pCtrl2_FKBP-mNG-TVMVLVA. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.3. Figure 16 
pCtrl2_T7.03_U9_FKBP-mNG-TVMV 
 
Figure S30 Vector map pCtrl2_T7.03_U9_FKBP-mNG-TVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134 
 
Figure S31 Vector map pCtrl2_T7.03_U9_FKBP-mNG-TVMVE118-134. Figure generated with SnapGene (GSL Biotech 
LLC). 
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pCtrl2_T7.03_U9_FKBP-mNG-TVMVLVA 
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13.4.4. Figure 20 
myc-SH3-mNG-TVMV 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGETVRFQ|SGIA* 
 
Figure S32 Vector map pCtrl2_T7.03_U9_myc-SH3- mNGTVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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myc-SH3-mNG-TVMV(E118-134)/LVA 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGETVRFQ|SGGAEAAAKEAAAKAGGFGTWACRVRASHGVCAQ*/AANDENYALVA
GIA* 
 
Figure S33 Vector map pCtrl2_T7.03_U9_myc-SH3- mNGTVMVE118-134. Figure generated with SnapGene (GSL Biotech 
LLC). 
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Figure S34 Vector map pCtrl2_T7.03_U9_myc-SH3- mNGTVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVsSH3L-TVMV/TVMV(C151A)-Strep 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGETVRFQ|SGNS
SSNNNNNNNNNNGPPPPLPPKRRRGGSGGSGGSGGSGGSGGSGGSGGSGSKALLKGVRDFNPISA
CVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKVKNSTQLQMKPVEGRDIIV
IKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTSFWQHWITTKDGQ
C/AGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWKFNADKISWGSFTL
VEDAPEDGGSGGSGWSHPQFEKGIA* 
 
Figure S35 Vector map pPRO24_MBP-TVMVsSH3L-TVMV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S36 Vector map pPRO24_MBP-TVMVsSH3L-TVMVC151A-Strep. Figure generated with SnapGene (GSL Biotech 
LLC). 
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MBP-TVMVwSH3L-TVMV/TVMV(C151A)-Strep 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGETVRFQ|SGNS
SSNNNNNNNNNNGPPPALPPKKRGGSGGSGGSGGSGGSGGSGGSGGSGSKALLKGVRDFNPISAC
VCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKVKNSTQLQMKPVEGRDIIVI
KMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTSFWQHWITTKDGQC
/AGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWKFNADKISWGSFTLV
EDAPEDGGSGGSGWSHPQFEKGIA* 
 
Figure S37 Vector map pPRO24_MBP-TVMVwSH3L-TVMV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S38 Vector map pPRO24_MBP-TVMVwSH3L-TVMVC151A-Strep. Figure generated with SnapGene (GSL Biotech 
LLC). 
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13.4.5. Figure 21 
MBP-TVMVTVMV/TVMV(C151A)-Strep 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGETVRFQ|SGNS
SSNNNNNNNNNNGSKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNG
ELTIKTMHGEFKVKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKS
VSSLVSESSHIVHKEDTSFWQHWITTKDGQC/AGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKF
VATYLDAADGWCKNWKFNADKISWGSFTLVEDAPEDGGSGGSGWSHPQFEKGIA* 
 
Figure S39 Vector map pPRO24_MBP-TVMVTVMV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S40 Vector map pPRO24_MBP-TVMVTVMVC151A-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
 
 
13.4.6. Figure 22 
myc-SH3-mNG-TVMV(E118-134)/LVA/(E118min)3 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGETVRFQ|SGSGGGGFGTWACRVRASHGVCAQ*/AANDENYALVAGIA*/FGTWA
CRFGTWACRFGTWACR* 
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13.4.7. Figure 23 
myc-mNG-SH3-TVMVF/YLFVQ-mCherry-Strep 
MSSGSSGEQKLISEEDLGPGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPNDGYEEL
NLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGASLTVNY
RYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGNGKRYR
STARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKGGASPAG
GAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYGGASPAAP
APAGETVRFQ|F/YLFVQGGASPAAPAPAGVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGE
GEGRPYEGTQTAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMN
FEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQ
RLKLKDGGHYDAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDEL
YKGGSGGSGWSHPQFEKGIA*
 
Figure S41 Vector map pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVFLFVQ-mCh-Strep. Figure generated with SnapGene 
(GSL Biotech LLC). 
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Figure S42 Vector map pCtrl2_T7.03_U9_myc-mNG-SH3-TVMVYLFVQ-mCh-Strep. Figure generated with SnapGene 
(GSL Biotech LLC). 
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13.4.8. Figure 26 
myc-mCh-TVMV 
MSSGSSGEQKLISEEDLGPGVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQ
TAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVT
QDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHY
DAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKGGASPAGG
ETVRFQ|SGIA* 
 
Figure S43 Vector map pCtrl2_T7.03_U9_myc-mChTVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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myc-mCh-TVMV-LVA 
MSSGSSGEQKLISEEDLGPGVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQ
TAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVT
QDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHY
DAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKGGASPAGG
ETVRFQ|SGSGGGGAANDENYALVAGIA* 
 
Figure S44 Vector map pCtrl2_T7.03_U9_myc-mChTVMVLVA. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.9. Figure 28 
myc-SH3-mNG-TEV 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGENLYFQ|SGIA* 
 
Figure S45 Vector map pCtrl2_T7.03_U9_myc-SH3-mNG-TEV. Figure generated with SnapGene (GSL Biotech LLC). 
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myc-SH3-mNG-TEVLVA 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGENLYFQ|SGGAEAAAKEAAAKAGGAANDENYALVAGIA* 
 
Figure S46 Vector map pCtrl2_T7.03_U9_myc-SH3-mNG-TEVLVA. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TEVsSH3L-TEV/TEV(C151A)-Strep 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGENLYQ|SGNSS
SNNNNNNNNNNGPPPPLPPKRRRGGSGGSGGSGGSGGSGGSGGSGGSGGESLFKGPRDYNPISST
ICHLTNESDGHTTSLYGIGFGPFIITNKHLFRRNNGTLVVQSLHGVFKVKNTTTLQQHLIDGRDMIII
RMPKDFPPFPQKLKFREPQREERICLVTTNFQTKSMSSMVSDTSCTFPSGDGIFWKHWIQTKDGQC
/SGSPLVSTRDGFIVGIHSASNFTNTNNYFTSVPKNFMELLTNQEAQQWVSGWRLNADSVLWGGH
KVFMVKPEEPFQPVKEATQLMNELVYSQGGSGGSGWSHPQFEKGIA* 
 
Figure S47 Vector map pPRO24_MBP-TEVsSH3L-TEV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S48 Vector map pPRO24_MBP-TEVsSH3L-TEVC151A-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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myc-SH3-mNG-HCV 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGDDVTPCSM|SGIA* 
 
Figure S49 Vector map pCtrl2_T7.03_U9_myc-SH3-mNG-HCV. Figure generated with SnapGene (GSL Biotech LLC). 
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myc-SH3-mNG-HCVLVA 
MSSGSSGEQKLISEEDLGGASPAGGAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAED
SEGKRGMIPVPYVEKYGGASPAGGVSKGEEDNMASLPATHELHIFGSINGVDFDMVGQGTGNPND
GYEELNLKSTKGDLQFSPWILVPHIGYGFHQYLPYPDGMSPFQAAMVDGSGYQVHRTMQFEDGAS
LTVNYRYTYEGSHIKGEAQVKGTGFPADGPVMTNSLTAADWCRSKKTYPNDKTIISTFKWSYTTGN
GKRYRSTARTTYTFAKPMAANYLKNQPMYVFRKTELKHSKTELNFKEWQKAFTDVMGMDELYKG
GASPAAPAPAGDDVTPCSM|SGGAEAAAKEAAAKAGGAANDENYALVAGIA* 
 
 
Figure S50 Vector map pCtrl2_T7.03_U9_myc-SH3-mNG-HCVLVA. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-HCVsSH3L-HCV/HCV(S151A)-Strep 
MGSGSIGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIF
WAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKT
WEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFL
VDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGV
LSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEI
MPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTGLGGGSGGGSGGGSETGDDVTPCSM|S
GNSSSNNNNNNNNNNGPPPPLPPKRRRGGSGGSGGSGGSGGSGGSGGSGGSGAKGSVVIVGRINL
SGDTAYSQQTRGAAGIAATSATGRDKNQVDGEVQVLSTATQSFLATCVNGVCWTVYHGAGSKTLA
GPKGPITQMYTNVDQDLVGWPAPPGARSMTPCTCGSSDLYLVTRHADVIPVRRRGDSRGSLLSPRP
VSYLKGSS/AGGPLLCPSGHVVGIFRAAVCTRGVAKAVDFIPVESMETTMRGGSGGSGWSHPQFEK
GIA* 
 
Figure S51 Vector map pPRO24_MBP-HCVsSH3L-GCV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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Figure S52 Vector map pPRO24_MBP-HCVsSH3L-HCV-Strep. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.10. Figure 30 
MBP-TVMVAI-nMagHigh1-pMagF2-TVMV-Strep; clone D1 as example of the whole library 
MGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHD
RFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPA
LDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKN
KHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGIN
AASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTGNSSSNNNNNNNNNNGETVRFQ|SGSGGGGREY
VRFAPGPGHTLYAPGGYDIMGYLDQIGNRPNPQVELGPVDTSCALILCDLKQKDTPIVYASEAFLYM
TGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTINTIRKAIDRNAEVQVEVVNFKKNGQRFVN
FLTIIPVRDETGEYRYSMGFQCETEGGASPAAPAPASPAAPAPSAPAGGHTLYAPGGYDIMGYLRQIR
NRPNPQVELGPVDTSCALVLCDLKQKDTPVVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPK
STRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCETEG
GGTKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKV
KNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHK
EDTSFWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKN
WKFNADKISWGSFTLVEDAPEDGGSGGSGWSHPQFEKGIA* 
 
Figure S53 Vector map pDESTara2_MBP-TVMVAI-L1-nMagHigh1-L2-pMagFast2-L3-TVMV-Strep. Figure generated with 
SnapGene (GSL Biotech LLC). 
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13.4.11. Figure 32 
 
Figure S54 Vector map pPRO24_MBP-HCVAI(HCV)TVMVsSH3L-HCV-Strep. Figure generated with SnapGene (GSL 
Biotech LLC). 
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Figure S55 Vector map pPRO24_MBP-HCVAI(HCV)TVMVsSH3L-HCVS152A-Strep. Figure generated with SnapGene (GSL 
Biotech LLC). 
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13.4.12. Figure S1 
FKBP-mNG-TVMV 
 
Figure S56 Vector map pCtrl2_FKBP-mNG-TVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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FKBP-mNG-TVMVE118-134 
 
Figure S57 Vector map pCtrl2_FKBP-mNG-TVMVE118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVFRB-TVMV 
 
Figure S58 Vector map pPRO24_MBP-TVMVFRB-TVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVFRB-TVMVC151A 
 
Figure S59 Vector map pPRO24_MBP-TVMVFRB-TVMVC151A. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVTVMV-FRB 
 
Figure S60 Vector map pPRO24_MBP-TVMVTVMV-FRB. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVTVMVC151A-FRB 
 
Figure S61 Vector map pPRO24_MBP-TVMVTVMVC151A-FRB. Figure generated with SnapGene (GSL Biotech LLC) 
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13.4.13. Figure S2 
FRB-mNG-TVMV 
 
Figure S62 Vector map pCtrl2_FRB-mNG-TVMV Figure generated with SnapGene (GSL Biotech LLC). 
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FRB-mNG-TVMVE118-134 
 
Figure S63 Vector map pCtrl2_FRB-mNG-TVMVE118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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MBP-TVMVFKBP-TVMV 
 
Figure S64 Vector map pPRO24_MBP-TVMVFKBP-TVMV. Figure generated with SnapGene (GSL Biotech LLC) 
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MBP-TVMVFKBP-TVMVC151A 
 
Figure S65 Vector map pPRO24_MBP-TVMVFKBP-TVMVC151A. Figure generated with SnapGene (GSL Biotech LLC) 
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MBP-TVMVTVMV-FKBP 
 
Figure S66 Vector map pPRO24_MBP-TVMVTVMV-FKBP. Figure generated with SnapGene (GSL Biotech LLC) 
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MBP-TVMVTVMVC151A-FKBP 
 
Figure S67 Vector map pPRO24_MBP-TVMVTVMVC151A-FKBP. Figure generated with SnapGene (GSL Biotech LLC) 
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13.4.14. Figure S3 
For protease constructs see 13.4.12. 
mNG-FKBP-TVMV 
 
Figure S68 Vector map pCtrl2_mNG-FKBPTVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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mNG-FKBP-TVMVE118 
 
Figure S69 Vector map pCtrl2_mNG-FKBP-TVMVE118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.15. Figure S4 
For protease constructs see 13.4.13. 
mNG-FRB-TVMV 
 
Figure S70 Vector map pCtrl2_mNG-FRB-TVMV. Figure generated with SnapGene (GSL Biotech LLC). 
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mNG-FRB-TVMVE118-134 
 
Figure S71 Vector map pCtrl2_mNG-FRB-TVMVE118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.16. Figure S5 
For protease constructs see 13.4.12 
mNG-TVMVFKBP 
 
Figure S72 Vector map pCtrl2_mNG-TVMVFKBP. Figure generated with SnapGene (GSL Biotech LLC). 
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mNG-TVMVFKBP-E118-134 
 
Figure S73 Vector map pCtrl2_mNG-TVMVFKBP-E118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.17. Figure S6 
For protease constructs see 13.4.13 
 
Figure S74 Vector map pCtrl2_mNG-TVMVFRB. Figure generated with SnapGene (GSL Biotech LLC). 
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pCtrl2_mNG-TVMVFRB-E118-134 
 
Figure S75 Vector map pCtrl2_mNG-TVMVFRB-E118-134. Figure generated with SnapGene (GSL Biotech LLC). 
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13.4.18. Figure S15 
pCtrl2_mKOkappa 
Promoter region: 
T7 promoter, lac operator, RBS, start codon 
CATGGGCTGCCTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAA
TAATTTTGTTTAACTTTAAGAAGGAGATATACATATG 
 
Figure S76 Vector map pCtrl2_mKOκ. Figure generated with SnapGene (GSL Biotech LLC). 
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pCtrl2_T7.100_sRBS_mKOκ 
T7.100 promoter (wild type T7 promoter), lac operator, strong RBS, start codon 
CCATGGTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCACCGGTAAAGAGGA
GAAAGGAGCATATG 
 
Figure S77 Vector map pCtrl2_T7.100_sRBS_mKOκ. Figure generated with SnapGene (GSL Biotech LLC). 
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pCtrl2_T7.03_sRBS_mKOkκ 
Promoter region: 
T7.03 promoter, lac operator, strong RBS, start codon 
CATGGTAATACGACTCACTACAGGGGAATTGTGAGCGGATAACAATTCCACCGGTAAAGAGGAG
AAAGGAGCATATG 
 
Figure S78 Vector map pCtrl2_T7.100_sRBS_mKOκ. Figure generated with SnapGene (GSL Biotech LLC). 
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pCtrl2_T7.03_U9_mKOkκ 
Promoter region: 
T7.03 promoter, lac operator, strong RBS, start codon 
CCATGGTAATACGACTCACTACAGGGGAATTGTGAGCGGATAACAATTCCACCGGTGATCCCTCC
TTACTAGTCTGCAGAAGGAGATATACATATG 
 
Figure S79 Vector map pCtrl2_T7.100_sRBS_mKOκ. Figure generated with SnapGene (GSL Biotech LLC). 
 
